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Abstract 
 
Neural tube defects (NTD) are severe congenital abnormalities, caused by failed 
closure of the embryonic neural tube, that affect approximately 1 in 1,000 
pregnancies worldwide. There is a paucity of epidemiological and qualitative 
research on NTDs within different ethnic communities in the UK. 
 
This thesis reports the findings of a mixed methods study conducted to explore 
NTD prevalence, pregnancy outcomes and attitudes towards prevention in different 
ethnic communities. For the quantitative study, congenital anomaly data 
supplemented with Department of Health termination data were used to explore 
the NTD prevalence and pregnancy decisions by maternal ethnicity. Semi-
structured interviews, combined with grounded theory methodology, explored 
women’s pre-pregnancy knowledge, attitudes and health behaviours with regard to 
folic acid supplementation, and subsequent pregnancy decisions.  
 
After adjustment for maternal deprivation and age, NTD prevalence was found to 
be nearly twice as high in Indian mothers and almost three times as high in 
Bangladeshi mothers, as in mothers of White ethnicity. The excess was particularly 
marked in Indian mothers for non-isolated NTDs. Through qualitative interviews, 
women detailed how more information on why folic acid should be taken needs to 
be given and that health professionals (HPs), such as GPs, are the preferred 
information source. It was also indicated that HPs who rarely see children with 
spina bifida are less likely to give a balanced view of the condition, in relation to a 
decision on possible pregnancy termination.  
 
An ethnic discrepancy in prevalence being more marked for non-isolated NTDs is 
indicative of the involvement of genetic factors. Increasing folic acid use among all 
population groups is essential and targeting a culturally sensitive education 
campaign at HPs is a crucial first stage in increasing supplementation among South 
Asian mothers. It is also of critical importance that those counselling mothers when 
spina bifida is detected, are fully informed of the condition themselves. 
 
5 
 
Contents 
 
1 INTRODUCTION TO NEURAL TUBE DEFECTS (NTDS)............................................ 17 
 CONGENITAL ANOMALIES OVERVIEW ............................................................................... 17 1.1
 CLINICAL PRESENTATION OF NTDS .................................................................................. 18 1.2
 NTD EPIDEMIOLOGY .......................................................................................................... 19 1.3
 PRIMARY PREVENTION OF NTDS: THE FOLIC ACID STORY ............................................... 20 1.4
 PRIMARY PREVENTION OF NTDS: OTHER FACTORS .......................................................... 24 1.5
 SECONDARY PREVENTION OF NTDS: PRENATAL DETECTION AND TOPFA .................... 26 1.6
2 NEURAL TUBE DEFECTS (NTDS) IN DIFFERENT ETHNIC COMMUNITIES ...... 28 
 A GLOBAL PERSPECTIVE ..................................................................................................... 28 2.1
2.1.1 Indian ethnicity .............................................................................................................. 29 
2.1.2 Black ethnicity ................................................................................................................ 31 
 UK FOCUS: WHAT IS KNOWN ABOUT NTDS, SPECIFICALLY HOW THEY CAN BE 2.2
PREVENTED, IN ETHNIC COMMUNITIES IN THE UK? ...................................................................... 32 
2.2.1 NTD Prevalence and Perinatal Mortality ..................................................................... 32 
2.2.2 Prenatal Screening and Termination of Pregnancy for Fetal Anomaly (TOPFA) ........ 35 
2.2.3 Knowledge and peri-conceptional use of folic acid: A systematic review and meta-
analysis 36 
2.2.4 Knowledge and peri-conceptional use of folic acid: Research since the systematic review 
was published .............................................................................................................................. 46 
2.2.5 Discussion ...................................................................................................................... 46 
3 STUDY DESIGN AND METHODOLOGY ........................................................................ 51 
 PHD RATIONALE ................................................................................................................ 51 3.1
 OVERALL PHD AIM ........................................................................................................... 52 3.2
 PHD OBJECTIVES ................................................................................................................ 52 3.3
 MIXED METHODOLOGY ..................................................................................................... 53 3.4
3.4.1 Background .................................................................................................................... 53 
3.4.2 Justification for using mixed methods ............................................................................ 53 
3.4.3 Study design ................................................................................................................... 54 
 INFORMATION GOVERNANCE ........................................................................................... 59 3.5
4 INTRODUCTION TO THE BRITISH ISLES NETWORK OF CONGENITAL 
ANOMALY REGISTERS (BINOCAR) DATASET AND PRELIMINARY 
EPIDEMIOLOGICAL EXPLORATIONS .................................................................................... 60 
 BINOCAR DATA BY REGISTER .......................................................................................... 60 4.1
6 
 
 TWINS/MULTIPLE BIRTHS ................................................................................................. 67 4.2
4.2.1 Twins/multiple births in the BINOCAR dataset ........................................................... 67 
4.2.2 Differences between singletons and twins / multiple births ........................................... 68 
 SIBLINGS WITH ANOMALIES IN NTD DATASET ................................................................. 70 4.3
 NTD SUBTYPE AND “BIRTH” PREVALENCE ....................................................................... 71 4.4
4.4.1 BINOCAR birth prevalence equation ............................................................................ 71 
4.4.2 Merging numerator and denominator datasets to calculate prevalence ......................... 74 
4.4.3 Using binomial regression to estimate NTD prevalence for aggregate binary data ....... 74 
4.4.4 NTD Prevalence for individual data years ..................................................................... 75 
4.4.5 NTD prevalence estimates by region .............................................................................. 76 
4.4.6 Quantifying the difference between including and excluding terminations in NTD birth 
prevalence denominator ............................................................................................................... 78 
4.4.7 Preliminary epidemiological explorations around NTD prevalence .............................. 79 
 CHAPTER SUMMARY AND IMPORTANT POINTS TO TAKE FORWARD ............................... 99 4.5
5 ETHNICITY: NTD BIRTH PREVALENCE AND THE NATURAL HISTORY OF 
NTD AFFECTED PREGNANCIES ............................................................................................. 101 
 INTRODUCTION ................................................................................................................ 101 5.1
 CALCULATING NTD PREVALENCE ESTIMATES FOR DIFFERENT ETHNIC GROUPS ........... 104 5.2
5.2.1 Explorations around missing ethnicity data for different registers .............................. 109 
5.2.2 Conclusions .................................................................................................................. 116 
 NTD PREVALENCE IN ETHNIC COMMUNITIES IN EMSYCAR AND SWCAR ................ 118 5.3
5.3.1 Isolated and Non-Isolated NTDs .................................................................................. 118 
5.3.2 Univariable explorations for ethnicity in the NTD dataset (EMSYCAR and SWCAR)
 121 
5.3.3 Multivariable model exploring the association between ethnicity and NTD prevalence
 124 
5.3.4 Conclusions .................................................................................................................. 133 
 NATURAL HISTORY OF NTD AFFECTED PREGNANCIES IN EMSYCAR AND SWCAR FOR 5.4
MOTHERS FROM DIFFERENT ETHNIC COMMUNITIES ..................................................................... 134 
5.4.1 Introduction ................................................................................................................. 134 
5.4.2 Preliminary analyses .................................................................................................... 135 
5.4.3 Univariable analyses for an exploration of the association between maternal ethnicity 
and whether an NTD affected pregnancy is terminated or not ................................................. 138 
5.4.4 Multivariable analyses exploring the association between ethnicity and whether an 
NTD affected pregnancy is terminated or not using a logistic regression model ...................... 142 
5.4.5 Conclusions .................................................................................................................. 149 
 CHAPTER SUMMARY AND IMPORTANT POINTS TO TAKE FORWARD ............................. 151 5.5
7 
 
6 EXPLORING THE PRE-PREGNANCY AND PREGNANCY KNOWLEDGE, 
ATTITUDES AND HEALTH BEHAVIOUR OF SOUTH ASIAN MOTHERS WITH A 
PREVIOUS NEURAL TUBE DEFECT (NTD) AFFECTED PREGNANCY ......................... 153 
 INTRODUCTION ................................................................................................................ 153 6.1
 METHODOLOGY ............................................................................................................... 156 6.2
6.2.1 Background .................................................................................................................. 156 
6.2.2 Aligning research with theory ...................................................................................... 157 
6.2.3 Statement about researcher involvement...................................................................... 159 
6.2.4 Participant recruitment................................................................................................ 159 
6.2.5 Interview procedure ...................................................................................................... 163 
6.2.6 Data collection and analysis ......................................................................................... 163 
6.2.7 Presentation of findings ............................................................................................... 165 
 FINDINGS .......................................................................................................................... 166 6.3
6.3.1 Pre-pregnancy knowledge and health behaviours, particularly with regards to folic acid: 
Giving meaning through detail and emphasis vs. gaining meaning through experience ......... 166 
6.3.2 Deciding to continue a spina bifida affected pregnancy: Seeing the whole picture (with 
human eyes) ............................................................................................................................... 188 
 CHAPTER SUMMARY AND IMPORTANT POINTS TO TAKE FURTHER ................................. 201 6.4
7 DISCUSSION ......................................................................................................................... 203 
 WHY IS AN ETHNIC DISCREPANCY IN NEURAL TUBE DEFECT (NTD) PREVALENCE 7.1
OBSERVED?..................................................................................................................................... 203 
7.1.1 Quantitative Study Limitations ................................................................................... 206 
7.1.2 Conclusions .................................................................................................................. 209 
 WHAT ARE THE BEST PREVENTION STRATEGIES FOR NTDS IN ETHNIC COMMUNITIES? 210 7.2
7.2.1 Qualitative study limitations ....................................................................................... 212 
7.2.2 Conclusions .................................................................................................................. 213 
 WHY DO WOMEN DECIDE TO CONTINUE A SPINA BIFIDA AFFECTED PREGNANCY AND 7.3
HOW CAN WE ENSURE IT IS A FULLY INFORMED DECISION ........................................................... 214 
7.3.1 Conclusions .................................................................................................................. 215 
 APPROPRIATENESS OF USING MIXED METHODOLOGY ..................................................... 216 7.4
 IMPLICATIONS FOR PRACTICE AND PREVENTION ............................................................ 217 7.5
 FURTHER RESEARCH ......................................................................................................... 219 7.6
 SUMMARY ......................................................................................................................... 220 7.7
8 APPENDIX A .......................................................................................................................... 237 
9 APPENDIX B .......................................................................................................................... 245 
10 APPENDIX C .......................................................................................................................... 252 
8 
 
11 APPENDIX D ......................................................................................................................... 253 
12 APPENDIX E .......................................................................................................................... 257 
 
 
 
 
  
9 
 
List of Figures 
 
Figure 1: Schematic representation for the four main severe neural tube defects 
(NTDs) .................................................................................................................................. 19 
Figure 2: Change in NTD prevalence between 1964 and 2004 ..................................... 23 
Figure 3: Flow diagram detailing process of selection of studies for inclusion in 
systematic review and meta-analysis ............................................................................... 40 
Figure 4: Meta-analysis of pre-conceptional folic acid use in Caucasians/Whites 
compared to non-Caucasians/non-Whites. .................................................................... 45 
Figure 5: Phases of research in relation to quantitative and qualitative study 
sequence ............................................................................................................................... 58 
Figure 6: Natural History of NTD affected pregnancies with a focus on “birth” 
outcomes included in the BINOCAR birth prevalence calculation ............................. 73 
Figure 7: Process of merging pregnancy level and aggregated data to calculated 
prevalence estimates ........................................................................................................... 74 
Figure 8: Birth prevalence by year for all NTD affected pregnancies and by NTD 
type ........................................................................................................................................ 75 
Figure 9: NTD birth prevalence estimates using all NTD cases and only live and still 
birth cases ............................................................................................................................. 76 
Figure 10: NTD prevalence per 10,000 conceptions  by month of conception for all 
NTDs combined and by NTD subtype ............................................................................ 97 
Figure 11: Ethnic breakdown for NTDs in EMSYCAR ................................................ 110 
Figure 12: Ethnic breakdown for EMSYCAR births ..................................................... 110 
Figure 13: Ethnic breakdown for NTDs in SWCAR ..................................................... 110 
Figure 14: Ethnic breakdown for SWCAR births .......................................................... 110 
Figure 15: Ethnic breakdown for NTDs in NorCAS .................................................... 110 
Figure 16: Ethnic breakdown for NorCAS births ......................................................... 110 
Figure 17: Ethnic breakdown for NTDs in CAROBB ................................................... 110 
Figure 18: Ethnic breakdown for CAROBB births ........................................................ 110 
Figure 19: Ethnic breakdown for NTDs in CARIS ....................................................... 111 
Figure 20: Ethnic breakdown for CARIS births ............................................................ 111 
Figure 21: Proportion of missing ethnicity data by NTD type and register ............. 113 
Figure 22: Proportion of missing ethnicity data by whether the NTD is isolated or 
not and register .................................................................................................................. 114 
10 
 
Figure 23: NTD pregnancy outcomes by maternal ethnicity ...................................... 136 
Figure 24: Proportion of NTD affected pregnancies resulting in TOPFA or not for 
different ethnic groups in EMSYCAR and SWCAR..................................................... 139 
Figure 25: Possible pathways for “knowing” and “not knowing” about folic acid 
benefits and pregnancy outcomes .................................................................................. 166 
  
11 
 
List of Tables 
 
Table 1: Key information for individual studies included in systematic review ....... 41 
Table 2: Breakdown by ethnicity of the number and proportion of participants in 
each study ............................................................................................................................ 42 
Table 3: BINOCAR register description ........................................................................... 62 
Table 4: Missing data for key variables by register ........................................................ 65 
Table 5: Breakdown of number of NTD affected babies that are singletons or part of 
a multiple set (twins or triplets), by register ................................................................... 67 
Table 6: Breakdown of the number malformed in multiple set by register ................ 67 
Table 7: Breakdown of siblings with anomalies variable (number and proportion) by 
register .................................................................................................................................. 71 
Table 8: Prevalence by year and 95% confidence intervals for all NTD affected 
pregnancies .......................................................................................................................... 76 
Table 9: Prevalence by register and 95% confidence intervals for all NTD affected 
pregnancies .......................................................................................................................... 78 
Table 10: Number of NTD affected pregnancies and Birth Prevalence for all NTDs 
and different subtypes ........................................................................................................ 78 
Table 11: Number and proportion of NTD affected pregnancies falling into the 
different multiple malformation groupings .................................................................... 81 
Table 12: NTD prevalence by type and whether the NTD is isolated or not.............. 82 
Table 13: Sex (number and proportion) breakdown for NTD affected pregnancies 
from different registers ....................................................................................................... 83 
Table 14: Female to male prevalence rate ratios by NTD subtype for affected 
pregnancies of any gestation length and those with gestation lengths of 18 weeks or 
longer .................................................................................................................................... 84 
Table 15: Female to male prevalence rate ratios by NTD type for isolated and non-
isolated affected pregnancies of 18 weeks gestation length or longer ........................ 84 
Table 16: Prevalence for isolated NTD cases by register and NTD type ..................... 84 
Table 17: Prevalence for non-isolated NTD cases by register and NTD type ............ 85 
Table 18: Maternal age group (number and proportion) breakdown for NTD 
affected pregnancies from different registers ................................................................. 86 
Table 19: NTD prevalence by maternal age group and NTD type .............................. 87 
Table 20: NTD prevalence rate ratios by maternal age group and NTD type ............ 87 
12 
 
Table 21: NTD prevalence rate ratios by maternal age group and whether the NTD 
is isolated or not .................................................................................................................. 88 
Table 22: Maternal deprivation quintile (number and proportion) breakdown for 
NTD affected pregnancies for English registers ............................................................. 89 
Table 23: Maternal deprivation quintile (number and proportion) breakdown for 
NTD affected pregnancies for Welsh register ................................................................. 90 
Table 24: NTD prevalence rate ratios by deprivation quintile and NTD type for 
English registers only ......................................................................................................... 90 
Table 25: NTD prevalence rate ratios by deprivation quintile and NTD type for NTD 
isolated cases for English registers only .......................................................................... 91 
Table 26: NTD prevalence rate ratios by deprivation quintile and NTD type for non-
isolated NTD cases for English registers only ................................................................ 91 
Table 27: NTD prevalence risk ratios by deprivation quintile for all NTD cases and 
broken down by whether the NTD is isolated or not for the Welsh register (CARIS)
 ............................................................................................................................................... 91 
Table 28:  Proportion of mothers in the NTD NorCAS dataset falling into the 
different BMI categories, including missing cases ......................................................... 93 
Table 29: Folic acid use breakdown for CARIS ............................................................... 94 
Table 30: Folic acid use breakdown for SWCAR ............................................................ 94 
Table 31: NTD prevalence per 10,000 conceptions for month-pairs for all NTD 
affected pregnancies and by NTD subtype ..................................................................... 96 
Table 32: NTD prevalence per 10,000 conceptions for month-pairs for all isolated 
NTD affected pregnancies and by subtype ..................................................................... 97 
Table 33: NTD prevalence per 10,000 conceptions for month-pairs for all non-
isolated NTD affected pregnancies and by subtype ...................................................... 98 
Table 34: NTD prevalence per 10,000 conceptions for month-pairs for all NTD 
affected pregnancies in NorCAS and CARIS vs. EMSYCAR, CAROBB and SWCAR
 ............................................................................................................................................... 99 
Table 35: Breakdown of number and proportion of NTD cases in the BINOCAR 
dataset with mothers falling into the different ethnic groups collected by registers
 ............................................................................................................................................. 102 
Table 36: NTD birth prevalence estimates by ethnicity for all registers ................... 105 
Table 37: NTD birth prevalence rate ratios by ethnicity for all registers .................. 105 
13 
 
Table 38: NTD birth prevalence rate ratio estimates by ethnicity for isolated NTD 
affected pregnancies for all registers .............................................................................. 106 
Table 39: NTD birth prevalence rate ratio estimates by ethnicity for non-isolated 
NTD affected pregnancies for all registers .................................................................... 106 
Table 40: NTD birth prevalence estimates by ethnicity for EMSYCAR and SWCAR 
only ...................................................................................................................................... 108 
Table 41: NTD birth prevalence rate ratio estimates by ethnicity for EMSYCAR and 
SWCAR ............................................................................................................................... 108 
Table 42: NTD birth prevalence rate ratio estimates by ethnicity for isolated NTD 
affected pregnancies for EMSYCAR and SWCAR ....................................................... 108 
Table 43: NTD birth prevalence rate ratio estimates by ethnicity for non-isolated 
NTD affected pregnancies for EMSYCAR and SWCAR ............................................. 108 
Table 44: Comparing aetiological vs. EUROCAT algorithm classification for isolated 
and non-isolated NTD cases in EMSYCAR ................................................................... 118 
Table 45: Comparing aetiological and EUROCAT algorithm classification systems 
for mothers of White, Indian and Bangladeshi ethnicity in EMSYCAR ................... 119 
Table 46: Breakdown of sex of baby by maternal ethnicity for NTD affected 
pregnancies in EMSYCAR and SWCAR, where sex is known and the gestation 
length is 18 weeks or longer ............................................................................................ 124 
Table 47: Binomial regression model to explore the association between ethnicity 
and NTD prevalence, unadjusted and adjusted for IMD quintile and maternal age 
for EMSYCAR and SWCAR ............................................................................................ 126 
Table 48: Binomial regression model to explore the association between ethnicity 
and NTD prevalence, stratified by deprivation quintile and adjusted for maternal 
age for EMSYCAR and SWCAR ..................................................................................... 127 
Table 49: Binomial regression model to explore the association between ethnicity 
and NTD prevalence, stratified by whether the NTD is anencephaly or spina bifida 
and adjusted for IMD quintile and maternal age for EMSYCAR and SWCAR ....... 129 
Table 50: Binomial regression model to explore the association between ethnicity 
and NTD prevalence for isolated NTDs, stratified by whether the NTD is 
anencephaly or spina bifida and adjusted for IMD quintile and maternal age for 
EMSYCAR .......................................................................................................................... 131 
Table 51: Binomial regression model to explore the association between ethnicity 
and NTD prevalence for non-isolated NTDs, stratified by whether the NTD is 
14 
 
anencephaly or spina bifida and adjusted for IMD quintile and maternal age for 
EMSYCAR .......................................................................................................................... 132 
Table 52: Missing data for additional variables by register ........................................ 135 
Table 53: Breakdown for different pregnancy outcomes in the NTD dataset for 
EMSYCAR and SWCAR .................................................................................................. 136 
Table 54: Number and proportion of prenatally detected NTD affected pregnancies 
that are terminated or not for different NTD subtypes in EMSYCAR and SWCAR
 ............................................................................................................................................. 137 
Table 55: Logistic regression model exploring the association between maternal 
ethnicity and whether the NTD affected pregnancy is terminated or not, unadjusted 
and adjusted for NTD type; maternal age; age, in weeks, at which the NTD is 
discovered; and deprivation of maternal residence for EMSYCAR and SWCAR ... 145 
Table 56: Logistic regression model exploring the association between ethnicity and 
whether the NTD affected pregnancy is terminated or not, stratified by whether the 
NTD is anencephaly or spina bifida and adjusted for maternal age; age, in weeks, at 
which the NTD is discovered and deprivation of maternal residence for EMSYCAR 
and SWCAR ....................................................................................................................... 147 
Table 57: Logistic regression model exploring the association between ethnicity and 
whether the isolated, spina bifida affected pregnancy is terminated or not, and 
adjusted for maternal age; age, in weeks, at which the NTD is discovered and 
deprivation of maternal residence for EMSYCAR ....................................................... 149 
Table 58: Key self-reported participant characteristics ................................................ 162 
 
 
 
 
 
 
 
 
 
 
15 
 
 
 
List of abbreviations 
 
ART Assisted Reproductive Technology 
BINOCAR British Isles Network of Congenital Anomaly Registers 
BME Black and minority ethnic 
BMI Body mass index 
CARIS Congenital Anomaly Register and Information Service for Wales 
CAROBB Congenital Anomaly Register for Oxfordshire, Berkshire and 
Buckinghamshire 
 
CMACE Centre for Maternal and Child Enquiries 
CMO Chief Medical Officer 
CNS Central Nervous System 
DH Department of Health 
EMSYCAR East Midlands and South Yorkshire Congenital Anomalies 
Register 
 
EUROCAT European Surveillance of Congenital Anomalies 
FSA Food Standards Agency 
GOSH Great Ormond Street Hospital 
GP General Practitioner 
HEA Health Education Authority 
ICD-10 International Classification of Diseases – version 10 
IMD Indices of multiple deprivation 
LSOA Lower super output area 
MRC Medical Research Council 
16 
 
MTHFR Methylene tetrahydrofolate reductase 
NCARDRS National Congenital Anomaly and Rare Disease Registration 
Service 
 
NCAS National Congenital Anomaly System 
NHS National Health Service 
NorCAS Northern Congenital Abnormality Survey 
NTD Neural tube defect 
ONS Office for National Statistics 
OR Odds ratio 
PCT Primary Care Trust 
PRR Prevalence rate ratio 
REC Research Ethics Committee 
SACN Scientific Advisory Committee on Nutrition 
SHINE Spina Bifida, Hydrocephalus, Information, Networking, Equality 
Association 
 
SWCAR South West Congenital Anomaly Register 
TOPFA Termination of pregnancy for fetal anomaly 
WHO World Health Organisation 
 
  
17 
 
1 Introduction to Neural Tube Defects (NTDs) 
 
In this Chapter, a general overview of congenital anomalies is given before the 
content is focused specifically on neural tube defects (NTDs). The clinical 
presentation of NTDs, their epidemiology and details of primary and secondary 
NTD prevention from the literature are given.  
 
 Congenital anomalies overview 1.1
 
Congenital anomalies (birth defects) are a diverse group of developmental 
disorders of the embryo and fetus (1). They have complex aetiology, involving both 
genetic and environmental factors, and in most cases the anomaly cannot be 
attributed to a single factor (2). Due to early miscarriages before the pregnancy is 
confirmed and later miscarriages where the anomaly has not been diagnosed, it is 
difficult to calculate a true incidence for congenital anomalies and birth prevalence 
is typically given (1). It is still termed birth prevalence when termination of 
pregnancy for fetal anomaly (TOPFA) cases are included as it would be expected 
that the majority of these would survive to birth if the pregnancy had not been 
terminated (2). Based on case ascertainment that includes live births, still births, 
fetal deaths from 20 weeks gestation and termination of pregnancy for fetal 
anomaly (TOPFA), approximately 1 in 40 pregnancies in Europe (2;3) are affected 
by birth defects: 80% result in live births and 18% in TOPFA in this setting (2). 
Congenital anomalies are the second most prevalent cause of infant deaths in the 
UK (1).  
 
Congenital heart defects are the most common group of birth defects followed by 
neural tube defects (NTDs), severe congenital abnormalities caused by failed 
closure of the embryonic neural tube. Closure is normally complete by day 28 of 
pregnancy, before many women know they are pregnant. NTDs affect between 0.5 
and 2 in every 1000 pregnancies worldwide (4).  
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 Clinical presentation of NTDs 1.2
 
The clinical severity varies between different types of NTD. Open spina bifida 
(myelomeningocele) is the most common type of NTD and results from a failure of 
the closure of the neural tube along the body axis during fetal development (3). The 
open spina cord is either covered by a meningeal sac or exposed. This phenotype is 
usually compatible with postnatal survival, however there is neurological 
impairment below the level of the lesion and some children will be unable to walk 
and commonly experience bowel and bladder problems (5). Hydrocephalus, a 
build-up of fluid in the brain, is often associated with open spina bifida. The open 
spinal lesion is typically closed surgically soon after the child is born or may be 
closed in utero in specific centres in recent years (3).  
 
Anencephaly, slightly less common than open spina bifida, results from failed 
closure of the cranial neural tube and there is a lack of brain and cranial vault. This 
severe NTD type is not compatible with life after birth. Craniorachischisis is much 
rarer and is characterised by the entire neural tube remaining open and, like 
anencephaly, affected pregnancies will result in either fetal loss or stillbirth. 
 
Encephalocele is more common than craniorachischisis but still relatively rare, and 
is characterised by the meningeal sac, which usually contains brain tissue, 
protruding from the skull. This phenotype can be lethal, depending on the extent of 
brain damage (5) (a schematic representation for all four NTDs described above is 
given in Figure 1). 
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Figure 1: Schematic representation for the four main severe neural tube defects (NTDs) 
Source: Copp et al, Natures Reviews Disease Primers (6)  
 
 NTD epidemiology  1.3
 
The report by Record and McKeown in 1949 was the first to highlight the complex 
epidemiology of NTDs, including the excess anencephaly prevalence in girls and 
the relative importance of parity when compared to maternal age (7). However, as 
early as 1844, the importance of the interaction of genetic and environment factors, 
specifically the importance of nutrition, in the aetiology of NTDs was identified (8).  
It is argued that an analysis in 1974 by Carter of the epidemiological data (9), led to 
the current view of a multifactorial cause of NTDs, with a genetic predisposition 
that is polygenic and involvement of several environmental factors (5).  It has been 
argued that results from epidemiological studies have been used to dissect the role 
of genetic factors on NTDs (10). Studies showing NTD recurrence within families 
and an increase in NTD prevalence in same-sex twins, provide evidence for a 
genetic influence (11). However, our understanding of the genetic basis for NTDs in 
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humans remains limited and few of the genes identified in mouse models have been 
implicated in human NTDs (4). 
 
A recent review of the epidemiological data by Au and colleagues describes how 
other factors shown to be associated with NTD risk include socio-economic status, 
ethnicity, maternal diabetes, maternal obesity, parental occupational exposures, 
hyperthermia during early pregnancy, caffeine use and medication use (10). 
Geographical variation in the prevalence of NTDs has been observed. In China, the 
NTD prevalence has been shown to be much higher in the North than the South 
since the early 1990’s (12). In the British Isles there is also a North South Divide with 
a higher prevalence observed in the North West when compared to the South East 
of England (11). Seasonal variation in NTD prevalence has been reported by some 
studies (13). An association between previous spontaneous abortions and NTDs, 
has also been reported (11). Finally, it is important to note that maternal use of 
valproic acid, used to treat epilepsy, is associated with significantly increased risk of 
NTDs in offspring (14). 
 
 Primary prevention of NTDs: The folic acid story 1.4
 
The most significant finding to emerge from NTD epidemiological studies is the 
link between intake of folic acid before and during early pregnancy (peri-
conceptionally) and NTD prevention. Evidence from observational and non-
randomised controlled trials on the effectiveness of folic acid supplementation had 
been building up over several years (15), including a case control study conducted 
in Western Australia using data collected between 1982 and 1984 (16). However, it 
was the 1991 Medical Research Council (MRC) double blind multicentre 
randomised controlled trial that was the first to provide unambiguous evidence of 
an association between folic acid intake and reduction in NTDs. There was shown 
to be a 72% reduction in NTD recurrences in women taking folic acid supplements 
(17). It was argued that although the trial was concerned with NTD recurrences, 
there was no reason to expect that folic acid wouldn’t have the same effect on first 
occurrence NTDs (17). Indeed, a randomised clinical trial in Hungary in 1992 
confirmed that folic acid also has a protective effect for first occurrence NTDs (18). 
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Establishing what the minimum effective dose for preventing NTDs is, has proved 
problematic (15) . Daly and colleagues described how a 22%, 41% and 47% 
reduction in risk of NTDs were associated with an intake of 100, 200 and 400 µg 
folic acid, respectively and that fortifying with folic acid doses above 400 µg, offers 
little further benefit (19). However, based on 14 studies that explored the effect of 
different doses of folic acid up to 1 mg per day on serum folate levels, Wald and 
colleagues described how there is a constant inverse dose-response relationship. 
They also found that a greater effect was observed when there was a lower baseline 
serum folate concentration. Although only doses of folic acid of up to 1 mg were 
included, it was argued based on a prediction model generated from the existing 
data, that NTD risk can be reduced by as much as 85% if 5 mg folic acid is taken 
daily (20). Described problems with such a model are that it doesn’t take into 
account heterogeneity of NTDs and population differences (15). In the 1991 MRC 
vitamin study 4mg folic acid was used to assess impact on NTD recurrences and in 
the 1992 Hungarian study by Czeizel and Dudas, 0.8mg to assess impact on first 
occurrence NTDs. A larger study subsequently conducted in China found a 
protective effect for first occurrence NTDs using 400 µg folic (21) (15). It is based on 
these studies and trials that it is recommended that all women planning to get 
pregnant take 400 µg folic acid per day and that 4 or 5 mg folic acid per day is taken 
by those at high risk of NTDs (3). Due to natural food folates being approximately 
50% less bioavailable than synthetic folic acid, it is of paramount importance that 
the latter is taken in addition to consuming any folate as part of a balanced diet (15). 
 
As stated in the introduction to the systematic review conducted and published as 
part of this PhD (22), in 1992 the Centers for Disease Control and Prevention in the 
United States recommended that 400 µg folic acid be taken daily by women who 
could become pregnant and 4mg by those with a previous NTD affected pregnancy. 
However, this advice and the subsequent major public health campaign in the 
United States, were shown to result in limited behavior change. As a result of this, 
and due to 50% of pregnancies in the United States being unplanned, the 
fortification of staple foods with folic acid was mandated in January 1998. There 
was also mandatory fortification less than a year later in Canada (15). Including 
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prenatal diagnoses of NTDs, there was shown to be a 27% decline in NTDs 
postfortification in the United States (23) and 46% decline in Canada (24).  
 
National recommendations for the peri-conceptional use of folic acid were also 
introduced in Australia in 1992 (25), with voluntary fortification of some foods with 
folic acid introduced in 1996 and mandatory fortification of bread in 2009 (25). 
Mandatory fortification was also considered in New Zealand but due to industry 
and consumer concerns, an enhanced voluntary bread fortification programme was 
adopted instead (25). It has been shown that post-fortification in Australia, there has 
been a population level increase in serum and red blood cell folate levels (26).  
There has been a marked decrease in the NTD prevalence in the Aboriginal 
population in Australia in the post-fortification period (27); this is of critical 
importance as health promotion campaigns for folic acid supplement use and 
voluntary fortification were shown to have little impact for this population group 
(28). 
 
In 1992, as a result of the landmark MRC study, the Department of Health (DH) 
recommended that 400 µg of folic acid be taken before conception and for the first 
twelve weeks of pregnancy (29). This is increased to 5 mgs for women at increased 
risk of NTDs (those with a previous NTD affected pregnancy, at risk of folate 
deficiency and mothers with diabetes and epilepsy). A Health Education Authority 
(HEA) Campaign was launched in February 1996 (30) as a result of findings that 
compliance with the DH recommendations were poor (29). Only 3% of the women 
in the study sample had taken folic acid in the preconception period (29).  An audit 
of the impact of the HEA campaign in 1996 to 1997 found that although knowledge 
of the beneficial effects of folic acid had increased, compliance was still low (31).  
 
Wald and Morris published research in 2007 that described how the NTD 
prevalence has changed between 1964 and 2004. However, they also accounted for 
under-reporting of NTD terminations, which is critical in presenting “true” 
prevalence estimates across all study years (32).  NTD Prevalence over this time 
period is shown in Figure 2. The figure shows that since the late 1980’s the 
prevalence has remained fairly constant. A previous publication from the same 
authors, but more broadly accounting for under-reporting of central nervous 
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system (CNS) defect terminations, also described a similar pattern (33). The authors 
detailed how the British National Food Survey estimated that between the early 
1980s and 1997 there was an increase in dietary folate by about 20% and that this 
would have at least partly influenced the decline in NTD prevalence. However, 
Wald and Morris also argued that folate intake might have been even greater than 
estimated, due to increased fortification of foods with folic acid in this period (33).  
 
 
Figure 2: Change in NTD prevalence between 1964 and 2004 
Source: Morris and Wald, Journal of Medical Screening (32) 
 
Another study reported that, up to six years after the folic acid supplementation 
policy was introduced in 1992 in the U.K., the rate of decline in NTD prevalence did 
not differ from the rate of decline before the policy had been implemented (34). A 
study conducted including data from a slightly later time period found that there 
has been a 32% decline in NTDs in the period 2000-2002 when compared with 1989-
1991 in the U.K. and Ireland.  However, this continued a pre-existing rate of decline 
in NTD frequency (35). Although it also difficult to ascertain how much of the 
decline detailed for the United States and Canada post-fortification is due to a pre-
existing reduction, a causal link is indicated by a drop in NTD rates co-occurring 
with an increase in red blood cell folate concentrations (36).  
 
No mandatory fortification policy has as yet been introduced in the U.K., or in fact 
anywhere in Europe. Due to poor compliance with the health advice, The Food 
Standards Agency (FSA) recommended mandatory fortification in 2007 in the U.K. 
24 
 
after conducting substantial research which showed that mandatory fortification 
was the option most favoured by consumers. However, this was deferred due to the 
Chief Medical Officer (CMO) having concerns about the link between high levels of 
folic acid intake and colorectal cancer (Tedstone et al, 2007). A subsequent review, 
commissioned by the CMO, found that there was not substantial evidence of an 
association between folic acid and colorectal cancer to alter the original 
recommendation (SACN, 2009). Mandatory fortification is currently under review 
by UK health minsters.  
 
In countries where there is no mandatory fortification policy, improvement in 
knowledge of the benefits of folic and its peri-conceptional use, is of particular 
importance. A recent survey conducted in 18 European countries exploring 
awareness and use of folic acid by women of reproductive age found that only 17% 
of women knew that folic acid can reduce NTD prevalence. 37% of women with a 
child reported taking folic acid (37).  
 
Studies using human subjects to investigate genes involved in the causation of 
human NTDs, have mainly focused on genes involved in folate one-carbon 
metabolism. The most widely studied and important finding to emerge from these 
studies is the C677T and A1298C polymorphisms of methylene tetrahydrofolate 
reductase (MTHFR), a gene encoding a crucial enzyme involved in folate 
metabolism (3). However, increased NTD risk in those with the C677T 
polymorphism, specifically the TT genotype, has only been found in some 
populations (38).  
 
 Primary prevention of NTDs: Other factors 1.5
 
It is argued that based on the findings of the key clinical trials showing the 
effectiveness of folic acid supplementation in NTD reduction (17;18;21), it is 
estimated that folic acid can prevent between 50 and 70% of NTDs (15).  Heseker 
and colleagues describe how, looking at studies exploring the effectiveness of folic 
acid supplementation, there is a greater decline in NTD prevalence in regions or 
populations with a higher baseline prevalence than those with a lower baseline 
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prevalence (39) (in line with what was observed by Wald and colleagues, detailed 
above(20)). It is argued there is a floor effect, a certain level below which folic acid 
does not seem to be effective, and countries with a prevalence of 7 to 8 per 10,000 
pregnancies might already have reached this “floor” level (39).  
 
It is of importance to note that the majority of NTD affected pregnancies in fact have 
folate levels which are within the normal range (40) and mouse models have shown 
that folate deficiency only causes NTDs in the presence of a genetic predisposition 
(3).  
 
The effectiveness of inositol in preventing folate-resistant NTDs has been shown in 
mouse models (3) and there has been evidence in humans for inositol as an 
alternative for those not responsive to folic acid (41). This resulted in a pilot clinical 
trial being conducted at the Institute of Child Health of inositol supplementation in 
women with a previous NTD affected pregnancy (3). 
 
The importance of B12 in folate metabolism and for further NTD risk reduction has 
been indicated: a study in Dublin found that women who are deficient in B12 had 
three times the risk of having an NTD affected pregnancy than those with adequate 
consumption (42). Professor John Scott, a world authority on vitamin B12 from 
Dublin, recommended that 2.5 µg of B12 should be taken in addition to folic acid 
before and during early pregnancy (43). However, although based on clear 
evidence, this recommendation was reported as a personal communication and 
additional research is required to further establish the effectiveness of vitamin B12 
in preventing NTDs and the optimal dose of B12 required (43).   
 
The importance of other possible environmental causes should also not be ignored, 
including addressing factors such as maternal diabetes and obesity as part of NTD 
prevention strategies, in addition to increasing folic acid intake (2).  For example, 
McMahon and colleagues described how even after adjustment for peri-
conceptional folic acid use, women who were obese still had double the odds of 
having an NTD affected pregnancy as women with a normal BMI (44). The biggest 
NTD risk reduction was observed in those taking folic acid who were 
overweight/obese when compared to those who were normal/underweight (44). 
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This is in line with what is previously described about groups with a higher 
baseline NTD prevalence experiencing a greater reduction in NTD risk when taking 
folic acid than those with a lower baseline prevalence (20;39). 
 
The effectiveness of various prevention strategies will also vary depending on the 
type of NTD. For example, there is increased risk of both anencephaly and spina 
bifida affected pregnancies in diabetic mothers. However, it is specifically for spina 
bifida affected pregnancies that maternal use of valproic acid has been shown to 
incur increased risk. The importance of folic acid for prevention of both 
anencephaly and spina bifida affected pregnancies, has been clearly proven. 
However, the evidence is less conclusive for encephalocele (5). 
 
Finally, whether an NTD occurs in isolation or in association with other birth 
defects is an important consideration when targeting prevention strategies. Even 
after excluding NTD cases occurring as part of known chromosomal, genetic or 
teratogenic syndromes, the remaining NTDs occurring in association with other 
defects are thought to be aetiologically distinct from those that are isolated 
(11;45).Mice studies have shown that a mutation in a single gene necessary for the 
correct development of more than one body system, can result in non-isolated 
NTDs (46). It is argued that non-isolated NTDs are unlikely to decline with folic 
acid usage (47;48). 
 
 Secondary prevention of NTDs: Prenatal detection and TOPFA 1.6
 
In England and Wales, NTDs have a high prenatal detection rate with 99.6% of 
anencephaly cases and 91.7% of spina cases detected prenatally (49). There is a high 
TOPFA rate for NTDs and, in line with the clinical picture, TOPFA rates are higher 
for anencephaly than spina bifida affected pregnancies. In Europe it was reported 
that 59% of spina bifida cases were terminated in 2007 (2). This figure went up to 
71% when countries where TOPFA is illegal were excluded. For anencephaly the 
TOPFA rate was 83% (2). It is argued that this high prenatal detection and 
therapeutic termination rate for NTDs could be making NTDs invisible with a 
consequence that there is less of an impetus behind primary prevention (2). 
27 
 
However, the majority of these cases might be invisible to the public eye but they 
are not to the families that they affect. It is of critical importance that NTD affected 
pregnancies that result in a TOPFA are included in prevalence calculations to 
present an accurate picture. 
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2 Neural tube defects (NTDs) in different ethnic communities 
 
This chapter starts with a broader global perspective of neural tube defects (NTDs) 
within different ethnic communities then focuses in on the situation in the U.K. The 
literature on NTD prevalence and perinatal mortality, prenatal screening and 
termination of pregnancy for fetal anomaly (TOPFA) and folic acid knowledge and 
use (including a systematic review published in the early stages of this doctoral 
thesis) within different ethnic communities in the U.K. is explored.  
 
 A global perspective 2.1
 
Flores and colleagues describe how low and middle-income settings bear the 
biggest burden of severe birth defects (50). This seems to be particularly the case in 
South East Asia with 8 countries, India, Sri Lanka, Thailand, Nepal, Indonesia, 
Bangladesh, Myanmar and Bhutan, reported in the “March of Dimes Global Report 
on Birth Defects” to have overall birth defect prevalence estimates of between 55 
and 65 per 1,000 live births (50;51). The World Health Organisation (WHO) in their 
strategic framework for the “Prevention and Control of Birth Defects in South-East 
Asia Region”, describe how prevalence estimates from The March of Dimes Birth 
Defects Foundation are generated based on epidemiological modelling and do not 
allow for exact comparisons between different countries. Nevertheless, congenital 
heart defects and NTDs are the most common birth defects in the South East Asia 
region, with the NTD prevalence shown to be particularly marked in Bangladesh, 
Bhutan, DPR Korea, India and Nepal (52).    
 
As described, one of the factors identified in epidemiological studies as influencing 
NTD prevalence is ethnicity (10). The relative contribution of genetic and 
environmental factors to observed differences in NTD prevalence for different 
ethnic groups is largely unestablished (53). There is also a complex interplay 
between ethnicity and geography with migration studies indicating that groups 
with high prevalence do not keep their high risk when they migrate but groups 
with low risk do (11). However, there are certain groups who seem to have an 
intrinsically higher  or lower risk: A very early study conducted by Leck exploring 
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the aetiology of NTDs reported that the anencephaly prevalence is high in Sikh 
communities, regardless of whether they live in areas with an overall high or low 
prevalence, while those of Black ethnicity have a low prevalence, regardless of 
where they reside (54). 
 
2.1.1 Indian ethnicity 
 
A high NTD prevalence in the Indian population has been frequently reported in 
the literature. Early studies reported the NTD rate to be particularly high in the 
North of India. Rates were as high as 8.8 per 1,000 births in areas where the 
population was largely Sikh and it was described how the high anencephaly 
prevalence in Sikhs was maintained after migration to the UK (55). Rates were still 
high in regions in the North of India that were not predominantly Sikh (55).  In 
1983, Baird described how the NTD rate was statistically significantly higher in the 
Sikh population than what was observed in the general population in British 
Columbia and that a higher proportion of Sikh cases were stillborn (56). In 1995, 
Millar and colleagues’ article exploring the health needs of individuals from 
different ethnic communities in Canada, describes the particularly marked NTD 
prevalence in women from India and the need to ensure all pregnant women, but 
women of Indian ethnicity specifically, take folic acid in the peri-conceptional 
period (57).  
 
Two recent systematic reviews have been conducted of the birth prevalence of 
NTDs in India (58;59). Studies in India that include NTD affected pregnancies that 
result in TOPFA are scarce and both reviews only included NTD birth cases in their 
calculations. In the first review, the random effects model combined NTD birth 
prevalence estimate across all the studies was 4.1 per 1,000 births (59). The second 
review, which included additional larger studies, reported an overall pooled NTD 
birth prevalence, using a random effects model, of 4.5 per 1,000 births (58). In the 
latter review, it was described how the highest prevalence was for the Northern 
region (7.7 per 1,000 births), which was statistically significantly higher than the 
prevalence for the Southern region (4.2 per 1,000 births). The still marked 
prevalence in the South was attributed to the inclusion of two studies: one 
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conducted in Davangere where a high NTD prevalence was reported (11 per 1,000 
births) (60) and a study conducted in Pondicherry where the prevalence was 5.7 per 
1,000 births (61). Consanguinity was shown to be a significant factor in both studies 
and argued by the authors of the review to be a potentially important contributor to 
observed prevalence excesses in the South, a typically lower prevalence area (58). 
Finally, studies included in two reviews were conducted over a large number of 
years, with the earliest study in the more extensive review published in 1968 and 
the most recent in 2013 (58). Allagh and colleagues describe how there is a clear 
drop in prevalence after 1995 and possible reasons for this could be increased 
awareness about folic acid and earlier detection of NTDs and subsequent 
therapeutic abortion (58). 
 
The Indian Council of Medical Research in 1988, five years after the MRC trial was 
launched, commenced their own double blind randomised controlled trial 
exploring the impact of folic acid supplementation on NTD recurrence in India. The 
Indian trial was terminated early in 1991, when the results of the MRC trial were 
published, for ethical reasons. In the Indian trial, NTD recurrence in the vitamin 
group was 2.92% and 7.04% in the placebo group, representing a 58.5% reduction in 
NTD recurrence in those who were taking folic acid. The difference didn’t quite 
reach statistical significance, however, this could have been because the study was 
slightly under-powered due to its early termination. As the recurrence rate was 
quite high in both groups, it was argued by the authors that the high NTD 
recurrence in India is something that needs to be investigated (62).  
 
A recent study conducted in Delhi, in North India, that included both women who 
did and didn’t continue their NTD affected pregnancy, found a significantly 
increased risk for NTDs in those who didn’t take folic acid peri-conceptionally. This 
was after adjustment for maternal age, occupation, consanguinity, occupation and 
household income (63). An increased risk of NTDs was also found in those who 
were vegetarian. When breaking the analysis down into the two main religious 
groups: Hindu and Muslim, it was described how Hindu women were more likely 
than Muslim women to follow a vegetarian diet and consanguineous marriages are 
uncommon among the former but common among the latter in North India (63). 
Deb and colleagues also found weak evidence of an association between vegetarian 
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dietary habits and NTD risk in a subsequent case control study conducted in Delhi, 
again including TOPFA cases (64). The authors described how an increased NTD 
risk in women who are vegetarian points towards the importance of micronutrients 
that could be lower in a vegetarian diet; specifically, B12, with low levels in 
pregnant mothers in India being previously reported (64;65).  
 
Public health action to address the overwhelming burden of NTDs in the Indian 
population is completely lacking. There is currently no national registry for birth 
defects in India (58) and, as described, the majority of studies conducted in this 
setting have only included NTD birth cases. Thus, the burden could be far greater 
than estimated (50). In 2005 Cherian and colleagues published their research in the 
Lancet showing that the NTD prevalence in the Balrampur District in Utter Pradesh 
in the North of India, one of the most underdeveloped areas of India, was one of the 
highest worldwide (6.57-8.21 per 1,000 live births)(66). As a result of this, Salvi and 
Damania wrote an article emphasising the critical importance of action being taken 
in India. They described the difficulties of providing folic acid supplements to all 
the women that need it and argued for fortification as an important tool to improve 
folate levels, although an appropriate staple food would need to be identified for 
fortification. They described how a national NTD prevention campaign, like the 
current mass campaign for HIV prevention in India, should be a priority (67). Flores 
and colleagues have described how, to date, in South East Asia, the only countries 
with current mandatory fortification policies in place are Indonesia and Nepal. 
They also highlighted the importance of addressing other known risk factors, such 
as B12 deficiency, in prevention policies (50). It is also of relevance to note the high 
rate of anencephaly affected pregnancies that were shown to be associated with 
other malformations (80%) in a study conducted in West India (68). As described, 
NTDs occurring in association with other defects are unlikely to decrease with folic 
acid supplementation (47). 
 
2.1.2 Black ethnicity 
 
The majority of the NTD epidemiological studies have been conducted in the 
United States and it has been shown both before and after fortification that the 
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highest NTD prevalence is in Hispanics, followed by non-Hispanic Whites and then 
non-Hispanic Blacks (15). However, many studies have failed to include prenatal 
diagnoses of NTDs in their prevalence estimates and therefore it is often difficult to 
ascertain what the “true” ethnic differences are (15). Dunlap and colleagues 
described how one study which compared the prevalence of NTDs pre and post 
fortification in the US in different ethnic groups (69) over-estimated the difference 
between non-Hispanic Whites and Hispanics because only 9 out of the 21 birth 
defects surveillance systems used included information about prenatal diagnoses 
(15). A study conducted in Cameroon found that the NTD prevalence was much 
higher than that reported for Black Americans. This led the authors to conclude that 
NTDs might not be as rare in sub-Saharan Black Africans as previously thought 
(70). TOPFA is illegal in Cameroon and none of the mothers involved in the study 
took folic acid peri-conceptionally (70). However, even after folic acid fortification 
in the United States, despite absolute gains for all ethnic groups, those of non-
Hispanic Black ethnicity still bear the biggest burden of having a low red blood cell 
(RBC) folate status (15;71). Thus, further research, including pregnancies that result 
in a termination, is required in the United States to ascertain whether the NTD 
prevalence is truly as low in Black Americans as current studies suggest. More 
studies also need to be conducted in Sub-Saharan Africa to ascertain the “true” 
prevalence among Black Africans and the impact of various environmental and 
genetic factors on this (70). 
 
 UK focus: What is known about NTDs, specifically how they can be 2.2
prevented, in ethnic communities in the UK?  
 
2.2.1 NTD Prevalence and Perinatal Mortality 
 
Leck reported in 1969 that the incidence of NTDs did not differ significantly 
between the local European population in Birmingham and the immigrant Pakistani 
population (72). Leck and Lancashire subsequently conducted a study over a much 
longer period (1960-1984) and actually found that there was weak statistical 
evidence that the birth prevalence of spina bifida is higher in Europeans than those 
of South Asian origin in Birmingham, although no significant differences were 
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found for anencephaly (73). It was also argued that terminations were unlikely to 
unduly affect the results as terminations were very rare in Birmingham before 1979 
and the long period studied was largely pre-1979 (73). 
 
Contrastingly,  Terry and colleagues described in 1985 that the congenital anomaly 
and perinatal mortality rates were high in mothers of Pakistani and Indian ethnicity 
in Birmingham (74).  It was described how mothers of Pakistani ethnicity also had 
the highest rate of consanguinity and increased maternal age, however, in Indian 
mothers, the rates for both of these factors were low (74). A study by Balarajan and 
colleagues, published in the same year, but with a much larger sample size, found 
that the mortality rates for stillbirth and infant deaths attributed to NTDs in 
England and Wales between 1975 and 1980 were highest in infants born to Indian 
and Bangladeshi mothers followed by Pakistani and Irish mothers for anencephaly. 
The ethnic differences were much less marked for spina bifida (75). It was also 
found in a study published a year previously, conducted in Bradford in the North 
of England, that the Asian population had higher rates of stillbirth and infant 
mortality due to congenital malformations than the non-Asian population. The 
Asian population also had an excess of multiple congenital anomalies (76). 
 
In 1989, Chitty and Winter reported that the NTD incidence was higher in the 
Pakistani population than the European population in the North West Thames 
region of England, and that this increased incidence partly accounted for the 
increased perinatal mortality in the former group (77). Although it is known that 
consanguinity rates are high in the Pakistani population, terminations were not 
included in the incidence calculation which makes it difficult to ascertain whether 
this is a true difference or due to the Pakistani population having fewer 
terminations (78). Indeed, Alberman in the same year described how data from the 
Office of Population Censuses and Surveys, showed that there was an excess of 
deaths due to congenital malformations in babies born to mothers born in Pakistan, 
followed by mothers born in India. However, they also argued that data, by 
maternal country of birth, on survivors and TOPFA cases would be important to 
establish true ethnic differences (79). As a result of this, Chitty and Winter 
published research the following year that included all NTD cases detected in the 
prenatal and perinatal period in a London hospital between 1980 and 1987.  
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However, it was described how routine ultrasound examination was not available 
until 1984. It was found that the NTD incidence was still statistically significantly 
higher in Pakistani than White women (80). 
 
More recent data from the “folic acid era” (post 1991) from the North Thames 
Region in the UK suggests that the rate of NTD affected pregnancies (including 
terminations) is higher in women of Pakistani or Indian origin (81). The authors also 
found that red cell folate concentrations were lower in Indian and Pakistani women 
and argued that further research is required to elucidate whether this is due a lower 
folic acid intake or genetic mutations in folate metabolising genes, or a combination 
of the two (81). Preliminary data from the West Midlands congenital anomaly 
register in 1995 also suggested that Pakistani women have a higher rate of NTD 
affected pregnancies (82). In 2013, it was reported in the Lancet, using an on-going 
prospective birth cohort in Bradford, the Born in Bradford study, that congenital 
anomaly rates were higher in Pakistani mothers than mothers of White British 
ethnicity. The excess in Pakistani mothers still remained after adjustment for 
deprivation and consanguinity accounted for almost a third of anomalies to 
mothers from this ethnic group (83). Although TOPFA cases were not included, the 
authors described how even after taking termination data into account, there was 
still an excess of congenital anomalies in mothers of Pakistani ethnicity (83).  
 
Obesity wasn’t a risk factor for congenital anomaly in the Born in Bradford cohort 
and there was little variation in diabetes between different ethnic groups, although 
numbers were small (83). However, the Health Survey for England, conducted in 
2004, found obesity levels were high in those of Pakistani, Black African and Black 
Caribbean ethnicity (84). The authors argued that poor diet, particularly for South 
Asians, and lower socio-economic status, are possible reasons for this (84). Women 
with type 2 diabetes are more likely to come from ethnic minority groups (85) and 
the risk of having an NTD affected pregnancy is increased in women who are obese 
or have diabetes (85;86). 
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2.2.2 Prenatal Screening and Termination of Pregnancy for Fetal Anomaly 
(TOPFA) 
 
Research on ethnic inequalities in the offer and uptake of prenatal screening for 
NTDs is limited and often comes secondary to research on screening for Down’s 
syndrome (87;88). Rowe and colleagues conducted a review to look at social and 
ethnic inequalities in the offer, utilisation and uptake of prenatal screening in the 
UK, clearly recognising the difference between utilisation and uptake, with the 
latter being dependent on whether women are offered the test in the first place (88). 
However, results for studies looking at Down’s syndrome and NTDs are reported 
together, despite the fact that only two (89;90) out of the ten studies in this section of 
the results reported on NTDs. The former found that there was no significant 
difference between ethnic groups in test acceptance (89) and the latter that less 
Asian than white women were offered screening (90). Overall it was concluded that 
South Asian women were less likely to be offered prenatal testing, although it was 
identified that very few studies actually considered this issue (88). It is difficult to 
say anything conclusive specifically about screening for NTDs due to limited 
evidence. 
 
A very insightful study that compared White and Pakistani women’s views towards 
prenatal testing and TOPFA for 30 different conditions found that Pakistani women 
would have testing for more conditions than White women, but less educated 
Pakistani women would have terminations for fewer conditions than less educated 
White women. However, regardless of ethnicity or education level, all women were 
in favour of terminations for the 4 most serious conditions specified, one of which 
was anencephaly (91). Although a clear advantage of this study was that conditions 
were just described and not named to reduce the effect of preconceived ideas, it was 
identified that in reality more information about individual conditions would be 
provided and other factors would influence a woman’s decision, such as 
miscarriage risk (91).  In another study, it was found that mothers of Pakistani 
ethnicity were less likely to terminate a pregnancy affected by a serious congenital 
anomaly than mothers of White or Indian ethnicity (92). 
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2.2.3 Knowledge and peri-conceptional use of folic acid: A systematic review and 
meta-analysis 
 
A systematic review by Stockley and Lund published in 2008 described how peri-
conceptional use of folic acid is still low in the UK, with 48% of women reporting 
taking folic acid as a best estimate and only 21% as the worst (93). It was argued 
that the factor most associated with low supplement use is unintended pregnancy, 
followed by age, socio-economic status and then ethnic group (93). However, while 
the majority of the UK studies included looked at folic acid knowledge and use in 
the UK with reference to age or socio-economic status, very few referred to 
ethnicity. Establishing how peri-conceptional use of folic acid varies by ethnicity is 
critical in helping to determine whether any “true” ethnic differences in NTD 
prevalence exist. To develop a better understanding of why women do or do not 
use folic acid, we need to look to studies assessing women’s knowledge of the role 
of folic acid in NTD prevention, and their sources of information. For ethnic 
communities, this is essential for the appropriate targeting of health education 
campaigns and/or for identifying why a fortification policy is so important. 
 
Therefore, a systematic review and meta-analysis was conducted in the early stages 
of this doctoral thesis to explore how knowledge and peri-conceptional use of folic 
acid for NTD prevention varies by ethnicity in the UK (22). This work was mainly a 
literature review with a small amount of original analysis. For this reason, and as 
the review was conducted so early on and informed key objectives for the later PhD 
work detailed in Chapter 3, detailed methods and findings are included below as 
part of this introductory chapter.  Discussion from the review is included as part of 
the wider discussion around what is known about NTDs and how they can be 
prevented in ethnic communities in the U.K, which can be found at the end of this 
chapter. There is also further discussion around the merits of mandatory 
fortification with folic acid in the final discussion of this thesis in Chapter 7. The 
published manuscript for the review can be found in Appendix A.  
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2.2.3.1 Methods 
 
2.2.3.1.1 Study selection 
 
Medline, Embase, Pubmed and Cochrane databases were searched by one reviewer 
as part of a wider literature review looking at NTDs within different ethnic 
communities (for example, for the wider search in Pubmed, keyword and MESH 
search terms: neural tube defect* and ethnic* were used). The titles, abstracts and 
full articles, where necessary, of the approximately 400 studies identified through 
this wider literature search were scrutinised to identify UK studies that used post-
1991 data: i.e. following publication of the Medical Research Council’s Vitamin 
study (17). The full articles of all relevant U.K papers were downloaded and 
referenced articles from these publications were also assessed for eligibility. Studies 
that included an assessment of folic acid knowledge or peri-conceptional use in 
women of non-White or non-Caucasian ethnicity were included in the final review, 
irrespective of study design.  (22). All U.K papers reviewed from the wider 
literature search were in English and therefore it was not necessary to consider 
placing any restrictions based on language.  
 
2.2.3.1.2 Study evaluation 
 
Within different ethnic groups, the number of women who knew about the benefits 
of folic acid use for NTD prevention, and their sources of information, and the 
number of women who took folic acid pre or peri-conceptionally, was assessed in 
the relevant studies. The influence of other factors on any observed associations 
between ethnicity and knowledge of folic acid benefits and whether folic acid was 
taken pre or peri-conceptionally, was also explored. Findings were evaluated in the 
context of individual studies’ strengths and limitations (22). For example, the 
number of individuals in the studies from non-White or non-Caucasian ethnic 
groups was of critical importance. 
 
As for the study selection process, only one reviewer evaluated the studies. 
However, the Preferred Reporting Items for Systematic reviews and Meta-Analysis 
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(PRISMA) statement, a 27 item checklist and four phase flow diagram (with slight 
adaptations to the latter), was utilised to ensure the adequate and appropriate 
reporting of the systematic review and meta-analysis (94). 
 
2.2.3.1.3 Meta-analysis 
 
Pre-conceptional folic acid use in Caucasians was compared with non-Caucasians 
across all relevant studies using a random effects model, a model that allows for 
variation between different studies i.e. the model allows the true effect to vary from 
one study to another (95). Relevant studies for inclusion were those in which there 
had been a quantification of pre-conceptional folic acid use in ethnic groupings that 
could be appropriately categorised as Caucasian and non-Caucasian (22). The 
analysis was conducted using the metan command in Stata (96), which is 
appropriate to use when conducting a meta-analysis for studies where two groups 
are compared. Using this method, a suitable summary statistic was estimated for 
each study and then a weighted average of that statistic was given across the 
studies. The outcome measure was an odds ratio (the odds of pre-conceptional folic 
acid use in the Caucasian ethnic group when compared to the non-Caucasian ethnic 
group) and the results of the analysis were summarised in a forest plot. It was also 
important to explore any publication or other bias in the meta-analysis and a test to 
explore the association between the observed effect size and study size was also 
carried out (22). This was done using the metafunnel command in Stata (96), which 
plots a graph with treatment effects for individual studies on the x axis and study 
size on the y axis (22). 
 
2.2.3.2 Results 
 
As shown in Figure 3, which summarises the process of selection of studies for 
inclusion, 49 U.K studies were identified from the wider literature search looking at 
NTDs within different ethnic communities. Of these, five studies were eligible for 
inclusion in the review as they assessed folic acid knowledge and/or use in those of 
non-White or non-Caucasian ethnicity using post-1991 data (22). The main reason 
for excluding papers was that folic acid knowledge or use was not considered in 
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those of non-White or non-Caucasian ethnicity (22). One notable example was 
Tedstone and colleagues’ qualitative study which was conducted as part of 
consumer research, commissioned by the Food Standards Agency (FSA), to further 
inform the discussion surrounding folic acid fortification policy (97). The study 
addressed questions around knowledge of the benefits of folic acid for NTD 
prevention and health practices before and during pregnancy, and minority ethnic 
participants were included (97). However, no specific results for these research 
questions, broken down by ethnicity, were reported (22). 
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Figure 3: Flow diagram detailing process of selection of studies for inclusion in 
systematic review and meta-analysis 
Source: Peake et al, Birth Defects Research (Part A) (22) 
 
Key information about the five studies, including study design and type of 
information that was reported, is given in Table 1. In Table 2, a breakdown of the 
number and proportion of participants in each study by ethnicity, is given.  
Records identified through wide 
literature search of neural tube 
defects within ethnic communities 
(n~400) 
Titles and abstracts and full articles 
where necessary scrutinised to 
identify UK studies (n=49) 
UK papers and referenced articles 
from these publications assessed for 
eligibility 
Articles included in review (n=5) 
Articles excluded (n=44): 
Did not consider folic acid 
knowledge or use for NTD 
prevention in women of non-
White or non-Caucasian 
ethnicity 
Articles assessed for comparability  
for meta-analysis (n=5) 
Meta-analysis of pre-conceptional 
folic acid use in Caucasians vs. non-
Caucasians (n=3) 
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Table 1: Key information for individual studies included in systematic review 
Study Study setting  Study Population Study design Study period Knowledge of 
folic acid 
benefits 
assessed? 
Peri-
conceptional 
folic acid use 
assessed? 
Other Information 
Krischer 
(1997) 
2 GP practices 
(presumed Bristol 
due to author’s 
location but 
unspecified) 
105 women from 
inner GP practice 
and 103 women 
from suburban GP 
practice; aged 15-
40 
Self-
completion 
questionnaire 
Inner city GP: 
Aug 1995 
Suburban 
GP: Dec 1995 
Yes No Women included whether or 
not they were attending 
antenatal appointments. 
Not stated how ethnicity 
was defined. 
Jessa and 
Hampshire 
(1999) 
GP antenatal clinics 
in Nottingham 
13 pregnant 
British Pakistani 
women attending 
consecutive 
antenatal clinics  
In-depth 
interview (in 
English, Urdu 
or Punjabi) 
Not stated Yes Yes Ethnicity was ascertained 
using names recorded on 
antenatal lists. 
Howell et 
al (2001) 
Antenatal clinics in 
Tower Hamlets, 
London 
249 women (120 
Bangladeshi and 
100 white) 
attending for first 
antenatal 
appointment 
Verbally 
administered 
questionnaire 
before 
appointment 
October 1997-
July 1998 
Yes Only pre-
conceptional 
folic acid use  
Self-described ethnic group. 
Brough et 
al (2009) 
Homerton Hospital 
antenatal clinic or 2 
community clinics 
in Hackney, East 
London 
402 pregnant 
women attending 
for first antenatal  
appointment 
Researcher-
led 
questionnaire 
June 2002-
May 2004 
No Yes. Before 6 
weeks 
gestation was 
of particular 
interest. 
Self-described ethnic group. 
Non-English speakers and 
those taking multi-vitamins 
(excluding folic acid and 
iron) excluded. 
Lane (2011) Three South Wales 
Hospitals’ antenatal 
clinics 
386 pregnant 
women 
Anonymous 
self-
completion 
questionnaire 
May 2010 Results were 
not broken 
down by 
ethnicity 
Yes Self-described ethnic group 
Source: Peake et al, Birth Defects Research (Part A) (22) 
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Table 2: Breakdown by ethnicity of the number and proportion of participants in each 
study 
 Number of cases (% of total in each study) 
 
Ethnicity Krischer, 
1997 
Jessa and 
Hampshire, 
1999 
Howell et 
al., 2001 
Brough et al., 
2009 
Lane, 2011 
White or 
Caucasian 
White: 
166 (80) 
 White: 
100 (40) 
Caucasian:  
155 (39) 
White: 
307 (80) 
Afro-
Caribbean 
15 (7)     
Asian 18 (9)   42 (10) 32 (8) 
Pakistani  13 (100)    
Bangladeshi   120 (48)   
African    111 (28)  
West Indian    66 (16)  
Black     15 (4) 
Chinese     2 (1) 
Mixed race     5 (1) 
Other/ 
Unknown 
9 (4)  29 (12) 28 (7) 25 (6) 
Source: Peake et al, Birth Defects Research (Part A) (22) 
 
2.2.3.2.1 Folic acid knowledge 
 
As shown in Table 1, three out of the five studies included in the final systematic 
review reported knowledge of the benefits of folic acid in women of non-White or 
non-Caucasian ethnicity. Howell and colleagues reported that in Tower Hamlets, in 
East London, only 35% of Bangladeshi women knew of the benefits of taking folic 
acid in comparison to 84% of White women. This was a statistically significant 
difference (p<0.001) (98). Contrastingly, Krischer reported that in an inner-city GP 
practice, with a multi-ethnic population, there were no key differences in 
knowledge of the link between folic acid and spina bifida between different ethnic 
groups (99). However, Krischer’s study was underpowered and the inner city 
practice only had 105 participants. In Jessa and Hampshire’s qualitative study, 
conducted in Nottingham, pregnant women of Pakistani ethnicity were interviewed 
about their knowledge, health beliefs and attitudes towards folic acid. None of the 
women interviewed knew exactly why folic acid should be taken (22;100). 
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The remaining two studies included in the review (101;102) did not report folic acid 
knowledge in participants, broken down by ethnicity, and it was not possible to 
infer any differences based on the relationship between knowledge and uptake (22). 
 
2.2.3.2.2 Folic acid use 
 
Four of the five included studies reported data on folic acid use.  
 
Jessa and Hampshire reported that none of the 13 Pakistani women interviewed in 
their qualitative study took folic acid in the peri-conceptional period (100). 
 
Howell and colleagues described how in a univariate analysis looking at the 
association between ethnicity and folic acid intake, White women were 5.7 times 
more likely to take folic acid pre-conception than Bangladeshi women (95% CI: 2.5, 
13.2). In the multivariate analysis, where the women’s age, school leaving age, social 
class, parity, planned pregnancy and whether they had heard about folic acid 
benefits, were adjusted for, White women were still 5.2 times more likely to take 
folic acid pre-conception than Bangladeshi women (95% CI: 1.1, 25.2) (98). 
 
Brough and colleagues also found ethnic differences in the pre-conception use of 
folic acid, in their study in Hackney, East London. It was described how pre-
conception folic acid use was highest in Caucasians (19%) followed by Asians (12%), 
West Indians (8%) and Africans (5%). The difference between Caucasians and 
Africans, was of statistical significance (p=0.038). A further 23% of Caucasians had 
started to take folic acid after conception but before neural tube closure (6 weeks 
gestation cut-off in this study). More Caucasian mothers initiated folic acid use 
before 6 weeks gestation than non-Caucasian mothers (p=0.001). Two key 
limitations of Brough and colleagues’ study were that it was not powered to 
investigate folic acid use and women who took multivitamins were excluded, which 
could have potentially biased the study towards participants of lower socio-
economic status. Furthermore, although several factors were explored in the study 
and it was also detailed how mothers from a higher socio-economic group or with 
higher education levels are more likely to use folic acid, there was no multivariable 
model: i.e. an exploration of the association between ethnicity and folic acid use, 
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adjusted for maternal education and socio-economic status (22;101). However, this 
might not have a huge impact on observed outcomes as there was only a modest 
difference in the association between ethnicity and folic acid intake between 
univariate and multivariate models, in Howell and colleagues’ study (98). 
 
Finally, Lane and colleagues, in their study including pregnant women from three 
South Wales Hospitals, reported that there were no ethnic differences in peri-
conceptional use of folic acid. However, numbers of participants in ethnic groups 
other than White British were small, which could have influenced the outcome 
(22;102).  
 
2.2.3.2.3 Sources of information on folic acid 
 
Advice from health professionals (HPs) (e.g., GPs and midwives) was the main 
reason given by participants in Lane’s study for starting to take folic acid (102). 
However, it was also reported that 81% of women who took folic acid based on 
their HPs’ advice, only started taking supplements after they became pregnant 
(102). Participants in Krischer’s study stated both the media (including magazines, 
newspapers, television and radio) and HPs as their sources of information on folic 
acid (99). In Jessa and Hampshire’s qualitative study, none of the Pakistani women 
interviewed said they could recall their GP giving them any folic acid advice. 
However, many said they would only take folic acid if their GP advised them to 
and prescribed it (22;100). 
 
2.2.3.2.4 Meta-analysis 
 
Data on peri-conceptional use of folic acid in Caucasian/White and non-
Caucasian/non-White women were assessed in two studies (101;102) and data on 
pre-conceptional use in three (99;101;102). Therefore, a meta-analysis of the 
association between ethnicity and whether folic acid was used pre-conceptionally, 
was carried out. As only two studies assessed knowledge of the benefits of taking 
folic acid it was not deemed appropriate to also carry out a meta-analysis in this 
area.  
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As the three studies assessing pre-conceptional folic acid use varied in the ethnic 
mix of their participants, and in one study ethnicity was not broken down any 
further than Caucasian British and Other (102), the comparison in the meta-analysis 
was between Caucasians/White and non-Caucasians/non-Whites. As shown in 
Figure 4, the meta-analysis across the three studies, using a random effects model, 
found that the odds of using folic acid before conception were nearly three times as 
high in Caucasian/White women as non-Caucasian/non-White women. Thus, 
when assessed individually, Howell and colleagues (98) and Brough and colleagues 
(101) found a statistically significant difference between Caucasians and non-
Caucasians in pre-conceptional folic acid use and Lane and colleagues did not. 
However, when the results for the three studies are pooled, there is a clear 
treatment effect. A test of heterogeneity between different studies was shown to be 
of borderline statistical significance (p=0.049), lending support to the selection of a 
random effects model for the analysis. Investigations for bias, found that no 
individual study unduly influenced the final treatment effect (22). 
 
Figure 4: Meta-analysis of pre-conceptional folic acid use in Caucasians/Whites compared 
to non-Caucasians/non-Whites. 
Source: Peake et al, Birth Defects Research (Part A) (22) 
 
 
46 
 
2.2.4 Knowledge and peri-conceptional use of folic acid: Research since the 
systematic review was published 
 
In 2014, Bestwick and colleagues reported the results of an audit of the Down’s 
syndrome and NTD screening service at the Wolfson Institute of Preventive 
Medicine in London, which also collects information on whether folic acid is taken 
or not (103). It was reported that Caucasians were more likely to take folic acid 
before pregnancy than non-Caucasians. Specifically, 35% of Caucasians, 18% of 
Afro-Caribbeans, 20% of South Asians, 22% of Oriental women and 23% of those of 
“Other” ethnicity took folic acid before pregnancy. This was after adjustment for 
several factors, including maternal age and diabetes. All differences between the 
Caucasian and non-Caucasian ethnic groups specified were statistically significant 
(103). 
 
2.2.5 Discussion 
 
As described, data from the “folic acid era” indicates that women of Indian (81) and 
Pakistani (81;82) ethnicity have an excess NTD prevalence. Data from 1975 to 1980 
from England and Wales, also found mortality rates for stillbirth and infant deaths 
attributed to NTDs were high in the Bangladeshi community (75). Data from the 
late 1970’s and 1980’s corroborating what is found in the 1990’s is interesting, even 
when terminations are taken into account in the earlier studies (80). However, it is 
also of interest that Leck and Lancashire’s research including data from an even 
earlier period (the earliest data year is 1960) found contrasting results: that there 
was weak statistical evidence that the spina bifida (but not the anencephaly) 
prevalence was higher in Europeans than South Asians (73). Looking back at Morris 
and Wald’s graph (Figure 2) detailing the change in NTD prevalence between 1964 
and 2004, the most marked decline is between the early and late 1980’s (32). The 
authors also previously described how the early 1980’s was a time when there 
started to be an increase in intake of dietary folate (33). It could be argued that Leck 
and Lancashire’s very early study gives a different picture to later research of ethnic 
differences as it included data from a period when the impact of dietary folate is 
unlikely to be substantial, pointing towards increased intake of folate or folic acid in 
the 1980s and 1990s as the reason for observed NTD excesses in mothers of South 
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Asian ethnicity.  However, there were identified limitations with Leck and 
Lancashire’s study, including missing data on ethnicity and them using too broad 
ethnic groupings (73). Ethnic groupings themselves also change over time making 
comparisons for specific ethnic groups over long time frames problematic. It is also 
of importance to take migration history into consideration when interpreting 
findings. For example, Sikh and Hindu families started to settle in the U.K in the 
1960s (104), emphasising how individuals included in the early studies are likely to 
be immigrants or first generation migrants and those in more recent data, second 
generation migrants. These individuals cannot be considered as a homogenous 
group and health behaviours during pregnancy have been shown to differ by 
generational status (105). Moreover, even when looking at a more restrictive time 
period, there are clear indications from the literature that ethnic differences are 
unlikely to be solely explained by discrepancies in folate or folic acid intake. 
 
For mothers of Pakistani ethnicity, recent research from the Born in Bradford study 
underlined the importance of consanguinity in explaining the excess congenital 
anomaly rate in Pakistani mothers when compared to those of White British 
ethnicity (83). This is supported by earlier research which also described maternal 
age as a possible contributory factor for mothers from this ethnic group (74). For 
NTD prevalence specifically, the importance of consanguinity in mothers of 
Pakistani ethnicity has been detailed (77). 
 
Contrastingly, for mothers of Indian ethnicity, consanguinity (74;106) or maternal 
age (74) does not seem to be a significant factor in congenital anomaly risk in the 
U.K. In fact, those of Indian ethnicity are a very interesting group with regards to 
NTD prevalence. As described in section 2.1, those of Indian ethnicity seem to keep 
their high NTD prevalence, regardless of where they reside (54). Looking at 
research in India, a high NTD prevalence has been specifically reported in the North 
(55;58), particularly among the Sikh population, but also among Hindus in certain 
areas (55). In contrast to the epidemic in the North, consanguinity is likely to be a 
significant factor in accounting for pockets of increased prevalence in the South (58). 
The importance of following a vegetarian diet for Hindus and consanguinity in 
Muslims in the North has also been highlighted (63). Reports of an excess of 
multiple congenital anomalies in the Asian population in the North of England (76) 
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and anencephaly affected pregnancies occurring in association with other 
malformations in a study conducted in the West of India (68), also further highlights 
the role of factors other than folic acid in explaining ethnic differences in NTD 
prevalence. 
 
However, the importance of folic acid cannot be ignored and Michie and colleagues 
described how lower red cell folate concentrations were found in mothers of 
Pakistani and Indian ethnic origin (81). The results of the systematic review and 
meta-analysis conducted as part of this thesis, found that Caucasians/Whites are 
more likely to take folic acid before conception than non-Caucasians/non-Whites 
(22), which was also shown in a study conducted after the review was published 
(103). Bestwick and colleagues described how 35% of Caucasians took folic acid 
before pregnancy, in contrast to 20% of South Asians (103). Findings from the 
review also indicated that South Asians are less likely to use folic acid. However, 
there were very few studies included in the final review and this would need to be 
substantiated with further research (22) . 
 
There are some key limitations of the published systematic review and meta-
analysis conducted in the early stages of this doctoral thesis. Included studies were 
conducted in diverse areas throughout the U.K. and of the three included in the 
meta-analysis, two were conducted in East London (98;101) and one in Wales (102). 
The ethnic make-up in Wales is very different to East London and combining the 
three studies in a meta-analysis could have introduced variation due to the 
geographical area that was sampled (22). The study periods for the three studies 
included in the meta-analysis were also diverse, which could have been a potential 
confounder. However, it is unlikely that variations in study periods would have 
greatly affected results as all were within the post-1991 “folic acid era” and folic 
acid usage in the U.K has been consistently low since folic acid supplementation 
policies were implemented (31;93). It is also a limitation of the available data that 
comparisons in the meta-analysis could only be made based on broad ethnic 
categories: Caucasian and non-Caucasian. Although this meant that it was not 
possible to draw conclusions about specific non-Caucasian groupings, it was very 
important in revealing whether U.K Caucasian (largely indigenous) women were 
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more or less likely to take folic acid before conception than non-Caucasians 
(including many migrant families) (22). 
 
Ethnicity was self-described in all studies included in the meta-analysis, which was 
a clear strength. All studies included in the meta-analysis were also conducted in 
antenatal clinics. In Howell and colleagues’ (98) and Brough and colleagues’ (101) 
study it was specifically detailed that this was the first antenatal visit, although this 
was not clearly stated in Lane’s (102) study. Conducting the research at the first 
antenatal visit is important as this is around 12 weeks and it is recommended that 
women take folic acid supplementation up until this time. Therefore, this is likely to 
have resulted in clearer recall about folic acid usage (22). 
 
Taking folic acid in the peri-conceptional period is a clear NTD preventative 
measure and exploring women’s knowledge of folic acid, including where they get 
their information from and whose advice they value, is critical in improving folic 
acid intake within particular communities. Jessa and Hampshire’s qualitative study 
(100) included in the systematic review was particularly revealing for this and 
highlighted the importance of more qualitative research being conducted in this 
area. They highlighted how Pakistani women trusted their GPs most to give them 
pre-pregnancy advice on folic acid. However, none of the women had received this 
information from their GP for their current pregnancy (22;100). GPs were also 
described as important sources of information on folic acid in Krischer’s study (99) 
and as the reason why women started taking folic acid in Lane’s study (102). 
However, critically, it was also detailed how women who took folic acid based on 
their GPs’ advice, were more likely to start late (22;102). 
  
Authors of four out of the five studies included in the systematic review (99-102) 
argued that fortification of food with folic acid is the most effective method to 
improve folate intake. Specifically, it was argued that ethnic minority foods such as 
wheat and chapatti flour need to be fortified to ensure ethnic communities also 
benefit from fortification (22;99-101). Thus, it was argued that carefully targeted, 
innovative education campaigns to promote supplement use together with a 
mandatory fortification policy, including the fortification of ethnic minority foods, 
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needs to be implemented to improve folic acid intake within different ethnic 
communities in the U.K. (22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51 
 
3 Study design and methodology 
 
In this chapter, the rationale behind conducting the PhD and key aims and 
objectives are first detailed. Background information to using mixed (quantitative 
and qualitative) methodology is then given and the decision to use this particular 
methodology is justified. Information on the study design is given, including an 
overview of methods, details of the different study phases and how the different 
components were weighted and integrated. There is a final paragraph with details 
on information governance.  
 
 PhD rationale 3.1
 
As described in Chapter 1, the increasing “invisibility” of neural tube defects 
(NTDs), likely due to their high prenatal detection and termination rate, has 
resulted in there being less of a drive behind their primary prevention in public 
health policy (2). There are inadequate surveillance systems in many settings which 
often do not capture termination of pregnancy for fetal anomaly (TOPFA) cases, 
and therefore the true NTD burden cannot be assessed.  In the U.K the importance 
of pre-conception care as a critical period when intervention can provide long term 
benefit is being increasingly recognised and there seems to have been a recent shift 
in attitude towards NTD prevention, with fortification finally being given real 
consideration. In contrast to the United States, where much of the NTD 
epidemiological research has been conducted, research in the U.K. is scarce. There is 
a real paucity of research specifically into NTD prevention within different ethnic 
communities in the U.K, although, worryingly, based on existing research, there 
seems to be an increased prevalence within certain ethnic groups. Women of non-
White ethnicity, have also been shown to be less likely to take folic acid before 
pregnancy than women of White ethnicity. Thus, there is a real need for updated 
prevalence estimates, that include TOPFA cases, by ethnicity in the U.K. (the last 
study was published in 1998 and included only preliminary data) and to evaluate 
the importance of other factors, including socio-economic status, which has largely 
been unrepresented. It is also crucial to better understand how women’s views and 
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knowledge before and during pregnancy shape their pregnancy decisions, to enable 
the effective targeting of NTD prevention strategies. 
 
 Overall PhD Aim 3.2
 
The overall aim of this doctoral thesis was to gain a better understanding of the 
NTD epidemiology, natural history and views and practices of women from 
different ethnic communities in the U.K, before and during early pregnancy, and to 
use this information to propose appropriate NTD prevention strategies. 
  
 PhD Objectives 3.3
 
1. To calculate accurate NTD prevalence estimates, which include TOPFA 
cases, for different ethnic groups in the U.K. 
 
2. To explore the impact of other factors e.g. socio-economic status, on any 
observed association between NTD prevalence and ethnicity. 
 
3. To explore the factors influencing women’s decisions of whether to continue 
an NTD affected pregnancy or not, including variation by ethnic groups. 
 
4. To assess in-depth information from women from ethnic communities about 
their knowledge, attitudes and  health behaviour before and during 
pregnancy, particularly with regards to folic acid supplementation, and how 
this impacts on decisions. 
 
 
 
 
 
 
53 
 
 Mixed Methodology 3.4
 
3.4.1 Background 
 
Johnson and Onwuegbuzie describe mixed methods research as a “third research 
paradigm” with quantitative research at one end of a continuum, qualitative 
research at the other end and mixed methods research in the middle (107). The same 
authors, after considering criteria that leaders in the field deem important for 
defining the methodology, described in 2007 a general definition for mixed methods 
research. It is stated that it combines quantitative and qualitative elements to enable 
a depth and breadth of understanding and also for corroboration (108). Similarly, 
Castro and colleagues  argue that using mixed methods can combine confirmatory 
results from quantitative multivariable analyses with “deeper structure” 
explorations drawn from the qualitative methods (109). However, that is not to say 
that mixed methods research is in fact superior to traditional quantitative and 
qualitative research and, as Johnson and Onwuegbuzie argue, a three paradigm 
(quantitative, qualitative and mixed methods) world is actually healthy and each 
has strengths and limitations and places of need (108).  
 
Lingard and colleagues describe the importance of clearly detailing the strategy for 
mixing methods, including the methods sequence, whether there is equal weighting 
for qualitative and quantitative components or one is prioritised over the other and 
how and when methods are integrated (110). Johnson and Onwuegbuzie argue that 
the lines between the quantitative and qualitative paradigms are less clear than is 
often presented (108). Therefore, Linguard and colleagues emphasise how good 
mixed methods research does not dichotomise the values and methods of the two 
paradigms but clearly articulates how and why there is an integration of the 
different aspects (110).  
 
3.4.2 Justification for using mixed methods 
 
The focus of this PhD is ethnicity. As Sheldon and Parker rightly highlight, even if 
ethnicity is self-reported, the ethnic categories which individuals are asked to 
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identify themselves with in the first place, are socially determined (111). Therefore, 
although it is of importance to collect this information, there also needs to be a 
degree of critical engagement with it. Using mixed methods for this PhD was 
viewed as essential to achieve the appropriate level of insight to enable all research 
questions to be addressed adequately.  Quantitative data were required to calculate 
up-to-date NTD prevalence estimates for different ethnic groups in the U.K and to 
start to explore how other key factors might affect these differences.  Quantitative 
data were also important for initial investigations of the factors affecting women’s 
decisions around whether to continue their NTD affected pregnancy or not. 
However, it was also crucial to understand women’s knowledge, attitudes, views, 
behaviour and cultural influences in relation to folic acid prevention and pregnancy 
decisions. It was not possible to explore this in the quantitative study and was only 
possible through the in-depth qualitative interviews.  The “why” that could only be 
explored to a certain extent using the quantitative data was further investigated in 
the qualitative study and enabled specific recommendations to be made. 
 
3.4.3 Study design 
 
3.4.3.1 Quantitative methods overview 
 
As described in further depth in Chapter 4, the British Isles Network of Congenital 
Anomaly Registers (BINOCAR), a network of regional congenital anomaly registers 
across the U.K. and Republic of Ireland, was viewed as the best data source for the 
quantitative research. Key reasons for this are that all registers are population 
based, include termination of pregnancy for fetal anomaly (TOPFA) cases and have 
multi-source reporting, to ensure case ascertainment is as high as possible. There 
were five BINOCAR registers that neural tube defect (NTD) cases were reported to 
which both collected ethnicity information and permission was granted to use the 
data for the study. Therefore, pseudonymised, individual level data was obtained 
from these five BINOCAR registers for all NTD cases between the years 2006 to 
2011 inclusive. Only NTD cases with mothers aged 16 or over were included for 
ethical reasons. Live and still birth denominator data from the Office for National 
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Statistics (ONS) were also obtained for the same data years and regions to enable 
NTD prevalence estimates to be calculated. 
 
Unfortunately, there is not currently a congenital anomaly register that covers any 
part of London, which, critically, is a very ethnically diverse area. It was, however, 
possible to obtain termination data, where an NTD was given as a reason for the 
termination, from the Department of Health (DH) for London. DH termination data 
were also obtained for the regions covered by two of the BINOCAR registers 
included in the study for the same data years. Requesting DH termination data 
from only two regions also covered by BINOCAR registers was viewed as necessary 
and sufficient to help to validate the completeness of the picture for terminations 
due to NTDs in the London DH data and also to conduct any other comparative 
analyses. Termination denominator data were also obtained from the DH. As 
described in chapter 5, there are both indications of under ascertainment in the DH 
dataset when an NTD is a reason for the termination and under reporting of 
terminations to the DH (112). The DH denominator data were used for important 
sensitivity analyses around NTD prevalence estimates (Chapter 4) and NTD 
termination cases were linked with NTD TOPFA cases in the BINOCAR dataset for 
explorations around ethnicity (Chapter 5). However, due to the stated problems, 
further investigations solely looking at the DH termination data for London were 
deemed unreliable.   
 
Stata versions 12 and 13  (96;113) were used to clean and analyse the data. To 
explore NTD prevalence, binomial regression, regression with proportions as the 
outcome (binomial distribution), was used. To explore the natural history of NTD 
affected pregnancies, logistic regression, regression with a binary outcome (binary 
distribution) was used. Statistical methods used in the quantitative research are 
explored in-depth in chapters 4 and 5. 
 
3.4.3.2 Quantitative study sample size calculation 
 
One early study conducted in England and Wales found that mortality rates for 
stillbirth and infant deaths attributed to NTDs for mothers born in 
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India/Bangladesh were nearly twice as high as to mothers born in the U.K (75). 
Another early study found that mothers of Pakistani ethnicity in London had a rate 
of NTD affected pregnancies that was more than double that for White mothers 
(80).  Analyses using data from 1995, from the West Midlands region of the U.K, 
found that the rate of NTD affected pregnancies to mothers of Pakistani ethnicity 
was more than five times higher than to mothers of White ethnicity. However, this 
was conducted using only preliminary data (82). 
 
Using the sampsi command in Stata, the minimum number of mothers from 
different ethnic groups required in the study population in order to detect a number 
of different NTD rate differences, were explored. Using this method, it was shown 
that to detect an NTD rate that is two times higher in mothers of Pakistani than 
White ethnicity, 11794 mothers would be required in the former ethnic group and 
196566 in the latter. To detect an NTD rate that is two times higher in mothers of 
Indian than White ethnicity, 11493 mothers would be required in the former ethnic 
group and 287315 in the latter. Finally, to detect an NTD rate that is two times 
higher in mothers of Bangladeshi than White ethnicity, 11191 mothers would be 
required in the former ethnic group and 559517 in the latter. 
 
3.4.3.3 Qualitative methods overview 
 
Mothers aged 18 years or older who had a previous NTD affected pregnancy, from 
ethnic communities, were recruited for in-depth semi-structured interview by 
advertisements in hospitals, specialist organisations, community and faith-based 
organisations and social media. Participation in the study was entirely voluntary. 
 
It was decided that grounded theory methodology would be used to both conduct 
and analyse the qualitative research due to its strongly inductive nature and focus 
on actions.  It was gaining in-depth information from interviewees about their 
knowledge, attitudes and experiences before and during their pregnancy affected 
by an NTD that was not unnecessarily forced down a particular direction due to 
researcher biases or pre-conceived ideas, which was of critical importance. The use 
of the constant comparative method, constantly comparing data with data, ensured 
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that the analysis and researcher interpretations were continually challenged and 
grounded in the data. NVivo 10 software (114) was used to analyse the data. In-
depth information about the grounded theory methodology and how it was used in 
the qualitative research is detailed in Chapter 6. 
 
3.4.3.4 Study Sequence 
 
Although the quantitative research was started first and key information was 
obtained which informed how the qualitative study was conducted: e.g. which 
ethnic groups to focus on, the quantitative study was not completed before the 
qualitative study began. This enabled results from the qualitative study to also shed 
new light on results from the quantitative study and how later analyses were 
conducted and interpreted (Figure 5). Therefore, although detailed methodology, 
findings and key conclusions from the quantitative study are presented first in 
Chapters 4 and 5 and then methodology, findings (with a stream of discussion 
throughout) and conclusions for the qualitative study in Chapter 6, this is not 
exactly the sequence of how things occurred.  
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Figure 5: Phases of research in relation to quantitative and qualitative study sequence 
 
3.4.3.5 Study Weighting 
 
Quantitative and qualitative components were essential to enable research 
questions to be addressed adequately, as detailed, and it was dependent on the 
research question being addressed as to whether each was given equal weighting or 
one took precedence over the other. However, overall, there was a stronger 
weighting for the quantitative study which was the bigger research component. 
  
3.4.3.6 Integration of quantitative and qualitative study components 
 
As shown in Figure 5, analyses of qualitative data in Phase 3 of the research were 
used to inform final analyses in the quantitative study in Phase 4 of the research. 
This was particularly apparent for explorations about pregnancy decisions. 
However, qualitative findings were not explicitly integrated with the quantitative 
findings around pregnancy decisions in Chapter 5 as it would have been 
Data collection 
Preliminary analyses 
Data collection and analysis On-going analyses 
Phase 1 
Phase 2 
Phase 3 
Phase 4 Final analyses Final analyses 
Quantitative study Qualitative study 
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problematic to do so before the qualitative research had even been detailed. It 
should therefore be kept in mind when reviewing conclusions for this aspect of the 
quantitative study that they were not without influence from the qualitative data. 
For these reasons, a detailed discussion with regards to the quantitative findings is 
saved for the final discussion (Chapter 7), where the findings from the two study 
components are more explicitly triangulated. 
 
 Information Governance 3.5
 
NHS Research Ethics Committee (REC) approval was granted for both the 
quantitative and qualitative study (REC reference: 12/LO/0890). There were also 
two substantial amendments to the original ethics application, which also received 
favourable opinions. The approval form for the most recent application can be 
found in Appendix B. It was also necessary to obtain section 251 approval for the 
quantitative study, due to the collection of sensitive patient data without explicit 
patient consent. Both the initial application and a subsequent amendment received 
approval and the approval form for the latter can be found in Appendix B. As part 
of this, an NHS Information Governance Toolkit was completed in early 2014 and 
renewed in 2015. Access to the BINOCAR data was granted by the BINOCAR 
Management Committee and permission was obtained from the Chief Medical 
Officer (CMO) for use of the DH termination data (the approval letter from the 
CMO is included in Appendix B). 
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4 Introduction to the British Isles Network of Congenital 
Anomaly registers (BINOCAR) dataset and preliminary 
epidemiological explorations 
 
In this Chapter the main data source for the quantitative study is introduced and 
initial investigations of NTD prevalence are carried out using both this dataset and, 
where appropriate, additional termination data obtained from the Department of 
Health. These initial explorations were conducted with the aim to inform the main 
analyses around ethnicity, detailed in Chapter 5. 
 
 BINOCAR data by register 4.1
 
The British Isles Network of Congenital Anomaly Registers (BINOCAR) is a 
network of regional congenital anomaly registers across the United Kingdom and 
Republic of Ireland. These regional registers were set up alongside the National 
Congenital Anomaly System (NCAS) to address both the under-ascertainment and 
also local research needs (115). Details of all registers included in the study, are 
given in Table 3. All registers are full members of the European Surveillance of 
Congenital Anomalies (EUROCAT), the European network of congenital anomaly 
registers, and are population based, collecting data on all pregnancies affected by 
congenital anomalies within the region. Although reporting to all registers is 
voluntary, case finding is active and there is multi-source reporting. Case 
ascertainment by regional registers is markedly better than the former NCAS, which 
didn’t record terminations of pregnancy for fetal anomaly (TOPFA) cases. However, 
it was shown that even when looking solely at live and still birth cases, only 60% of 
the cases that were notified to the regional congenital anomaly registers were also 
notified to NCAS (115). In addition to multiple source notification, routine audits by 
regional registers of their data ensure that as many congenital anomaly cases are 
captured as possible (116;116). High levels of ascertainment have also been 
confirmed through register comparisons through BINOCAR and EUROCAT (117). 
However, different regions have been shown to differ in antenatal detection over 
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time and in the extent to which postnatal cases are notified (117). As shown in Table 
3, the East Midlands and South Yorkshire Congenital Anomalies Register 
(EMSYCAR) has no upper age limit, for the Northern Congenital Abnormality 
Survey (NorCAS) it is 12 years, South West Congenital Anomaly Register (SWCAR) 
18 years, for the Congenital Anomaly Register for Oxfordshire, Berkshire and 
Buckinghamshire (CAROBB) only cases diagnosed up to 1 year of age are notified 
and for the Congenital Anomaly Register and Information Service for Wales 
(CARIS) the upper age limit is also one year (excluding chromosomal and 
syndromic cases). However, the discrepancy in postnatal notifications is unlikely to 
be great due to very few postnatal notifications in fact being made to any register 
(118). Moreover, for congenital anomalies such as neural tube defects (NTDs), 
which have a high prenatal detection rate (49), this is likely to present less of a 
problem than for defects such as congenital heart disease (117).  
 
The key data variables obtained from BINOCAR registers specifically for NTD cases 
notified between 2006 and 2011, is given in Table 4, along with an indication of the 
missing data for each variable. “NTD cases” were extracted based on International 
Classification of Diseases (ICD) 10 codes: Anencephaly and similar malformations 
(Q00); Encephalocele (Q01) and Spina bifida (Q05), with all sub-codes included. The 
“Anencephaly and similar malformations” group is simply referred to as 
“Anencephaly” in the rest of this thesis, although Craniorachischisis is also 
included under this grouping. As shown, completeness for most variables across 
the registers is consistently high; notable exceptions are body mass index (BMI) of 
the mother, which has very poor completion in all registers apart from NorCAS, 
and the sex of baby (although completeness is much better in NorCAS). Critically 
ethnicity has 13% and 16% missing data in EMSYCAR and SWCAR respectively 
and 45% missing data in NorCAS. 
 
It is of importance to note the on-going communication that went on with 
BINOCAR staff and register representatives throughout the duration of this 
research, to query and further explore obtained data in order to better understand it 
and interpret results. 
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Table 3: BINOCAR register description 
Register name (short 
name)  
Population coverage Year established Annual notification Case Ascertainment 
Minimum and 
maximum age at 
diagnosis 
Population 
Characteristics 
(based on ONS 
2011 birth data) 
East Midlands and 
South Yorkshire 
Congenital 
Anomalies Register 
(EMSYCAR) 
All mothers normally 
resident within South 
Yorkshire and the 
counties of Derbyshire, 
Nottinghamshire, 
Lincolnshire, 
Leicestershire, Rutland 
and Northamptonshire 
(74,000 births annually) 
1997 1,400 
Voluntary, multi-
source reporting: 
Includes antenatal 
clinics, delivery 
suites, neonatal 
screening, neonatal 
and special care baby 
units, cytogenetics 
laboratories, clinical 
genetics, pathology, 
paediatric surgery 
and departments of 
child health.   
No lower age limit 
(all early losses and 
terminations with 
anomalies 
registered). Also, no 
upper age limit. 
82% White; 2% 
Black/Black British; 
6% Asian/Asian 
British 
Northern Congenital 
Abnormality Survey 
(NorCAS) 
Mothers resident in 
North East England 
and North Cumbria 
(32,000 births annually) 
1985 800 
Voluntary, multi-
source reporting: 
Includes 
ultrasonographers, 
geneticists, midwives, 
radiographers, 
obstetricians, 
paediatricians from a 
wide range of 
specialties, 
pathologists, 
cardiologists, 
fetal medicine 
specialists and 
surgeons. 
No lower age limit 
(all early losses and 
terminations with 
anomalies 
registered). Upper 
age limit: 12 years 
90% White; 1% 
Black/Black British; 
3% Asian/Asian 
British 
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Congenital Anomaly 
Register for 
Oxfordshire, 
Berkshire and 
Buckinghamshire 
(CAROBB) 
1991-2004: Oxfordshire 
only (7,000 births)    
2005 onwards: Whole 
of Oxfordshire, 
Berkshire and 
Buckinghamshire 
(30,000 births annually) 
1991 700 
Voluntary, multi-
source reporting: 
Includes antenatal 
clinics, obstetric 
ultrasound, delivery 
suites, special care 
baby units, 
cytogenetic 
laboratory, paediatric 
pathology and the 
Down’s syndrome 
service. 
No lower age limit 
(all early losses and 
terminations with 
anomalies 
registered). Upper 
age limit 1 year  
74% White; 4% 
Black/Black British; 
11% Asian/Asian 
British 
South West 
Congenital Anomaly 
Register (SWCAR) 
South West SHA 
(formerly Avon, 
Gloucestershire and 
Wiltshire; Dorset and 
Somerset and South 
West Peninsula) 
(approx 59,000 births 
annually) 
2002 1,500 
Includes Ultrasound, 
Cytogenetics, 
Pathology 
(Postmortem 
Reports), Delivery 
Suites, Gynae Wards, 
Neonatal Intensive 
Care Units, 
Paediatricians, 
Physiotherapy, X-ray, 
Sub specialist 
consultants e.g. 
paediatric renal 
medicine/surgery, 
orthopaedics, 
genetics, cardiac 
databases, fetal 
medicine. 
No lower age limit 
(all early losses and 
terminations with 
anomalies 
registered). Upper 
age limit 18 years 
87% White; 1% 
Black/Black British; 
2% Asian/Asian 
British 
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Congenital Anomaly 
Register and 
Information Service 
for Wales (CARIS) 
All of Wales (approx 
35,000 births annually) 
1998 1,200 
Voluntary, multi-
source reporting: 
Includes antenatal 
clinics, delivery units,  
paediatric depts., 
ophthalmology, 
cytogenetics, 
pathology, 
orthopaedics, 
maxillo-facial and 
regional centres of 
paediatric surgery 
No lower age limit 
(all early losses and 
terminations with 
anomalies 
registered). Upper 
age limit 1 year 
(excl chromosomal 
anomalies and 
syndromes that are 
included 
irrespective of age) 
86% White; 1% 
Black/Black British; 
2% Asian/Asian 
British 
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Table 4: Missing data for key variables by register 
Register name 
(short name)  
Number of 
NTD cases 
notified 
between 
2006 and 
2011 (based 
on Feb 2014 
EUROCAT 
update) 
% missing for key variables 
Year 
of 
outc
ome 
Primary 
Care 
Trust of 
mother's 
residenc
e at birth 
outcome 
Number of 
babies/fetuse
s affected  
Number 
of 
malforme
d in 
multiple 
set  
Multiple 
malformatio
n code1 
Sex of 
baby for 
cases 
with 
gestatio
n length 
<18 
weeks 
Sex of 
baby for 
cases 
with 
gestatio
n length 
>=18 
weeks 
Ethnicity 
of 
mother2  
Age of 
mothe
r at 
outco
me 
Materna
l BMI at 
booking 
Index of 
Multiple 
Deprivation 
(IMD) 2010 
score/quintil
e of mother's 
residence at 
birth 
outcome3 
East Midlands 
and South 
Yorkshire 
Congenital 
Anomalies 
Register 
(EMSYCAR) 
511 0 0.39 0 0 0 80.38 22.19 12.92 1.57 100 0.39 
Northern 
Congenital 
Abnormality 
Survey (NorCAS) 
288 0 13.40 0 0 0 29.37 6.17 45.83 0 23.26 11.81 
Congenital 
Anomaly Register 
for Oxfordshire, 
Berkshire and 
Buckinghamshire 
(CAROBB) 
216 0 0.47 0 0 0 77.42 30.08 38.43 0.46 96.76 0 
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South West 
Congenital 
Anomaly Register 
(SWCAR) 
326 0 0.31 0.31 0 0 74.14 34.76 7.06 0 94.17 0 
Congenital 
Anomaly Register 
and Information 
Service for Wales 
(CARIS) 
303 0 2.02 0 0 0 53.64 21.76 32.01 0 94.06 2.02* 
 
1
Multiple malformation code gives indication of whether NTD occurs in isolation or in association with other defects. 
2Broadly based on the ONS 2001 census classification 
3The IMD score, based on maternal postcode, is calculated in a different way for England and Wales and the two are not directly comparable. 
 
67 
 
 Twins/Multiple Births 4.2
 
4.2.1  Twins/multiple births in the BINOCAR dataset 
 
Data were obtained from BINOCAR for individual NTD affected babies. Through 
early explorations of the dataset it was found that there were a number of cases that 
were part of a multiple set; between 4 and 5% of the cases for each register were 
multiples, with NorCAS being the exception where nearly 7% of cases were. 
Overall, there were 78 multiples in the dataset (Table 5). In 63 of the multiple cases 
only one fetus had a malformation (this included the triplet pregnancy) and in 15 
both fetuses were affected. While most registers had more multiple pregnancies in 
which only one fetus was affected compared with two affected fetuses, the CARIS 
register had an equal number of both (Table 6).  
 
Table 5: Breakdown of number of NTD affected babies that are singletons or part of a 
multiple set (twins or triplets), by register 
Number of 
babies/fetuses in 
pregnancy of 
affected NTD 
case 
No. (%) in each register 
EMSYCAR NorCAS CAROBB SWCAR CARIS Total 
1 489 (96) 
268 
(93.06) 
207 
(95.83) 
312 
(95.71) 
289 
(95.38) 
1565 
(95.19) 
2 22 (4.31) 19 (6.6) 9 (4.17) 13 (3.99) 14 (4.62) 77 (4.68) 
3 0 1 (0.35) 0 0 0 1 (0.06) 
Number 
unknown 0 0 0 1 (0.31) 0 1 (0.06) 
Total 511 288 216 326 303 1644 
 
Table 6: Breakdown of the number malformed in multiple set by register 
Number malformed 
in multiple set 
No. (%) in each register 
EMSYCAR NorCAS CAROBB SWCAR CARIS Total 
1 19 (86.36) 17 (85) 9 (100) 11 (84.62) 7 (50) 63 (80.77) 
2 3 (13.64) 3 (15) 0 (0) 2 (15.38) 7 (50) 15 (19.23) 
Total 22 (100) 20 (100) 9 (100) 13 (100) 14 (100) 78 (100) 
 
When restricting the dataset to multiples where both fetuses/babies had a 
malformation, it became very apparent that there were four cases in the dataset that 
corresponded to only two pregnancies i.e. there were two twin pregnancies where 
both fetuses had been registered as having an NTD (both of these came from 
68 
 
CARIS). It was not deemed appropriate to include both of these pregnancies twice, 
as maternal factors would be included twice and the focus of this research is the 
NTD prevalence in pregnant women from different ethnic communities. Therefore, 
each pregnancy was defined as an affected pregnancy and one fetus from each of 
these two pregnancies was excluded from the analysis. For one twin pregnancy 
both fetuses had the same disease and pregnancy outcome and so either case could 
be dropped while for the other, the most severe case was kept in the dataset. The 
result was that each line in the dataset corresponded to an NTD affected pregnancy. 
When further exploring the dataset to look at previous siblings with an NTD i.e. 
recurrence in the dataset, it became clear that there were a further two cases which 
were twin pregnancies but only one from each had been included in the NTD 
dataset. 
 
4.2.2 Differences between singletons and twins / multiple births 
 
The dilemma still remained of how to handle multiple pregnancies in the analyses. 
There is not currently a straightforward solution for this and there is no “standard” 
approach from the literature. However, a clear excess in non-chromosomal 
congenital anomalies in multiple births when compared to singletons (119) most 
commonly in monochorionic twins and specifically anomalies of the central nervous 
system (120) has been reported; both studies included fetal deaths from 20 weeks 
gestation and terminations of pregnancy for fetal anomaly in their case definition. 
Glinianaia and colleagues’ (2008) study was focussed on the North of England and 
was not sufficiently powered to look at differences between different anomalies 
(120). Previous research has specifically detected an increased prevalence of 
anencephaly in multiples when compared to singletons (121-123), although all 
studies were limited by the fact that only live and/or still birth cases were included. 
Looking at the NTD dataset from BINOCAR, the proportion of anencephaly cases in 
multiple pregnancies (53%) is higher than in singleton pregnancies (40%) and the 
difference is of statistical significance (p=0.034). There is no statistically significant 
difference in the proportion of spina bifida cases in multiples pregnancies (39%) 
when compared to singletons (48%) (p=0.138). 
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It has been reported that a fifth of multiple birth non-chromosomal anomaly cases 
also have a twin with a congenital anomaly (119). In the BINOCAR NTD dataset, if 
NTD cases rather than NTD pregnancies are included, overall (including 
chromosomal cases) in 19% of multiples both twins had a malformation (Table 6) 
and excluding chromosomal cases 18%. It has long been established that 
discordancy does not mean that genetic factors are not important (124). 
 
It is also known that older mothers are more likely to have multiple pregnancies 
(125) and using the NTD dataset there was found to be a higher proportion of twins 
in the 40+ age group (13%) than any of the other age groupings (between 3 and 6%) 
(p=0.032); this is specific for the spina bifida subgroup where 18% of mothers of 
affected pregnancies are 40 or over (p=0.002). When chromosomal cases are 
removed from the analyses, the effect remains very similar (17% of mothers are 40 
or over) (p=0.013). 
  
It has been shown that living in an area of lower deprivation, one possible 
explanation being the better access to Assisted Reproductive Technology (ART), is 
associated with a higher twinning rate (125). Using only NTD affected pregnancies 
from the four English registers (NorCAS; EMSYCAR; SWCAR and CAROBB) to 
compare deprivation of maternal residence between multiples and singletons, there 
were found to be no statistically significant differences (p=0.914). 
  
The focus of this research is ethnicity, with a key research question being whether 
the NTD prevalence is higher in certain ethnic communities. Therefore it is relevant 
to note that, according to the literature, there are high twinning rates in central 
African countries and low twinning rates in South Asian countries (126). However it 
was difficult to look at ethnic differences between the singleton and multiples 
groups in the BINOCAR NTD dataset due to small numbers; although all cases in 
the multiple with two malformations group were White, this was not statistically 
significant (p=0.923) and chromosomal cases being excluded made little difference 
(p=0.995).  
 
Another key research area for this study was to explore the natural history of NTD 
affected pregnancies within different ethnic communities. The main outcome 
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measure for this area of research was whether the pregnancy was terminated or not. 
It has been shown from the literature that twin pregnancies are less likely to be 
terminated than singleton pregnancies and critically there is a difference in the 
termination rate between multiple pregnancies where both fetuses have an anomaly 
and where only one twin is affected (119), as would be expected. In the BINOCAR 
dataset, multiple pregnancies where both fetuses have a malformation and 
singleton affected pregnancies have similar termination rates ((10 out of 13 (77%) 
and 1,253 out of 1,565 (80%) of pregnancies are terminated, respectively)). 
Termination rates for multiple pregnancies where there is only one affected fetus, 
are much lower ((32 out of 63 (51%) of pregnancies are terminated)) (p<0.001). 
However, as shown, no association was detected between ethnicity and whether the 
pregnancy was singleton or multiple and so twin pregnancies are unlikely to have a 
significant impact on analyses. 
 
In conclusion, taking into consideration whether the pregnancy is singleton, 
multiple with one malformation or multiple with two malformations is unlikely to 
affect the study outcomes greatly. However, based on observed differences and 
reported differences from the literature, it was decided that sensitivity analyses 
would be carried out after the main analyses, exploring the impact of excluding 
multiple pregnancies.  
 
 Siblings with anomalies in NTD dataset 4.3
 
A further level of complexity in the dataset that needed to be given due 
consideration before calculating prevalence estimates was NTD recurrence. The 
“Siblings with anomalies” variable which designates whether a case has a sibling 
with a congenital anomaly and whether it is the same defect is poorly completed in 
all registers except CARIS and therefore, was not used in the analysis (Table 7). This 
is unfortunate as although it would not have been possible to use this variable to 
assess the actual recurrence rate, as there is no denominator data for the number of 
siblings a case has, it would have been useful to link two NTD cases in the dataset  
with the same mother as the recurrence risk is higher than the first time risk for 
NTDs (10). 
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Table 7: Breakdown of siblings with anomalies variable (number and proportion) by 
register 
Siblings with 
anomalies  
No. (%) in each register 
EMSYCAR NorCAS CAROBB SWCAR CARIS Total 
Same anomaly1 10 (1.96) 0 0 0 
10 
(3.32) 20 (1.22) 
Different anomaly 20 (3.91) 0 0 0 
20 
(6.64) 40 (2.44) 
Same and a different 
anomaly2 7 (1.37) 0 1 (0.46) 0 
1 
(0.33) 9 (0.55) 
No anomaly 7 (1.37) 0 0 0 
214 
(71.1) 
221 
(13.46) 
Not known 467 (91.39) 
288 
(100) 
215 
(99.54) 
326 
(100) 
56 
(18.6) 
1352 
(82.34) 
Total 511 288 216 326 301 1,642 
 
1 NTD 
2 NTD and another congenital anomaly 
 
 NTD subtype and “birth” prevalence 4.4
 
4.4.1 BINOCAR birth prevalence equation 
 
BINOCAR and EUROCAT calculate a “birth” prevalence for congenital anomalies 
that has the number of cases of congenital anomaly resulting in live births (CALB), 
stillbirths (CASB), late miscarriages (CALM) and terminations of pregnancy for fetal 
anomaly (TOPFA) (CATOPFA) in the numerator and the total number of live births 
(LB) and still births (SB) in the population, in the denominator. This value is then 
multiplied by 10,000 to give congenital anomaly birth prevalence per 10,000 births.  
The “birth” prevalence equation is as follows: 
 
𝑝 = 10,000 ×
𝐶𝐴𝐿𝐵+𝐶𝐴𝑆𝐵+𝐶𝐴𝐿𝑀+𝐶𝐴𝑇𝑂𝑃𝐹𝐴
𝐿𝐵+𝑆𝐵
      (1) 
 
For all registers, denominator data (live and stillbirths) is based on Office for 
National Statistics (ONS) statistics for births over the same time period, which are 
viewed as robust statistics. 
 
72 
 
The term “birth” prevalence can be misleading and from the name it might be 
assumed that only CALB and CASB cases are included in the numerator; however, it 
is so called due to convention with the four “birth” or pregnancy outcomes in the 
numerator and only births (but not TOPFA or late miscarriages) in the population in 
the denominator. Moreover, as detailed in the introduction to this thesis in 
Chapter1, it would be expected that the majority of TOPFA cases would survive to 
birth if the pregnancy had not been terminated (2). It is only ever possible to 
calculate a birth prevalence rather than a true incidence for congenital anomalies 
due to early fetal losses that are not included in any of the data sources.  
 
Figure 6 shows the natural history of NTD affected pregnancies with the blue circle 
containing  cases that will largely be included in the BINOCAR birth prevalence 
estimates, although there will also be some early losses in this period that wouldn’t 
be included. The diagram is an oversimplification as scans are carried out, and 
NTDs detected, throughout pregnancy with the earliest prenatal discovery 
occurring at 8 weeks and the latest at 32 weeks in the dataset. However, the main 
scans are at 12 and 20 weeks with peaks in NTD detection around these time points. 
Again, TOPFA are carried out over various weeks in the dataset, ranging from 8 to 
37 weeks; however, the majority are carried out within a few weeks of the NTD 
being detected and there are therefore peaks for this pregnancy outcome just after 
12 weeks and just after 20 weeks. The circle in Figure 6 goes beyond birth as there 
are few cases in the dataset that are detected postnatally.  
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Figure 6: Natural History of NTD affected pregnancies with a focus on “birth” outcomes 
included in the BINOCAR birth prevalence calculation 
 
As described in the previous section, two cases which had a corresponding case 
from the same pregnancy, i.e. both twins had an NTD, were dropped from the 
dataset making the dataset by pregnancy rather than case. Although technically the 
BINOCAR birth prevalence equation refers to NTD cases, as described, only two 
cases were dropped and it meant that maternal ethnicity would not be included 
twice for the same pregnancy. 
 
Conception 
12 week scan – 
NTD diagnosed 
20 week scan – 
NTD diagnosed 
Live/still birth – 
NTD diagnosed 
High rate of early (largely 
undiagnosed) spontaneous abortions 
Late fetal losses 
TOPFA 
TOPFA 
Fetal losses 
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4.4.2 Merging numerator and denominator datasets to calculate prevalence 
 
The BINOCAR NTD (numerator) dataset was collected separately from the ONS 
denominator (all live and still births within the population) dataset. The former 
included individual pregnancy level data, whereas the latter only contained 
aggregated data. For this reason, the NTD dataset had to be transformed into an 
aggregate format (collapsed) before being merged with the denominator dataset to 
explore NTD prevalence (Figure 7). 
 
 
 
Figure 7: Process of merging pregnancy level and aggregated data to calculated prevalence 
estimates 
 
4.4.3 Using binomial regression to estimate NTD prevalence for aggregate binary 
data 
 
In order to explore the associations between NTD prevalence and other factors in 
the dataset, binomial regression was used. For prevalence rate ratios (PRRs), the 
reference group was always the group with the highest number of births. 95% 
confidence intervals are usually presented alongside prevalence and PRR estimates, 
as they give an indication of the possible effect sizes compatible with the data. 
However, p-values are also sometimes included in tables and often quoted in the 
text as they give a quantification of the significance level. If confidence intervals for 
the prevalence estimate for one group does not overlap with those from another 
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group and if the confidence interval for a PRR does not cross 1, then a statistically 
significant difference is indicated. Where only summary statistics are available, 
exact binomial confidence intervals are presented instead, which are comparable to 
confidence intervals generated using the binomial regression method, using the 
binreg command, in STATA. All analyses were conducted in STATA. 
 
4.4.4 NTD Prevalence for individual data years 
 
As described in Chapter 1, there are phenotypic and aetiological differences 
between the different types of NTD. This includes a marked female excess for 
anencephaly affected pregnancies specifically and there is debate around whether 
encephalocele should even be considered an NTD due to its distinct genetic, 
environmental and clinical background (127).  Therefore, in addition to calculating 
an overall NTD birth prevalence for all pregnancies in the dataset, it was important 
to look at birth prevalence for individual NTD types. 
  
The prevalence for all NTD affected pregnancies and then by NTD type was first 
calculated for individual years due to several years’ data being included in the 
dataset (2006 to 2011 inclusive). These results are presented in Figure 8. 
 
 
Figure 8: Birth prevalence by year for all NTD affected pregnancies and by NTD type 
 
It is also interesting to compare prevalence estimates for all NTD cases based on the 
BINOCAR equation with prevalence estimates where only live and still birth cases 
are included (Figure 9). Many studies on NTD prevalence are based solely on 
76 
 
live/still birth ascertainment, and can be seen to grossly underestimate the true 
NTD prevalence. As Figure 9 shows, there is a huge discrepancy in the NTD 
prevalence, across all data years, between estimates that include and exclude 
TOPFA and late miscarriage cases. 
 
 
Figure 9: NTD birth prevalence estimates using all NTD cases and only live and still birth 
cases 
 
Comparing prevalence estimates (for all NTD cases) between individual years, there 
are shown to no significant differences (Table 8). It was therefore deemed 
appropriate to combine the data for the different years (2006-2011) in the analysis.  
 
Table 8: Prevalence by year and 95% confidence intervals for all NTD affected 
pregnancies 
Year Total NTD prev/10,000 births 95% CI 
2006 12.51 11.06-14.09 
2007 11.29 9.94-12.78 
2008 10.75 9.44-12.18 
2009 12.81 11.37-14.37 
2010 12.64 11.24-14.18 
2011 12.85 11.43-14.40 
 
4.4.5 NTD prevalence estimates by region 
 
As described in the introduction to this thesis in Chapter 1, a North/South divide 
with regards to NTD prevalence in the British Isles, has been reported in the 
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literature (11). Looking at the NTD prevalence for different regions, across all years, 
in the BINOCAR NTD dataset, it was found that the overall prevalence was 
significantly higher in the area covered by CARIS and NorCAS than EMSYCAR and 
SWCAR (Table 9). This increase was largely driven in both registers by an increase 
in reported spina bifida cases.  
 
NTDs are listed as one of the anomalies of possible concern on the CARIS website, 
due to its high prevalence (128). Despite a decline from 115 NTDs per 10,000 births 
in a 1957 study in South Wales by Laurence (129) to 21 per 10,000 in a study 
covering part of South Wales in 1992 by Cotter and colleagues (130) to 19 per 10,000 
in 1998 when the CARIS register started collecting data, the decline seems to have 
stopped since 2008 (128). 
 
A study looking at data from NorCAS reported that the NTD prevalence decreased 
significantly in the period 1984 to 1996, although in 1996 the prevalence was still 14 
per 10,000 births (131). In a subsequent study, the overall NTD prevalence across 
the years 1991 to 1999 inclusive was reported to be 15.6 in the Northern region in 
comparison to 12.3 in the North West Thames region, 12.6 in Wessex and 11.9 in 
Oxford (117).  
 
It could be that any observed regional differences are in fact due to natural variation 
i.e. can be explained by other factors such as deprivation. However, a study 
exploring localised clustering and geographical variation of congenital anomalies 
for the same registers included in Rankin and colleagues (117) study found that 
even after adjusting for maternal age and deprivation, there was still geographical 
variation at the region and hospital catchment area level (132). Therefore, it was 
seen as important, in light of these findings, to keep the potential impact of regional 
differences in mind for future analyses. 
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Table 9: Prevalence by register and 95% confidence intervals for all NTD affected 
pregnancies 
Register 
Total number of NTD 
affected pregnancies 
Total 
number 
of births 
Total Prev/10,000 births 95% CI 
EMSYCAR 511 442057 11.56 10.58-12.61 
NorCAS 288 199321 14.45 12.83-16.22 
CAROBB 216 181658 11.89 10.36-13.59 
SWCAR 326 318251 10.24 9.16-11.42 
CARIS 301 210900 14.27 12.71-15.98 
 
Combining all years and regions’ data collected in the study, gives an NTD birth 
prevalence of 12 per 10,000 (Table 10) which is comparable with reports in the 
literature.  
 
Table 10: Number of NTD affected pregnancies and Birth Prevalence for all NTDs and 
different subtypes 
NTD 
Number 
Prev/10,000 births 
LB SB Late Miscarriage TOPFA Total 
All NTDs 298 34 14 1,296 1,642 12.14 
Anencephaly 36 17 8 612 673 5.00 
Encephalocele 39 * * 137 185 1.37 
Spina bifida 223 11 3 547 784 5.80 
 
*Cells with values less than 5 have been suppressed  
 
4.4.6 Quantifying the difference between including and excluding terminations in 
NTD birth prevalence denominator 
 
As described, NTD affected pregnancies that result in TOPFA are included in the 
numerator of the BINOCAR birth prevalence equation but only live and still births, 
and not terminations in the population studied, are included in the denominator. 
The reason for this is that births correspond to official ONS statistics and are the 
most robust estimates. Moreover, for most congenital anomalies that do not have a 
high TOPFA rate, this is unlikely to distort the outcomes greatly. However, in the 
BINOCAR dataset for the study, 1296 out of 1642 (79%) NTD affected pregnancies 
resulted in TOPFA and therefore it was seen as important to quantify the difference 
between an NTD birth prevalence estimate that includes and excludes terminations 
in the denominator. Termination denominator data for the regions covered by 
EMSYCAR and SWCAR for the years 2006 to 2011 inclusive, were obtained from the 
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Department of Health (DH). Only terminations carried out from 10 weeks gestation 
were included to exclude early social terminations as, as described, early fetal losses 
are not captured by BINOCAR and the earliest gestation for a TOPFA case in the 
NTD dataset is 8 weeks. The NTD birth prevalence was reduced to 10 per 10,000 
births (95% CI: 9.54, 10.94) when terminations were included in the denominator 
from 11 per 10,000 births (95% CI: 10.28, 11.78) when terminations were not 
included. However, the difference was not statistically significant. It was therefore 
deemed appropriate to continue to use the BINOCAR birth prevalence calculation, 
particularly as it was only possible to obtain denominator data for key variables in 
the study, such as deprivation, for births (and also to enable comparisons with the 
current literature).  
 
4.4.7 Preliminary epidemiological explorations around NTD prevalence 
 
In the Introduction to this thesis (Chapter 1) it was detailed how several factors are 
shown to be associated with NTD risk, in addition to ethnicity. It was not possible 
to obtain information on maternal illness, such as diabetes or epilepsy, any 
occupational exposures or medication use (questions about these additional factors 
were asked in the qualitative study detailed in Chapter 6). However, information 
was collected from BINOCAR on sex of fetus, maternal age, deprivation of maternal 
residence, maternal body mass index, folic acid use and year and month of outcome 
(to explore seasonality). It was important to explore the relative impact of each of 
these factors on NTD prevalence, to ascertain whether any associations as reported 
in the literature were found, and thus their likely impact on the main analyses 
around ethnicity.  
 
4.4.7.1 NTD type and whether the NTD is isolated or not 
 
Prevalence estimates for different NTD subtypes for individual data years (Figure 8) 
and for all years combined (Table 10) have been presented due to detailed 
aetiological and phenotypic differences in the literature. It is important, therefore, to 
explore the association between key factors, such as maternal age, on NTD 
prevalence for individual NTD subtypes, due to expected differences. However, it is 
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also essential to be critical of the extent to which NTD subtype differences for 
different factors as described in the literature, are also found in the BINOCAR 
dataset. Differences were explored for anencephaly and spina bifida subtypes but 
not for encephalocele, due to the small number of cases. However encephalocele 
cases were included in analyses of outcomes for all NTDs combined. 
 
As detailed in Chapter 1, in addition to aetiological differences between different 
NTD subtypes being described in the literature, it is also argued that NTDs that 
occur in association with other defects are aetiologically distinct from those that are 
isolated (11;45). This is of particular importance when exploring NTD prevalence as 
non-isolated NTDs are not expected to decrease with folic acid usage (47;48).  
However, an early study found that once the type of NTD has been taken into 
account, the sex ratio and geographic prevalence are similar for isolated and 
multiple malformation NTD cases. Thus, the authors argued that, after stratifying 
by NTD subtype, making further distinctions between isolated and non-isolated 
NTD sub-groups might not be appropriate (133). Despite this, classification systems 
for congenital anomalies that take aetiology into account have since been developed 
(134;135). Using one of these classification systems, sex ratio and geographic 
prevalence differences were first explored in the current dataset, to determine the 
appropriateness of any further stratification by whether the NTD is isolated or not.  
 
4.4.7.1.1 Classification of isolated and non-isolated cases 
 
A multiple malformation group variable, which gives an indication of whether an 
NTD occurs in isolation or in association with other defects, was obtained from 
BINOCAR for all five registers included in the study. The variable is generated 
using EUROCAT’s multiple congenital anomaly algorithm, which designates 
congenital anomalies to certain categories based on International Classification of 
Diseases (ICD) 10 coding. As shown in Table 11, NTD cases can be categorised as 
syndromic, chromosomal, NTD isolated, isolated other or multiple malformations 
(NTDs associated with other malformations but not recognised conditions).  The 
classification system is hierarchical and only considers one category at a time i.e. the 
first potential category to be considered is chromosomal. If cases do not have a 
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chromosomal ICD-10 code, the next potential category is considered. The final 
category to be considered is the “potential multiple anomalies” if the case does not 
fit into any of the previous categories (135). Although potential multiples are 
usually reviewed by clinicians and geneticists, it is likely that some will be missed. 
 
Table 11: Number and proportion of NTD affected pregnancies falling into the different 
multiple malformation groupings 
Multiple Malformation Group Number Percent 
Syndrome 21 1.28 
Chromosomal 81 4.93 
Isolated Other 19 1.16 
Multiple Malformations 273 16.63 
NTD Isolated 1,248 76 
Total 1,642 100 
 
Due to small numbers in individual sub-groups and due to the fact that NTD cases 
designated as multiple malformations may be recognised as syndromes in the  
future i.e. the grouping is open to change, syndromic, chromosomal, multiple 
malformations and isolated other cases were grouped as a “non-isolated NTD” 
category. Isolated other cases were included in the “non-isolated” grouping as 
babies with isolated other defects have a single congenital defect (the majority in the 
dataset are amniotic band sequence defects) which is present in addition to the 
NTD, therefore there is likely to be something else happening to the embryo during 
development. 
 
An additional classification system for isolated and non-isolated NTD cases, based 
on a local aetiological variable, exists for CAROBB and EMSYCAR. The aetiological 
variable has similar sub-groupings to those based on the EUROCAT algorithm, 
although syndromic cases are simply designated as multiple malformations cases, 
recognising the difficulty of drawing a distinction between the two. This variable is 
thought to provide a more accurate representation of whether an NTD is isolated or 
not as each case is reviewed individually and coded accordingly. However, there is 
strong agreement between the two classification systems and thus classifications 
based on the EUROCAT algorithm, which covers all registers, has been used in the 
majority of analyses (and unless specified). In analyses where there were indications 
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that the lack of agreement between the two classification systems could impact on 
observed outcomes, this has been highlighted and discussed.  
 
4.4.7.1.2 NTD prevalence by NTD subtype and malformation type 
 
The overall birth prevalence for non-isolated NTDs (2.91 per 10,000 births) is 
markedly lower than for isolated NTDs (9.23 per 10,000 births) as it much less 
common to have the former than the latter (394 and 1248 in the dataset respectively) 
(Table 12). For non-isolated NTD cases, spina bifida is more likely to be the NTD 
than anencephaly (Table 12). 
 
Table 12: NTD prevalence by type and whether the NTD is isolated or not 
Malformation type (n) 
Prev/10,000 births (95% CI) 
Anencephaly (n=673) Spina bifida (n=784) Total (n=1642) * 
Isolated NTD (1248) 4.14 (3.81-4.50) 4.30 (3.95-4.66) 9.23 (8.73-9.76) 
Non-isolated NTD (394) 0.84 (0.69-1.01) 1.50 (1.30-1.72) 2.91 (2.63-3.22) 
 
*Total does not equal Anencephaly + spina bifida as encephalocele cases are also included. 
 
4.4.7.1.3 Sex ratio 
 
Analyses of sex in the BINOCAR dataset presented problems; if the whole NTD 
dataset is used (1642 cases) there are 40% of cases that have 
unknown/indeterminate sex. Calculating NTD prevalence for cases of known sex 
will therefore be an underestimate as the denominator is live and still births where 
very few births are of unknown/indeterminate sex. NTD prevalence estimates by 
sex should therefore only be used to compare the prevalence between males and 
females within different NTD subtypes in the dataset rather than for looking at 
absolute figures. Moreover, when unknown/indeterminate sex cases are removed, 
the proportion of anencephaly cases falls from 41% to 26% as this more severe NTD 
phenotype is detected earlier in pregnancy, usually around the 12 week scan, when 
sex determination is more difficult. Therefore, NTD prevalence estimates by sex 
could also be biased due to under-representation of anencephaly cases. 
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There is a further level of complexity with exploring sex in the current dataset, 
which is that although sex determination is much more reliable around the second 
scan, taken as 18 weeks gestation for the purpose of analyses, 23% of cases with 
known sex have a gestation length of less than 18 weeks; 39% of these cases come 
from NorCAS which has the lowest proportion of indeterminate/not known cases 
(16%) (Table 13). If the dataset is restricted to those cases with a gestation length of 
18 weeks or longer, only 29% of anencephaly cases from the original dataset remain 
due to the early detection and higher termination rate for this more severe 
phenotype. Overall 91% of anencephaly affected pregnancies are terminated in 
contrast to 70% of spina bifida cases, and 93% of terminations occur within two 
weeks of the NTD being discovered.  
 
Table 13: Sex (number and proportion) breakdown for NTD affected pregnancies from 
different registers 
Sex 
No (%) in each register 
EMSYCAR NorCAS CAROBB SWCAR CARIS Total  
Male 130 (25.44) 
112 
(38.89) 51 (23.61) 
83 
(25.46) 
97 
(32.23) 
473 
(28.81) 
Female 146 (28.57) 
129 
(44.79) 56 (25.93) 
84 
(25.77) 
103 
(34.22) 
518 
(31.55) 
Indeterminate/Not 
known  235 (45.99) 
47 
(16.32) 109 (50.46) 
159 
(48.77) 
101 
(33.55) 
651 
(39.65) 
Total 511 288 216 326 301 1,642 
 
Based on the limited available data there are significantly more females affected by 
NTDs than males for all pregnancies with NTD diagnosed at any gestation (female 
to male PRR = 1.15; 95% CI: [1.02, 1.30]). This sex difference is also significant for 
those with gestation lengths of 18 weeks or longer for all NTDs combined (1.18; 95% 
CI: [1.20, 1.36]) and for spina bifida cases (1.19; 95% CI: [1.01, 1.42]); for anencephaly 
cases there is a greater female predominance but due to the small numbers, the 
difference doesn’t reach significance (1.24; 95% CI: [0.87, 1.79]) (Table 14). The 
prevalence rate ratios for isolated and non-isolated cases are very similar for both 
NTD subtypes and for all NTDs combined (Table 15), which is in agreement with 
what is reported by Dolk and colleagues (133). 
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Table 14: Female to male prevalence rate ratios by NTD subtype for affected pregnancies 
of any gestation length and those with gestation lengths of 18 weeks or longer 
NTD 
Female/Male Prevalence rate ratios (95% CI) 
Cases of known sex Cases of known sex with gestation lengths >17 weeks 
Anencephaly 1.13 (0.89-1.45) 1.24 (0.87-1.79) 
Spina Bifida 1.16 (0.99-1.37) 1.19 (1.01-1.42) 
Total  1.15 (1.02-1.30) 1.18 (1.02-1.36) 
 
Table 15: Female to male prevalence rate ratios by NTD type for isolated and non-isolated 
affected pregnancies of 18 weeks gestation length or longer 
NTD 
Female/Male Prevalence rate ratios (95% CI) 
Isolated cases of known sex 
with gestation lengths >17 
weeks 
Non-isolated cases of known sex with 
gestation lengths >17 weeks 
Anencephaly 1.24 (0.81-1.90) 1.26 (0.64-2.50) 
Spina Bifida 1.20 (0.98-1.47) 1.18 (0.86-1.63) 
Total  1.19 (1.00-1.41) 1.15 (0.89-1.49) 
 
4.4.7.1.4 Geographic prevalence 
 
However, from the current analysis of the BINOCAR dataset, it is clear that the 
significantly higher spina bifida prevalence in NorCAS specifically occurs within 
isolated cases (Table 16) and in CARIS within non-isolated cases (Table 17). This is 
not in agreement with the earlier research and it is difficult to disentangle why 
exactly this might be. Stevenson and colleagues (2004) argue that the focus is on 
associated anomalies as developmental anomalies occurring with NTDs but this is 
also the case with twinning (47). Perhaps it is not a coincidence that CARIS has both 
a higher proportion of non-isolated NTD cases and twins where both have a 
malformation or that NorCAS has an increased prevalence which is largely driven 
by isolated cases and also has the highest proportion of twin pregnancies than any 
other region, the majority of which are twins where only one has an anomaly. 
  
Table 16: Prevalence for isolated NTD cases by register and NTD type 
Register (n) 
Prev/10,000 (95% CI) 
Anencephaly (n=560) Spina bifida (n=581) Total (n=1248) 
EMSYCAR (394) 4.14 (3.56-4.79) 4.14 (3.56-4.79) 8.91 (8.06-9.84) 
NorCAS (235) 4.97 (4.04-6.05) 5.72 (4.72-6.87) 11.79 (10.33-13.40) 
CAROBB (169) 4.57 (3.64-5.66) 4.07 (3.20-5.11) 9.3 (7.95-10.82) 
SWCAR (240) 3.39 (2.78-4.10) 3.58 (2.96-4.30) 7.54 (6.62-8.56) 
CARIS (210) 4.13 (3.30-5.09) 4.55 (3.69-5.56) 9.96 (8.66-11.40) 
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Table 17: Prevalence for non-isolated NTD cases by register and NTD type 
Register (n) 
Prev/10,000 (95% CI) 
Anencephaly (n=113) Spina bifida (n=203) Total (n=394) 
EMSYCAR (117) 0.86 (0.61-1.18) 1.29 (0.98-1.67) 2.65 (2.19-3.17) 
NorCAS (53) 0.85 (0.50-1.37) 1.3 (0.85-1.91) 2.66 (1.99-3.48) 
CAROBB (47) 0.88 (0.50-1.43) 1.38 (0.89-2.03) 2.59 (1.90-3.44) 
SWCAR (86) 0.72 (0.46-1.08) 1.35 (0.98-1.82) 2.7 (2.16-3.34) 
CARIS (91) 0.9 (0.54-1.41) 2.47 (1.84-3.23) 4.31 (3.47-5.30) 
 
4.4.7.1.5 Conclusions 
 
A central research question of this PhD is whether the NTD prevalence is higher 
within different ethnic communities. Although it will not be possible to make any 
aetiological conclusions based on this research alone, possible causative factors can 
be suggested. Based on described differences between isolated and non-isolated 
NTDs in the literature, regional differences identified in the current dataset, even 
after stratification by NTD type, and due to feasibility in terms of numbers, it was 
decided that whether the NTD is isolated or not would be taken into consideration 
in future analyses, where possible. 
 
4.4.7.2 NTD prevalence estimates by maternal age 
 
In the literature, it has been shown that there is an increased NTD risk for mothers 
older than 40 years of age and those younger than 19, and that the increase is higher 
for spina bifida than anencephaly cases (136). 
 
Maternal age from the BINOCAR NTD dataset for this study was found to be 
roughly normally distributed, following a similar pattern to population level live 
and still birth data. 
  
As live and still birth data by maternal age was obtained from ONS broken down 
into different age groups (<20; 20-24; 25-29; 30-34; 35-39; 40+), maternal age for 
affected pregnancies in the BINOCAR dataset was also broken down into these age 
groups in the analyses. Table 18 below summarises the maternal age group 
86 
 
breakdown for NTD affected pregnancies from different registers. As shown, there 
are a higher proportion of older mothers in CAROBB when compared with the 
other registers, which is a reflection of the underlying population. 
  
Table 18: Maternal age group (number and proportion) breakdown for NTD affected 
pregnancies from different registers 
Age group 
No (%) in each register 
EMSYCAR NorCAS CAROBB SWCAR CARIS Total  
<20 50 (9.78) 28 (9.72) 10 (4.63) 23 (7.06) 31 (10.3) 142 (8.65) 
20-24 106 (20.74) 75 (26.04) 31 (14.35) 62 (19.02) 84 (27.91) 358 (21.8) 
25-29 133 (26.03) 86 (29.86) 67 (31.02) 88 (26.99) 76 (25.25) 450 (27.41) 
30-34 116 (22.7) 63 (21.88) 50 (23.15) 86 (26.38) 65 (21.59) 380 (23.14) 
35-39 78 (15.26) 28 (9.72) 47 (21.76) 55 (16.87) 39 (12.96) 247 (15.04) 
40+ 20 (3.91) 8 (2.78) 11 (5.09) 12 (3.68) 6 (1.99) 57 (3.47) 
Not known 8 (1.57) 0 (0) 0 (0) 0 (0) 0 (0) 8 (0.49) 
Total 511 288 216 326 301 1,642 
 
NTD prevalence estimates by maternal age group were calculated initially for all 
isolated and non-isolated NTD cases combined for spina bifida and anencephaly 
subtypes, as well as an overall prevalence including all subtypes, to compare 
outcomes with what has been found in the literature.  Isolated and non-isolated 
NTD cases were then looked at separately to see whether there were any differences 
between them. 
  
Table 19, which contains absolute prevalence estimates, shows that the NTD 
prevalence is statistically significantly higher in mothers under 20 years of age 
(15.08; 95% CI: [12.71, 17.77]) than mothers aged 30-34 (10.55; 95% CI: [9.52, 11.66]). 
However, although the ONS denominator data contains all mothers under 20 years 
of age, there are eight NTD affected pregnancies in the BINOCAR data where the 
mother is under 16 years of age that have not been included in the study for ethical 
reasons. In a sensitivity analysis, in which these 8 cases are added to the total, the 
prevalence for the under 20 age group increases to 15.93 (95% CI: [13.49, 18.69]) 
making the prevalence for this age group now also statistically significantly higher 
than in the 25-29 (12.20; 95% CI: [11.10, 13.38]) and of borderline significance higher 
than the 35-39 (11.91; 95% CI: [10.47, 13.49]) age group. No further details are 
known about these 8 cases, including the NTD type, and therefore it is not possible 
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to take this any further than to state that the exclusion of under 16s has led to a 
slight prevalence underestimate in the under 20 age group. 
 
Table 19: NTD prevalence by maternal age group and NTD type 
Age group 
Prev/10,000 births (95% CI) 
Anencephaly Spina Bifida Total  
<20 6.48 (4.96-8.32) 7.33 (5.70-9.27) 15.08 (12.71-17.77) 
20-24 5.61 (4.76-6.57) 6.02 (5.13-7.01) 13.05 (11.73-14.47) 
25-29 4.88 (4.19-5.65) 5.80 (5.05-6.64) 12.20 (11.10-13.38) 
30-34 4.19 (3.55-4.92) 5.19 (4.47-5.99) 10.55 (9.52-11.66) 
35-39 4.77 (3.88-5.81) 5.88 (4.89-7.02) 11.91 (10.47-13.49) 
40+ 5.62 (3.67-8.23) 4.75 (2.98-7.19) 12.31 (9.33-15.95) 
 
Prevalence rate ratios, by maternal age group, are given in Table 20, with the 25-29 
age group selected as the reference group due to the highest numbers of births 
being in this category. As is shown, the overall NTD prevalence is statistically 
significantly higher in the under 20 group (p=0.028) and statistically significantly 
lower in the 30-34 age group (p=0.036) when compared to the 25-29 reference 
group. No statistically significant differences were detected by NTD subtype. 
 
Table 20: NTD prevalence rate ratios by maternal age group and NTD type 
Age group 
Prevalence Rate Ratios (95% CI) 
Anencephaly Spina Bifida Total  
25-29 (ref) 4.88 5.80 12.20 
<20 1.33 (0.99-1.77) 1.26 (0.96-1.66) 1.24 (1.02-1.49) 
20-24 1.15 (0.93-1.43) 1.04 (0.85-1.27) 1.07 (0.93-1.23) 
30-34 0.86 (0.69-1.07) 0.89 (0.74-1.09) 0.86 (0.75-0.99) 
35-39 0.98 (0.77-1.25) 1.01 (0.81-1.27) 0.98 (0.84-1.14) 
40+ 1.15 (0.76-1.74) 0.82 (0.53-1.27) 1.01 (0.77-1.33) 
 
Conducting the analyses separately for isolated and non-isolated NTD affected 
pregnancies (Table 21), for isolated NTD cases, the NTD prevalence is statistically 
significantly higher in the under 20 (p=0.054) and lower in the 40+ (p=0.046) age 
groups, than the 25-29 age group. For non-isolated NTD affected pregnancies, the 
prevalence is higher in the 40+ age group than the reference group (p<0.001) and 
this is shown to be specifically for the anencephaly subtype (PRR 3.84; 95% CI: 1.98, 
7.43). No other differences by NTD subtype were detected in these sub-analyses. If 
chromosomal cases are excluded from the non-isolated cases, there is no longer a 
statistically significant excess in the 40+ group. This may be related to the risk for 
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three chromosomal conditions in the dataset (Down’s syndrome, Patau syndrome 
and Edward’s syndrome) increasing with increasing maternal age. Interestingly, 
when chromosomal cases are excluded, the prevalence in the 30-34 age group is 
shown to be statistically significantly lower than the reference group (p=0.009).  
  
Table 21: NTD prevalence rate ratios by maternal age group and whether the NTD is 
isolated or not 
Age group 
Prevalence Rate Ratios (95% CI) 
Isolated Non-Isolated Non-isolated minus chromosomal 
25-29 (ref) 9.47 2.74 2.50 
<20 1.23 (1.00-1.53) 1.24 (0.83-1.85) 1.28 (0.85-1.93) 
20-24 1.04 (0.88-1.21) 1.18 (0.89-1.57) 1.20 (0.89-1.61) 
30-34 0.89 (0.76-1.04) 0.77 (0.57-1.04) 0.65 (0.46-0.90) 
35-39 0.92 (0.77-1.10) 1.18 (0.87-1.61) 0.70 (0.47-1.02) 
40+ 0.68 (0.47-0.99) 2.13 (1.39-3.26) 0.21 (0.69-2.13) 
 
4.4.7.2.1 Summary 
 
There is an increased NTD prevalence in young mothers, under 20 years of age, in 
comparison to mothers aged 25-29. This agrees with the published literature. The 
increased prevalence in the under 20s, was shown to be specifically for isolated 
NTD cases. An increased NTD prevalence for mothers aged 40+ when compared to 
those aged 25-29, specifically for anencephaly, is seen for non-isolated NTD cases. 
This appears to be due to an excess of NTDs occurring in association with 
chromosomal defects, which becomes more common with increasing maternal age.  
  
4.4.7.3 NTD prevalence estimates by maternal deprivation 
 
An increased risk of NTD affected pregnancies in mothers who live in more 
deprived areas has been reported in many studies (137). One possibility is that this 
risk may be mediated by folic acid use, as folic acid use and level of deprivation are 
highly correlated (101;137). 
 
Both England and Wales have developed an index of multiple deprivation (IMD), at 
the small area level, based on lower super output area (LSOA) which in turn is 
created from postcode. It is called multiple deprivation as it recognises a number of 
89 
 
different types of deprivation domains. The English 2010 IMD includes: Income; 
Employment; Health and Disability; Education, Skills and Training; Barriers to 
Housing and Services; Crime and Living Environment, and the Welsh 2011 IMD 
includes: Income; Employment; Health; Education; Geographical Access to Services; 
Community Safety; Physical Environment and Housing. The domains are made up 
of different indicators and the overall deprivation score is made up of ranked 
domain scores for each area; the overall score is then ranked and it is from this 
ranking that deprivation quintiles, deciles etc. are created. The English and Welsh 
IMDs are not directly comparable, two key reasons being that they are produced for 
different areas and there are indicator differences (138;139). 
 
For the English IMD score or Welsh IMD (WIMD) score, a higher score indicates 
greater deprivation. For the English IMD quintile or WIMD quintile, quintile 5 is the 
least deprived and quintile 1 the most deprived.  
 
The IMD deprivation quintile rather than score was included in the analyses as live 
and still birth denominator data were obtained from ONS by deprivation quintile. A 
breakdown of the number and proportion of affected pregnancies falling into the 
different quintiles for all English registers is included in Table 22 and a breakdown 
for the different quintiles for CARIS (Wales) given in Table 23. CAROBB has the 
highest proportion of cases in the least deprived quintile (quintile 5), as a reflection 
of the underlying population. 
 
Table 22: Maternal deprivation quintile (number and proportion) breakdown for NTD 
affected pregnancies for English registers 
Deprivation quintile (IMD) 
No (%) in each register 
EMSYCAR NorCAS CAROBB SWCAR Total  
1 (most deprived) 170 (33.27) 92 (31.94) 21 (9.72) 69 (21.17) 352 (26.25) 
2 129 (25.24) 57 (19.79) 34 (15.74) 63 (19.33) 283 (21.1) 
3 76 (14.87) 49 (17.01) 42 (19.44) 79 (24.23) 246 (18.34) 
4 70 (13.7) 35 (12.15) 38 (17.59) 57 (17.48) 200 (14.91) 
5 (least deprived) 64 (12.52) 21 (7.29) 81 (37.5) 58 (17.79) 224 (16.70) 
Not known  2 (0.39) 34 (11.81) 0 0 36 (2.68) 
Total 511 (100) 288 (100) 216 (100) 326 (100) 1341 (100) 
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Table 23: Maternal deprivation quintile (number and proportion) breakdown for NTD 
affected pregnancies for Welsh register 
Welsh deprivation quintile (WIMD) No (%)  
1 (most deprived) 92 (30.56) 
2 61 (20.27) 
3 67 (22.26) 
4 44 (14.62) 
5 (least deprived) 31 (10.30) 
Not known  6 (1.99) 
Total 301 (100) 
 
To calculate prevalence rate ratios, quintile 1 was chosen as the baseline due to there 
being the most births within this quintile. It was found that the NTD prevalence 
was statistically significantly lower in the quintile 4 (0.76; 95% CI: 0.64, 0.91) and 
quintile 5 (0.80; 95% CI: 0.67, 0.94) than quintile 1. The trend was tested by fitting 
quintile as a continuous variable. It was found that for each unit increase of quintile, 
the risk ratio was 0.93 (95% CI: 0.90, 0.96) (p<0.001) i.e. the NTD prevalence was 
shown to be higher in more deprived areas.  
 
When looking at anencephaly and spina bifida subtypes individually, the same 
outcome is observed for quintile 4 but not quintile 5, where the difference doesn’t 
reach statistical significance (p=0.06).  Interestingly, the difference between quintile 
3 and quintile 1 and quintile 2 and quintile 1 is stronger for spina bifida than 
anencephaly, although the differences do not reach statistical significance (p=0.06 
and p=0.08 respectively) (Table 24).  
 
Table 24: NTD prevalence rate ratios by deprivation quintile and NTD type for English 
registers only 
Deprivation quintile (IMD) 
Prevalence rate ratios (95% CI) 
Anencephaly Spina Bifida Total  
1 (most deprived) (ref) 5.58 6.47 13.09 
2 0.93 (0.73-1.17) 0.82 (0.65-1.03) 0.90 (0.77-1.05) 
3 0.87 (0.68-1.12) 0.79 (0.62-1.01) 0.87 (0.74-1.02) 
4 0.72 (0.55-0.94) 0.72 (0.56-0.92) 0.76 (0.64-0.91) 
5 (least deprived) 0.78 (0.61-1.01) 0.80 (0.63-1.01) 0.80 (0.67-0.94) 
 
When looking at isolated NTD cases specifically, there is also weak evidence that 
the difference between quintile 2 and quintile 1 for spina bifida is of statistical 
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significance (p=0.05) (Table 25).  For non-isolated NTDs, there are no statistically 
significant differences (Table 26).  
 
Table 25: NTD prevalence rate ratios by deprivation quintile and NTD type for NTD 
isolated cases for English registers only 
Deprivation quintile (IMD) 
Prevalence rate ratios (95% CI) 
Anencephaly Spina Bifida Total  
1 (most deprived) (ref) 4.76 5.02 10.19 
2 0.87 (0.67-1.13) 0.76 (0.59-0.99) 0.87 (0.72-1.04) 
3 0.84 (0.64-1.11) 0.81 (0.62-1.06) 0.88 (0.73-1.06) 
4 0.68 (0.51-0.92) 0.67 (0.50-0.89) 0.73 (0.60-0.89) 
5 (least deprived) 0.80 (0.61-1.06) 0.79 (0.60-1.03) 0.81 (0.67-0.98) 
 
Table 26: NTD prevalence rate ratios by deprivation quintile and NTD type for non-
isolated NTD cases for English registers only 
Deprivation quintile (IMD) 
Prevalence rate ratios (95% CI) 
Anencephaly Spina Bifida Total  
1 (most deprived) (ref) 0.82 1.45 2.90 
2 1.27 (0.72-2.26) 1.00 (0.64-1.59) 1.02 (0.74-1.41) 
3 1.02 (0.55-1.89) 0.73 (0.44-1.23) 0.83 (0.58-1.18) 
4 0.92 (0.48-1.77) 0.90 (0.55-1.47) 0.88 (0.62-1.25) 
5 (least deprived) 0.68 (0.34-1.38) 0.83 (0.51-1.37) 0.75 (0.52-1.08) 
 
Looking at prevalence rate ratios for CARIS and only for total cases within the 
register and broken down into isolated and non-isolated cases (there was no 
breakdown by NTD subtype due to small numbers), the NTD prevalence is 
statistically significantly lower in quintile 5 than quintile 1, and this is shown to be 
specifically for isolated NTD cases (p=0.011) (Table 27). 
 
Table 27: NTD prevalence risk ratios by deprivation quintile for all NTD cases and 
broken down by whether the NTD is isolated or not for the Welsh register (CARIS) 
Deprivation quintile (IMD) 
Prevalence risk ratios (95% CI) 
Isolated Non-Isolated Total  
1 (most deprived) (ref) 11.51 5.57 17.08 
2 0.82 (0.56-1.22) 0.71 (0.40-1.28) 0.79 (0.57-1.09) 
3 1.13 (0.78-1.63) 0.73 (0.40-1.34) 1.00 (0.73-1.37) 
4 0.85 (0.56-1.29) 0.52 (0.25-1.05) 0.74 (0.52-1.06) 
5 (least deprived) 0.51 (0.30-0.85) 0.76 (0.39-1.45) 0.59 (0.39-0.88) 
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4.4.7.3.1 Summary 
 
The overall pattern for NTD prevalence by deprivation is in line with what is found 
in the literature: there is an excess prevalence in quintile 1 (most deprived) when 
compared to quintile 4 and quintile 5 (least deprived). This excess was shown to be 
specifically for isolated cases, which is interesting in light of the high correlation 
that has been described between deprivation and lack of folic acid use, and the fact 
that non-isolated NTDs are not expected to decline with folic acid usage (47;48). A 
similar effect is observed for anencephaly and spina bifida subtypes.  
 
4.4.7.4 Maternal body mass index (BMI) in the BINOCAR dataset 
 
An association between obesity and increased risk of NTDs has been reported by 
several studies (44) and a meta-analysis of eight studies found an almost two-fold 
increased risk of NTDs in women who were obese; there was a greater increase for 
spina bifida than anencephaly affected pregnancies  (44;140). It has also been shown 
that the protective effect of folic acid for NTDs is greater in overweight or obese 
women than underweight or women of normal body mass index (BMI) (44). 
 
BMI values in the NTD dataset were categorised using the International 
Classification system, as Underweight (<18.50), Normal (18.50-24.99), Overweight 
(25.00-29.99) and Obese (≥30) (141). As shown in Table 4 previously and Table 28, 
NorCAS only has 23% of data missing for this variable in comparison to all other 
registers that have more than 94% of the data missing. Therefore, only data from 
NorCAS can be used to explore maternal BMI.  
 
Unfortunately, it is only possible to give a descriptive analysis using the BINOCAR 
dataset rather than to calculate actual prevalence as no denominator data are 
available.  
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Table 28:  Proportion of mothers in the NTD NorCAS dataset falling into the different 
BMI categories, including missing cases 
Maternal BMI group No (%) 
Underweight 5 (1.74) 
Normal 99 (34.38) 
Overweight 59 (20.49) 
Obese 58 (20.14) 
Not known/Missing 67 (23.26) 
Total 288 (100) 
 
Despite not having any denominator data, it was found in a study using data from 
2007 that the percentage of obese pregnant women in the region covered by 
NorCAS was almost 16% (142). It is also known from the Centre for Maternal and 
Child Enquiries (CMACE) report on maternal obesity in the UK that approximately 
5% of all women giving birth in the region covered by NorCAS were obese in 2010 
(143). This is in contrast to 38% in 2007 and 25% in 2010 of mothers of NTD cases 
classified as obese (and 26% of mothers across all data years (Appendix C: Table C 
1)) in NorCAS where BMI is known, indicating a possible excess for NTD cases.  
Using the NorCAS data, no significant differences were found in the proportion of 
mothers falling into the different BMI categories between anencephaly and spina 
bifida subtypes or between isolated and non-isolated cases (Both tables in Appendix 
C: Table C 1 and Table C 2). 
 
4.4.7.4.1 Summary 
 
There seems to be an excess of NTD cases among obese mothers in the BINOCAR 
dataset. However, it would only be possible to conduct further, limited explorations 
(with no denominator data) of maternal BMI using data from NorCAS. 
 
4.4.7.5 Folic acid use in the BINOCAR dataset 
 
As stated in the Introduction this thesis (Chapter 1), the clear association between 
folic acid intake and NTD reduction led to the 1992 Department of Health (DH) 
recommendation that 400 µg of folic acid be taken before conception and for the first 
twelve weeks of pregnancy. This has resulted in between 21% and 48% of women 
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taking folic acid peri-conceptionally in the U.K. (93). However, there have been 
mixed findings as to whether there has been a clear decline in NTDs in the UK 
during the folic acid era (35) or there has been no change to the existing rate of 
decrease pre-1992 (34).  
 
Self-reported folic acid usage is only reported by two registers: SWCAR and CARIS. 
A study assessed the quality of folic acid usage recording in the SWCAR, by 
comparing recording in SWCAR with computerised and paper prenatal records 
(144). It was found that when information was reported that any folic acid had been 
taken in the records, this was transferred correctly to SWCAR in all cases. However, 
timing of folic acid use was not always transferred correctly. There was found to be 
no statistically significant difference in the recording of folic acid use in pregnancies 
affected by NTDs and those not affected by NTDs (144). A breakdown of the folic 
acid usage data in CARIS and SWCAR is given in Table 29 and Table 30. As shown, 
the proportion of not known/not recorded is lower in CARIS (32%) than SWCAR 
(44%). 
  
Table 29: Folic acid use breakdown for CARIS 
Self-reported folic acid use No (%) 
At least 0.4 mg folic acid supplement taken regularly, started pre-conceptionally 17 (6.85) 
Folic acid supplement taken irregularly/post-conceptionally/unknown 
dose/dose < 0.4 mg 
130 
(52.42) 
No folic acid supplement 22 (8.87) 
Folic acid use not recorded for this woman 
26 
(10.48) 
Folic acid use not recorded by this maternity unit/clinician 
53 
(21.37) 
Total 248 (100) 
 
Table 30: Folic acid use breakdown for SWCAR 
Self-reported folic acid use No (%) 
Folic acid taken pre and post conceptionally 21 (6.44) 
Folic acid taken only post conceptionally 7 (2.15) 
Folic acid not taken 17 (5.21) 
Folic acid taken, timing unknown 139 (42.64) 
Not known if folic acid taken 142 (43.56) 
Total 326 (100) 
 
Although data are collected differently by CARIS and SWCAR, if the datasets are 
dichotomised into any use of folic acid or no use of folic acid, then the proportion of 
95 
 
any use is similar for CARIS and SWCAR (87% and 91% respectively). Missing data 
is ignored in this comparison and timing of folic acid use is not taken into account 
as this was not always found to be recorded correctly in the SWCAR data in the 
audit mentioned (144). However, the usefulness of combining the folic acid data in 
this way is questionable as, looking solely at the CARIS dataset, only 12% of those 
who take folic acid take it at the correct dose and peri-conceptionally.  
 
Due to the high correlation between folic acid use and deprivation reported in the 
literature (101), it could be argued that deprivation is a good proxy for folic acid 
use. However, it is difficult to assess correlation in the current dataset, due to 
problems with recording timing of folic acid use and missing data, as stated. No 
attempt has been made to analyse further “folic acid use” using the BINOCAR data, 
however, this has been explored in the qualitative research (Chapter 6).  
 
4.4.7.5.1 Summary  
 
Peri-conceptional use of folic acid is a critical factor to take into account when 
exploring NTD prevalence, due to the strong association between folic acid use and 
NTD risk reduction. However, due to its poor and imprecise recording within the 
BINOCAR dataset, it cannot be explored further in the quantitative analyses. 
 
4.4.7.6 Month of conception in the BINOCAR dataset 
 
Several studies have reported seasonal variation in the prevalence of NTDs (per 
conceptions), with a peak in conceptions in the summer months (13;145;146). 
Castilla and colleagues reported variations for anencephaly specifically (145) and 
Bound and colleagues only found seasonality for spina bifida in isolated cases and 
for anencephaly in non-isolated cases (13). It is argued that due to the same 
conception peak for schizophrenia and NTDs, and also left-handedness and artistic 
intuition, there might be some underlying process that is common to all of these 
(147). 
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Table 31 shows the NTD prevalence per 10,000 conceptions for month pairs e.g. Jan-
Feb, for all NTD types combined and then for anencephaly and spina bifida 
subtypes individually. For the numerator, conception months for NTD affected 
pregnancies in the BINOCAR dataset were calculated by subtracting the gestation 
length (in days) from the date of birth outcome (only month and year were obtained 
due to date of birth outcome being patient identifiable information, so each outcome 
for each affected pregnancy was designated as occurring on the 15th of the month). 
Denominator data for all conceptions for the same period (2006-2011) and regions 
covered by the BINOCAR data were obtained from ONS. ONS calculated an 
estimated date of conception by subtracting the completed weeks gestation from the 
birth date and then extracted month of conception from this so it could be used for 
the analysis.  It is known from the literature that there tends to be a peak in 
conceptions (for all births) around November-December and troughs around 
March-May and August-September (148), which is mirrored in the obtained 
conception denominator data from ONS.  
 
There is not shown to be any statistically significant differences in the conception 
prevalence between any of the month pairs for all NTD subtypes combined and for 
anencephaly and spina bifida subtypes individually.  (Table 31 and visually 
represented in Figure 10).  
 
Table 31: NTD prevalence per 10,000 conceptions for month-pairs for all NTD affected 
pregnancies and by NTD subtype 
Month pairs 
NTD prevalence/10,000 conceptions (95% CI) 
Anencephaly Spina Bifida Total (all NTDs) 
Jan-Feb 4.99 (4.09-6.03) 5.73 (4.76-6.84) 12.35 (10.91-13.93) 
Mar-Apr 5.13 (4.22-6.17) 5.73 (4.76-6.83) 11.78 (10.38-13.31) 
May-Jun 4.49 (3.64-5.48) 5.79 (4.82-6.90) 11.49 (10.10-13.01) 
Jul-Aug 4.87 (4.00-5.88) 5.73 (4.78-6.82) 11.91 (10.52-13.44) 
Sept-Oct 5.26 (4.35-6.29) 5.75 (4.80-6.83) 12.61 (11.18-14.16) 
Nov-Dec 5.61 (4.69-6.67) 6.44 (5.44-7.56) 13.66 (12.19-15.25) 
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Figure 10: NTD prevalence per 10,000 conceptions by month of conception for all NTDs 
combined and by NTD subtype 
 
The NTD prevalence per 10,000 conceptions for month pairs for isolated and non-
isolated NTD affected pregnancies separately are shown in Table 32 and Table 33 
respectively. Again, when stratifying the analyses in this way, there are not shown 
to be any statistically significant differences in the conception prevalence between 
any of the month pairs for all NTD subtypes combined and for anencephaly and 
spina bifida subtypes individually. 
 
Table 32: NTD prevalence per 10,000 conceptions for month-pairs for all isolated NTD 
affected pregnancies and by subtype 
Month pairs 
NTD prevalence/10,000 conceptions (95% CI) 
Anencephaly Spina Bifida Total (all NTDs) 
Jan-Feb 4.29 (3.46-5.36) 4.38 (3.54-5.36) 9.55 (8.29-10.95) 
Mar-Apr 4.39 (3.55-5.36) 4.25 (3.43-5.21) 9.05 (7.83-10.41) 
May-Jun 3.52 (2.77-4.41) 4.35 (3.52-5.33) 8.85 (7.64-10.19) 
Jul-Aug 3.93 (3.14-4.84) 4.15 (3.35-5.09) 8.93 (7.73-10.27) 
Sept-Oct 4.54 (3.71-5.52) 4.41 (3.58-5.37) 9.84 (8.59-11.23) 
Nov-Dec 4.65 (3.81-5.62) 4.61 (3.78-5.58) 10.05 (8.79-11.43) 
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Table 33: NTD prevalence per 10,000 conceptions for month-pairs for all non-isolated 
NTD affected pregnancies and by subtype 
Month pairs 
NTD prevalence/10,000 conceptions (95% CI) 
Anencephaly Spina Bifida Total (all NTDs) 
Jan-Feb 0.70 (0.39-1.15) 1.35 (0.91-1.94) 2.80 (2.13-3.60) 
Mar-Apr 0.74 (0.42-1.20) 1.48 (1.01-2.09) 2.73 (2.07-3.51) 
May-Jun 0.97 (0.60-1.49) 1.44 (0.98-2.04) 2.64 (2.00-3.42) 
Jul-Aug 0.95 (0.59-1.45) 1.58 (1.10-2.20) 2.98 (2.30-3.79) 
Sept-Oct 0.71 (0.41-1.16) 1.34 (0.90-1.91) 2.76 (2.12-3.54) 
Nov-Dec 0.96 (0.60-1.45) 1.83 (1.32-2.47) 3.61 (2.88-4.48) 
 
An early study by Bound and colleagues, exploring seasonal variation of congenital 
anomalies in the Fylde of Lancashire, found that there was significant seasonal 
variation for NTDs based on month of last menstrual period. Specifically, they 
found that when the NTD prevalence was high (5.5 per 1000 births), conceptions 
were higher between the months of December and May (13). NorCAS and CARIS 
have already been shown to stand out from other registers in previous analyses. 
Although the prevalence in these two registers is not as high (1.4 per 1000 births) as 
in the Bound et al study, it seemed worthwhile to ask whether there is a different 
seasonal pattern in NTD conceptions for these registers when compared to the 
others. For the higher prevalence registers (NorCAS and CARIS) there was not 
shown to be any statistically significant differences in the conception prevalence 
between any of the month pairs and this was also the case for the lower prevalence 
registers (EMSYCAR, CAROBB and SWCAR) (Table 34). However, it was 
interesting  that it was specifically between September and October that the NTD 
conception prevalence was statistically significantly higher for the higher 
prevalence registers (NorCAS and CARIS) (16.86; 95% CI: [13.91, 20.25]) than the 
lower prevalence registers (EMSYCAR, CAROBB and SWCAR) (10.77; 95% CI: 
[9.21, 12.52]); between May and June the NTD conception prevalence was also of 
borderline statistical significance higher in the former (14.62; 95% CI: [11.83, 17.87]) 
than the latter (10.14; 95% CI: [8.60, 11.88]) (Table 34). 
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Table 34: NTD prevalence per 10,000 conceptions for month-pairs for all NTD affected 
pregnancies in NorCAS and CARIS vs. EMSYCAR, CAROBB and SWCAR 
Month 
pairs 
NTD prevalence/10,000 conceptions (95% CI) 
All NTDs for NorCAS and 
CARIS 
All NTDs for EMSYCAR, CAROBB and 
SWCAR 
Jan-Feb 11.65 (9.18-14.58) 12.66 (10.92-14.60) 
Mar-
Apr 14.76 (11.97-18.00) 10.48 (8.91-12.24) 
May-
Jun 14.62 (11.83-17.87) 10.14 (8.60-11.88) 
Jul-Aug 14.24 (11.52-17.40) 10.91 (9.33-12.68) 
Sept-
Oct 16.86 (13.91-20.25) 10.77 (9.21-12.52) 
Nov-
Dec 15.74 (12.94-18.96) 12.75 (11.06-14.62) 
 
4.4.7.6.1 Summary 
 
Seasonal differences in conceptions are interesting when looking at higher and 
lower prevalence registers separately. However, it was not possible to explore this 
further in subsequent analyses.  
 
 Chapter Summary and Important Points to Take Forward 4.5
 
 78 multiple pregnancies were recorded in the dataset. As the predisposing 
pregnancy risk factors for infants from a multiple pregnancy are the same 
(although they can affect individuals from a multiple set differently), this 
has been accounted for in the analyses by taking affected pregnancies as the 
denominator, with the most severe NTD as the outcome of the pregnancy. 
This leaves 76 multiple pregnancies in the dataset. Sensitivity analyses 
comparing a dataset with and without multiples have been carried out after 
the main analyses.  
 
 The NTD prevalence is higher in NorCAS and CARIS than the other three 
registers, in line with a North/South divide as reported in the literature; this 
increase is largely due to spina bifida cases and is specifically for isolated 
NTD cases in NorCAS and non-isolated NTD cases in CARIS. 
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 Looking at sex in the dataset is difficult as anencephaly cases are often 
detected and terminated before sex determination is reliable and this 
variable is of limited usefulness in subsequent analyses. 
 
 The excess prevalence in mothers under 20 years of age is supported by the 
published literature; this is also shown to be specifically for isolated NTD 
cases in the dataset. An excess prevalence for mothers aged forty plus is only 
detected for non-isolated NTDs, specifically chromosomal cases.  
 
 The overall pattern for NTD prevalence by deprivation is in line with the 
literature; there is an excess prevalence in mothers who live in more 
deprived areas. This again is shown to be specifically for isolated NTDs.  
 
 Maternal BMI is an important variable but incompletely recorded in all 
registers except for NorCAS. In comparison with the percentage of all 
mothers known to be obese in the Northern region, there seems to be an 
excess of mothers classified as obese in the NTD dataset. 
 
 Folic acid use is poorly completed, particularly with regard to the timing of 
use. Folic acid use has therefore only been explored further in the qualitative 
study.  
 
 Although there seems to be an interesting seasonal discrepancy between 
higher and lower prevalence registers in the dataset, it was not possible to 
explore this further in subsequent analyses. 
 
 These explorations have highlighted the value of differentiating between 
isolated and non-isolated NTD cases and NTD subtype, where possible, in 
analyses. 
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5 Ethnicity: NTD birth prevalence and the natural history of 
NTD affected pregnancies 
 
 Introduction 5.1
 
The focus of this chapter is ethnicity and centres in particular on, (a) whether the 
NTD birth prevalence varies by ethnicity and (b) the natural history of NTD 
affected pregnancies for different ethnic groups.  
 
There has been wide debate around the usefulness and appropriateness of 
exploring ethnicity in epidemiological research. A clear distinction must be made 
between race, based on biology and largely discredited as being able to provide 
biological explanations for disease and ethnicity, which is a social construct and 
informs about cultural or national identity (149;150). Race is something that is 
defined from the outside whereas ethnicity carries with it a sense of self-
identification (149). The two are often used interchangeably with ethnicity 
sometimes used as a “euphemism” for race (149;150). 
 
Some researchers have been highly critical of the use of ethnicity as an independent 
variable in epidemiological studies. It has been argued that having ethnicity as the 
central focus of research can be misleading, due to socio-economic factors being 
underplayed, and that rather than looking at minority groups per se, we should 
focus on the social impacts on these groups (149). While others have recognised the 
limitations of having ethnicity as a variable such as difficulties of measurement; 
having categories that are too broad and the risk of ethnocentricity, designating a 
“standard” group, they recognise that ethnicity can be of value beyond social terms. 
However, a consideration of socio-economic differences should not be secondary to 
a consideration of cultural and genetic differences when ethnicity is explored (150).  
Much can be done to improve the value of ethnicity in epidemiological research; 
collecting the best data possible but also identifying its shortfalls upfront and not 
drawing conclusions beyond the data at hand. Collecting any additional data that 
might help to understand why there might be a difference by ethnic group, is 
essential (150;151). 
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In the current study, ethnicity is the focus.  Ethnicity data reported to BINOCAR 
registers is self-reported and is broadly based on the ONS 2001 census classification 
(A breakdown of 2001 census ethnic groupings is given in Appendix D in Table D 
1). However, it actually consists of a mixture of higher level and lower level 
groupings, with those of Mixed ethnicity simply designated as Mixed rather than 
White and Black Caribbean; White and Black African etc. and those of White 
ethnicity simply designated as White rather than White British; White Irish etc. 
Speaking to a representative from EMSYCAR, having different White categories has 
been found to lead to confusion and for this reason it is simply collected as White. 
For all other ethnic groups lower level e.g. Pakistani, Black African groupings are 
used. A breakdown of the number of NTD cases in the BINOCAR dataset with 
mothers falling into each of the possible ethnic categories collected is given in Table 
35. Missing and not stated ethnicity have been combined as ‘not known’. 
 
Table 35: Breakdown of number and proportion of NTD cases in the BINOCAR dataset 
with mothers falling into the different ethnic groups collected by registers 
Ethnicity NTD cases n (%) 
White1 1115 (67.90) 
Mixed2 5 (0.30) 
Indian 31 (1.89) 
Pakistani 25 (1.52) 
Bangladeshi 10 (0.61) 
Other Asian 12 (0.73) 
Black Caribbean 5 (0.30) 
Black African 15 (0.91) 
Other Black 0 (0) 
Chinese 0 (0) 
Other ethnic group 23 (1.40) 
Not known 401 (24.42) 
Total 1642 (100) 
 
1Contains White British; Irish; Other White background; All White groups 
2Contains White and Black Caribbean; White and Black African; White and Asian; Other Mixed 
background 
 
In analyses, Mixed and Other Asian categories are merged with the “Other ethnic 
group” and simply designated as “Other ethnic group.” This is in line with obtained 
ONS ethnicity denominator data for all live and still births for the same region and 
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years covered by the BINOCAR dataset in this study (Other Black and Chinese 
would also be included in the “Other ethnic group” category but there are no cases 
in the dataset).  
 
It is of importance to note here that ethnicity in the live and still birth denominator 
data is ethnicity of the baby, as stated by the mother, and ethnicity in the BINOCAR 
dataset, as detailed, is ethnicity of the mother. This is a limitation of the available 
data. However, Dattani and colleagues found that when Birth registration and NHS 
Numbers for Babies (NN4B) data (contains ethnicity of the baby) were linked to 
Maternity Hospital Episode Statistics (HES) data (contains ethnicity of the mother) 
there was agreement between the baby’s ethnicity and mother’s ethnicity in 87% of 
cases in 2006 (152) and 75% of cases in 2007 (153). 
 
The way in which prevalence data is presented could be argued to be ethnocentric 
as White is taken as the reference group in prevalence rate ratios, however 
individual prevalence estimates are also often presented. Moreover, White is not 
chosen as the reference group as it is seen as the “standard” ethnic group but 
because the highest number of births (the denominator) are in this group, and it was 
for this reason, for example, that deprivation quintile 1 (most deprived) was chosen 
as the reference group in Chapter 4. Additionally, although there is very little 
existing research on NTD prevalence in different ethnic communities in the UK, a 
very early study found that still births and infant deaths attributed to NTDs were 
higher in Indian and Bangladeshi mothers (75). More recent data from the North 
Thames Region in the UK indicated that the rate of NTD affected pregnancies 
(including terminations) is higher in women of Pakistani or Indian origin (81) and 
an increased NTD prevalence in mothers of Pakistani ethnicity has also been 
reported by Tonks and colleagues in the West Midlands (82). It is therefore 
hypothesised, based on this very limited evidence, that the NTD prevalence will be 
higher in mothers of Bangladeshi, Indian and Pakistani ethnic origin than mothers 
of White ethnicity. The impact of a number of different factors, including 
deprivation of maternal residence, on any observed association between ethnicity 
and NTD prevalence is considered in this chapter. However, it is not possible to 
explore the impact of pre-pregnancy and pregnancy attitudes and experiences, such 
as folic acid use, diet, any religious observance etc. These factors have been 
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explored in-depth in a qualitative study of mothers who have had a pregnancy 
affected by an NTD (Chapter 6).  
 
 Calculating NTD prevalence estimates for different ethnic groups 5.2
 
As in previous analyses, and described in Chapter 4, aggregated denominator data 
(live and still births) were obtained from ONS and merged with pregnancy level 
NTD BINOCAR data to form an aggregated dataset for calculating prevalence 
estimates. Firstly, NTD prevalence was compared by ethnicity for all NTD affected 
pregnancies in the BINOCAR dataset where ethnicity is not missing (complete 
cases). Looking at absolute prevalence estimates, for all NTD subtypes combined, 
the only statistically significant difference observed is that the prevalence is lower 
for mothers of “Other” ethnicity (4.98 per 10,000; 95% CI: 3.65, 6.79) than mothers of 
White (10.32 per 10,000; 95% CI: 9.73, 10.94) or Indian (13.45 per 10,000; 95% CI: 9.46, 
19.13) ethnicity (Table 36). However, it is very difficult to say anything meaningful 
about the “Other” ethnic group due to the eclectic nature of this group. 
 
Calculating prevalence rate ratios, with mothers of White ethnicity chosen as the 
reference group for reasons stated previously, looking at anencephaly affected 
pregnancies specifically, Indian mothers were shown to be nearly twice as likely to 
have an NTD affected pregnancy as White mothers (PRR 1.72; 95% CI: 1.05, 2.84) 
(Table 37); the 95% confidence interval for Indian mothers when compared to White 
mothers did not include 1, providing evidence to support a statistically significant 
difference (p=0.032). Although Bangladeshi mothers were shown to be nearly twice 
as likely as White mothers to have a spina bifida affected pregnancy (Table 37), due 
to the smaller numbers in this group and the wide confidence interval (PRR 1.83; 
95% CI: 0.82, 4.09) this was not a statistically significant difference (p=0.14). 
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Table 36: NTD birth prevalence estimates by ethnicity for all registers 
Ethnicity 
Prevalence/10,000 births (95% CI) 
All NTDs* Anencephaly Spina bifida 
White 10.32 (9.73-10.94) 4.02 (3.66-4.42) 5.14 (4.73-5.59) 
Indian 13.45 (9.46-19.13) 6.94 (4.25-11.32) 4.33 (2.33-8.06) 
Pakistani 9.49 (6.41-14.05) 4.17 (2.31-7.54) 3.79 (2.04-7.05) 
Bangladeshi 15.69 (8.44-29.18) 4.70 (1.52-14.59) 9.41 (4.23-20.95) 
Black Caribbean 10.51 (4.37-25.25) 2.10 (0.30-14.90) 8.40 (3.15-22.40) 
Black African 7.66 (4.62-12.71) 3.57 (1.70-7.50) 3.06 (1.38-6.82) 
Other ethnic group 4.98 (3.65-6.79) 1.99 (1.22-3.25) 2.24 (1.41-3.56) 
*Includes encephalocele 
 
Table 37: NTD birth prevalence rate ratios by ethnicity for all registers 
Ethnicity 
Prevalence rate ratios (PRR) (95% CI) 
All NTDs Anencephaly Spina bifida 
White (ref) 10.32 4.02 5.14 
Indian 1.30 (0.91-1.86) 1.72 (1.05-2.84) 0.84 (0.45-1.57) 
Pakistani 0.92 (0.62-1.37) 1.04 (0.57-1.89) 0.74 (0.39-1.38) 
Bangladeshi 1.52 (0.82-2.83) 1.17 (0.38-3.64) 1.83 (0.82-4.09) 
Black Caribbean 1.02 (0.42-2.45) 0.52 (0.07-3.71) 1.63 (0.61-4.37) 
Black African 0.74 (0.45-1.24) 0.89 (0.42-1.87) 0.60 (0.27-1.33) 
Other ethnic group 0.48 (0.35-0.66) 0.50 (0.30-0.82) 0.44 (0.27-0.70) 
 
Interestingly, when splitting the dataset into isolated and non-isolated cases, with 
categorisation based on the EUROCAT multiple congenital anomaly algorithm, as 
detailed in the previous chapter, no effect was observed for isolated cases, apart 
from the lower prevalence in mothers of “Other” ethnicity (Table 38). However, for 
non-isolated cases Indian mothers were nearly 3 times as likely (PRR 2.64; 95% CI: 
1.57, 4.44) (p<0.001) and Bangladeshi mothers more than 3 times as likely (PRR 3.19; 
95% CI: 1.32, 7.71) (p=0.01) as White mothers to have an NTD affected pregnancy     
(Table 39). Specifically, the prevalence of anencephaly (as a non-isolated NTD) in 
Indian mothers was five times higher (PRR 5.43; 95% CI: 2.61, 11.30) (p<0.001) and 
for Bangladeshi mothers, the spina bifida prevalence was more than three times 
higher (PRR 3.63; 95% CI: 1.16, 11.39) (p=0.03) for babies with a non-isolated NTD 
than in White mothers (Table 38 and Table 39).  
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Table 38: NTD birth prevalence rate ratio estimates by ethnicity for isolated NTD affected 
pregnancies for all registers 
Ethnicity 
Prevalence rate ratios (95% CI) 
All NTDs Anencephaly Spina bifida 
White (ref) 7.85 3.38 3.85 
Indian 0.88 (0.54-1.45) 1.02 (0.51-2.06) 0.79 (0.37-1.66) 
Pakistani 0.87 (0.55-1.39) 0.90 (0.45-1.81) 0.79 (0.39-1.59) 
Bangladeshi 1.00(0.41-2.40) 0.93 (0.23-3.72) 1.22 (0.39-3.80) 
Black Caribbean 0.80 (0.26-2.49) 0.62 (0.09-4.41) 1.09 (0.27-4.38) 
Black African 0.65 (0.35-1.21) 0.90 (0.40-2.03) 0.53 (0.20-1.42) 
Other ethnic group 0.48 (0.33-0.68) 0.51 (0.30-0.88) 0.39 (0.22-0.69) 
 
 
Table 39: NTD birth prevalence rate ratio estimates by ethnicity for non-isolated NTD 
affected pregnancies for all registers 
Ethnicity 
Prevalence rate ratios (95% CI) 
All NTDs Anencephaly Spina bifida 
White (ref) 2.46 0.64 1.29 
Indian 2.64 (1.57-4.44) 5.43 (2.61-11.30) 1.00 (0.32-3.15) 
Pakistani 1.08 (0.51-2.29) 1.78 (0.56-5.67) 0.59 (0.15-2.37) 
Bangladeshi 3.19 (1.32-7.71) 2.46 (0.34-17.68) 3.63 (1.16-11.39) 
Black Caribbean 1.71 (0.42-6.86) 0.00 (0) 3.24 (0.80-13.09) 
Black African 1.04 (0.43-2.51) 0.80 (0.11-5.76) 0.79 (0.20-3.18) 
Other ethnic group 0.51 (0.27-0.95) 0.39 (0.10-1.59) 0.58 (0.25-1.31) 
 
Simply ignoring missing data can reduce precision and introduce bias into the 
analyses (154). As shown in Table 4 of Chapter 4 there is huge variability between 
different registers in the amount of ethnicity data that is missing. Whereas 
EMSYCAR and SWCAR only have 12.92% and 7.06% of their data missing 
respectively, the other three registers have more than 32% of their data missing for 
ethnicity and for NorCAS as much as 45.83% of the data are missing. Registers were 
dichotomised into those with more than 87% of their ethnicity data complete 
(SWCAR and EMSYCAR: so-called “complete” ethnicity registers) and the 
remaining three registers which have less than 68% completeness for ethnicity 
(NorCAS, CAROBB and CARIS: so-called “incomplete” ethnicity registers). The 
outcomes of complete case analyses using “complete” (EMSYCAR and SWCAR) 
ethnicity registers only, as shown in Table 40; Table 41; Table 42 and Table 43 
below, can be compared with the outcomes described above for complete case 
analyses using data from all registers, as shown in Table 36; Table 37; Table 38 and 
Table 39.  
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For analyses using “complete” ethnicity registers only, it was found that Indian 
mothers were nearly twice as likely (PRR 1.86; 95% CI: 1.26, 2.75) (p=0.002) and 
Bangladeshi mothers more than three times as likely (PRR 3.10; 95% CI: 1.61, 5.97) 
(p=0.001) as White mothers to have an NTD affected pregnancy (Table 41). For the 
complete case analyses including data from all registers (Table 37), there was an 
excess anencephaly prevalence for Indian mothers when compared to White 
mothers (PRR 2.56; 95% CI: 1.52, 4.31) (p<0.001), however, in this analysis using 
data only from the “complete” ethnicity registers, the excess is more marked. 
Additionally, Bangladeshi mothers are shown to have a spina bifida prevalence that 
is more than four times that for White mothers (PRR 4.29; 95% CI: 1.91, 9.61) 
(p<0.001) in analyses using only “complete” ethnicity registers (Table 40 and Table 
41).  
 
When stratifying by whether or not the NTD is isolated, a similar pattern between 
the two sets of analyses (complete case analyses for all registers vs. complete case 
analyses for “complete” ethnicity registers) is observed: For non-isolated NTD 
cases, there is an excess overall for all NTDs combined for Indian and Bangladeshi 
mothers when compared to White mothers and specifically anencephaly affected 
pregnancies are higher in Indian and spina bifida affected pregnancies higher in 
Bangladeshi mothers (Table 39 and Table 43). However, the excess is much greater 
in the “complete” ethnicity registers’ analyses where anencephaly non-isolated 
NTD affected pregnancies are more than 7 times as likely in Indian mothers (PRR 
7.28; 95% CI: 3.29, 16.15) (p<0.001) and spina bifida non-isolated NTD affected 
pregnancies more than 8 times as likely in Bangladeshi mothers (PRR 8.45; 95% CI: 
2.67, 26.73) (p<0.001) as White mothers (Table 43). There is also shown to be an 
excess of spina bifida non-isolated NTD affected pregnancies in Black Caribbean 
mothers when compared to White mothers (PRR 4.10; 95% CI: 1.01, 16.69) in the 
“complete” ethnicity registers analyses; however, this difference only just reaches 
statistical significance, and should be treated with caution (Table 42 and Table 43). 
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Table 40: NTD birth prevalence estimates by ethnicity for EMSYCAR and SWCAR only 
Ethnicity 
Prevalence/10,000 births (95% CI) 
All NTDs Anencephaly Spina bifida 
White 11.49 (10.65-12.41) 4.80 (4.27-5.41) 5.52 (4.95-6.17) 
Indian 21.38 (14.55-31.42) 12.33 (7.43-20.45) 5.75 (2.74-12.06) 
Pakistani 14.96 (9.30-24.08) 6.16 (2.93-12.92) 6.16 (2.93-12.92) 
Bangladeshi 35.66 (18.53-68.61) 7.90 (1.98-31.61) 23.74 (10.66-52.90) 
Black Caribbean 14.41 (5.99-34.63) 2.88 (0.41-20.43) 11.52 (4.32-30.71) 
Black African 13.50 (7.99-22.80) 5.78 (2.60-12.87) 5.78 (2.60-12.87) 
Other ethnic group 5.40 (3.55-8.20) 2.45 (1.32-4.56) 2.21 (1.15-4.24) 
 
Table 41: NTD birth prevalence rate ratio estimates by ethnicity for EMSYCAR and 
SWCAR 
Ethnicity 
Prevalence rate ratios (95% CI) 
All NTDs Anencephaly Spina bifida 
White (ref) 11.49 4.80 5.52 
Indian 1.86 (1.26-2.75) 2.56 (1.52-4.31) 1.04 (0.49-2.20) 
Pakistani 1.30 (0.80-2.11) 1.28 (0.61-2.71) 1.11 (0.53-2.36) 
Bangladeshi 3.10 (1.61-5.97) 1.64 (0.41-6.60) 4.29 (1.91-9.61) 
Black Caribbean 1.25 (0.52-3.02) 0.60 (0.08-4.27) 2.08 (0.78-5.58) 
Black African 1.17 (0.69-1.99) 1.20 (0.54-2.70) 1.05 (0.47-2.35) 
Other ethnic group 0.47 (0.31-0.72) 0.51 (0.27-0.96) 0.40 (0.21-0.78) 
 
Table 42: NTD birth prevalence rate ratio estimates by ethnicity for isolated NTD affected 
pregnancies for EMSYCAR and SWCAR 
Ethnicity 
Prevalence rate ratios (95% CI) 
All NTDs Anencephaly Spina bifida 
White (ref) 8.74 4.02 4.12 
Indian 1.32 (0.77-2.24) 1.64 (0.81-3.31) 1.00 (0.41-2.42) 
Pakistani 1.31 (0.76-2.27) 1.09 (0.45-2.66) 1.28 (0.57-2.88) 
Bangladeshi 1.81 (0.68-4.84) 0.98 (0.14-7.01) 2.88 (0.92-8.97) 
Black Caribbean 0.99 (0.32-3.07) 0.72 (0.10-5.11) 1.40 (0.35-5.62) 
Black African 0.99 (0.51-1.92) 1.20 (0.49-2.91) 0.94 (0.35-2.51) 
Other ethnic group 0.51 (0.32-0.81) 0.55 (0.28-1.07) 0.48 (0.24-0.96) 
 
Table 43: NTD birth prevalence rate ratio estimates by ethnicity for non-isolated NTD 
affected pregnancies for EMSYCAR and SWCAR 
Ethnicity 
Prevalence rate ratios (95% CI) 
All NTDs Anencephaly Spina bifida 
White (ref) 2.75 0.79 1.40 
Indian 3.58 (1.99-6.44) 7.28 (3.29-16.15) 1.17 (0.29-4.76) 
Pakistani 1.28 (0.47-3.45) 2.23 (0.54-9.19) 0.63 (0.09-4.50) 
Bangladeshi 7.17 (2.95-17.46) 5.01 (0.69-36.30) 8.45 (2.67-26.73) 
Black Caribbean 2.09 (0.52-8.43) 4.23*e-7 (0) 4.10 (1.01-16.69) 
Black African 1.75 (0.72-4.26) 1.22 (0.17-8.85) 1.37 (0.34-5.59) 
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Other ethnic group 0.36 (0.13-0.96) 0.31 (0.04-2.26) 0.17 (0.02-1.26) 
 
5.2.1 Explorations around missing ethnicity data for different registers 
 
There were discrepancies between a complete case analysis using data from all 
registers and complete case analysis using data only from “complete” ethnicity 
registers (those with more than 87% of their ethnicity data complete) when 
exploring NTD prevalence estimates by ethnicity. Hence, this warranted further 
investigation before determining whether any subsequent complete cases analyses 
should include data from all registers or just those with very good ethnicity 
completion. 
 
5.2.1.1 Exploring whether ethnicity representation in each register reflects the ethnicity of 
the underlying population 
 
Comparing ethnicity completeness in the NTD dataset with that in the denominator 
population (all live and still births for the same geographical area) from ONS, 24% 
of ethnicity data is missing in the NTD dataset, whereas only 8% is missing in the 
ONS dataset. Therefore, simply ignoring missing ethnicity data for the 
“incomplete” (less than 68% complete) registers, will reduce precision of prevalence 
estimates. However, it is also of interest to look at where ethnicity is not missing, to 
compare the ethnic breakdown in the NTD dataset between different registers and 
to see whether it is similar to that in the denominator dataset. A breakdown by 
ethnicity for NTDs and births for EMSYCAR is shown in Figure 11 and Figure 12; 
for SWCAR in Figure 13 and Figure 14; for NorCAS in Figure 15 and Figure 16 ; for 
CAROBB in Figure 17 and Figure 18 and for CARIS in Figure 19 and Figure 20. 
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Figure 11: Ethnic breakdown for NTDs in 
EMSYCAR     
Figure 12: Ethnic breakdown for EMSYCAR 
births 
 
 
  
Figure 13: Ethnic breakdown for NTDs in 
SWCAR          
Figure 14: Ethnic breakdown for SWCAR births 
 
 
  
Figure 15: Ethnic breakdown for NTDs in 
NorCAS          
Figure 16: Ethnic breakdown for NorCAS births 
 
 
  
Figure 17: Ethnic breakdown for NTDs in 
CAROBB        
 
Figure 18: Ethnic breakdown for CAROBB 
births 
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Figure 19: Ethnic breakdown for NTDs in 
CARIS     
         
Figure 20: Ethnic breakdown for CARIS births 
  
 
Of the “complete” ethnicity registers, EMSYCAR covers the most ethnically diverse 
population with this diversity reflected in the NTD dataset; however, there is a clear 
excess of Indian and Bangladeshi NTD cases when compared to births to mothers of 
the same ethnicity. SWCAR covers a much less ethnically diverse area than 
EMSYCAR, with only 1% of births to Indian mothers in SWCAR when compared to 
2.5% in EMSYCAR. The proportion of NTD affected pregnancies to mothers of 
Bangladeshi ethnicity is more than twice as high as births to mothers from the same 
ethnic group in the region covered by SWCAR. However, the actual number of 
affected pregnancies is small (2 to Bangladeshi mothers in SWCAR).  
 
For the “incomplete” ethnicity registers, for NorCAS, the lack of ethnic diversity in 
the NTD dataset is not very surprising as the underlying population is not very 
ethnically diverse, with 91% of births to mothers of White ethnicity and the next 
highest proportion of births after mothers of “Other” ethnicity (6%) is 1% to 
mothers of Pakistani ethnicity. The same is true of CARIS, which also does not cover 
a very ethnically diverse area, and is reflected in the NTD dataset. What is 
surprising, however, is the lack of ethnic diversity in the NTD dataset from 
CAROBB when compared to the underlying population in which only 76% of births 
are to mothers of White ethnicity, 6% to mothers of Pakistani ethnicity and 4% to 
mothers of Indian ethnicity. 
 
5.2.1.2 Comments from register representative about ethnicity completion 
 
As part of the on-going dialogue with BINOCAR staff and register representatives 
about the data, some important indicators of why ethnicity data might be missing 
were given. A representative from NorCAS described how completion was poorer 
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for the earlier years of the data extract before the established proforma that 
encouraged women to record ethnicity had been developed. This was supported by 
a review of the NTD dataset as for the first three years of the study (2006 to 2008) 
61% of the ethnicity data is missing and for the last three (2009 to 2011) this falls to 
32%. Interestingly, the opposite was true for CARIS which had less missing for the 
first three years of the study (23%) than the last three years (40%). For CAROBB 
there was no difference between the two data year groups. 
 
Representatives from CAROBB noted that asking about ethnicity was sometimes 
difficult, due to its sensitive nature, and people are not always sure which ethnic 
category they fall into. This indicated the potential for bias as ethnicity information 
might be more likely to be recorded for women from certain ethnic groups than 
others. 
 
Understanding why ethnicity information reported to registers might be missing is 
further compounded by the fact that although it should be recorded somewhere in 
the patient’s notes, it can be difficult to find i.e. if it is not recorded well, it may not 
be reported.  
 
5.2.1.3 NTD subtype 
 
The observed prevalence differences by ethnicity between the two sets of analyses 
(analyses using data from all registers and analyses using only data from 
“complete” ethnicity registers) was very interesting when looking at individual 
NTD subtypes. A breakdown for the missing data for ethnicity by register for 
different NTD subtypes is shown in Figure 21. This further accentuates the 
difference in the proportion of missing ethnicity data between EMSYCAR/SWCAR 
and the other registers; however, importantly, there seems to be an excess of 
missing data for anencephaly for NorCAS and CARIS. As the excess prevalence in 
Indian mothers was shown to be specifically for anencephaly cases, the excess 
missing for anencephaly cases would certainly have an impact on the number of 
affected pregnancies to Indian mothers that could be observed. This could lead to 
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an underestimate for the prevalence rate ratio for mothers of Indian when 
compared to mothers of White ethnicity. 
 
 
Figure 21: Proportion of missing ethnicity data by NTD type and register 
 
5.2.1.4 Isolated vs. Non-Isolated NTDs 
 
When the analyses were split for isolated and non-isolated cases, a similar pattern 
was observed for complete case analyses using data from all registers and that only 
including “complete” ethnicity registers. However, the prevalence excess for Indian 
and Bangladeshi mothers was more marked in the “complete” ethnicity registers 
analyses, as described. The proportion of isolated and non-isolated NTD affected 
pregnancies that occur within each register (total for each register adds up to 100%), 
is shown in Appendix D in Figure D 1. The pattern is similar for different registers, 
although the difference between the proportion of isolated cases in CARIS (69.77; 
95% CI: 64.24, 74.90) and NorCAS (81.60; 95% CI: 76.63, 85.90) is statistically 
significant. Looking at the proportion of missing ethnicity data for isolated and non-
isolated cases by register, as shown in Figure 22, there is not a huge discrepancy for 
any of the registers; the difference is greatest for CARIS, where there is an excess of 
missing data for isolated cases, but this does not reach statistical significance. 
Therefore, missing ethnicity data does not appear to include an over or under 
representation of non-isolated cases. 
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Figure 22: Proportion of missing ethnicity data by whether the NTD is isolated or not and 
register 
 
5.2.1.5 Exploration of missing ethnicity through ad hoc data linkage between TOPFA 
cases in the NTD dataset and termination data from the DH 
 
As stated, 1296 out of 1642 NTD affected pregnancies in the BINOCAR dataset 
resulted in TOPFA (79%). Termination data from the DH covering the same regions 
and years has been obtained where the principal medical condition for the 
termination is an NTD. Whereas 24% of pregnancies in the BINOCAR NTD dataset 
have missing ethnicity data, only 4% of cases in the DH termination dataset have 
ethnicity that is not stated/missing. As the majority of NTDs result in a termination, 
it was important to link the two datasets to enable further exploration of possible 
bias in missing BINOCAR ethnicity data. However, information gained from the 
linkage cannot be extrapolated to affected pregnancies that result in live or still 
births. There is also some under ascertainment in the DH dataset as an NTD might 
be the true reason for the termination but this reason is not always given, and there 
are also indications of under reporting of terminations to the DH (112).  
 
A combination of region (based on register), primary care trust (PCT) of maternal 
residence, month of termination, year of termination, age of mother and gestation 
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length were used to uniquely identify affected pregnancies. There were no 
duplicates (i.e. this combination of variables uniquely identified pregnancies) in the 
DH dataset but there was one duplicate case in the BINOCAR dataset, when 
restricting the latter to pregnancies that resulted in a termination. This duplicate 
was shown to consist of two distinct pregnancies, rather than being a true duplicate 
as although the two records matched on NTD type in addition to matching on the 
variables listed above, they didn’t match on sex of fetus or age of discovery. The 
ethnicity of the mother was White in one case and not known in the other. Using 
this combination of variables to link affected pregnancies common to both the 
BINOCAR and DH dataset is not perfect and because of this, records had to match 
on all variables i.e. it was a conservative match. Moreover, the fact that this 
combination of variables did not uniquely identify every affected pregnancy in the 
BINOCAR dataset highlights how a match between the two datasets might not be a 
true match in every case. Therefore, ethnicity data from the DH dataset could not be 
used to populate missing ethnicity data in the BINOCAR dataset in addition to 
being used as an exploratory tool for whether there might be any bias in the missing 
ethnicity data. 
 
After matching and looking at where ethnicity was known in both datasets (n=188), 
ethnicity matched for merged records in the majority of cases (98%), however there 
were four instances where they didn’t. This supports the argument that the match is 
correct in most cases. Looking at cases where ethnicity is known in the DH dataset 
but not known in the BINOCAR dataset (n=54), the majority are White (71%), 
however there is also a high proportion that are Pakistani (20%). Breaking the data 
down by register, all of the latter come from CAROBB. In fact, although the 
numbers are small, as many mothers of White ethnicity have missing data as 
mothers of Pakistani ethnicity in CAROBB ((11/42 (26%) of White mothers and 
11/12 (92%) of Pakistani mothers have missing data)). However, it would be 
expected that the missing data would mainly be for mothers of White ethnicity, 
simply because this is the larger ethnic group. This indicates a possible bias for 
missing ethnicity data in the CAROBB region, which is supported by the anecdotal 
evidence described in section 5.2.1.2. There is no indication, from this data linkage, 
that this is the case in the other regions. 
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5.2.1.6 Exploring whether mothers of Indian and Bangladeshi ethnicity live in more 
deprived areas in regions covered by “complete” ethnicity registers 
 
As an association between deprivation and NTD prevalence has been reported, an 
important final consideration is whether it is possible that Indian and Bangladeshi 
mothers live in areas that are more deprived in the regions covered by “complete” 
when compared to “incomplete” ethnicity registers. It was found that the 
proportion of births to mothers of Indian ethnicity in deprivation quintile 1 (most 
deprived quintile) is significantly higher in NorCAS when compared to all other 
registers and the proportion in deprivation quintile 1 in CAROBB is significantly 
lower than in all other registers. Looking at births to Bangladeshi mothers, both the 
proportion of births in deprivation quintile 1 for CAROBB and SWCAR is 
statistically significantly lower than the proportion in this quintile for other 
registers. However, the number of births to mothers of Bangladeshi ethnicity overall 
is relatively small (A breakdown of proportion of births and confidence intervals for 
different deprivation quintiles for Bangladeshi and Indian mothers for different 
registers is given in Table D 2, Table D 3, Table D 4, Table D 5 and Table D 6 in 
Appendix D). What can be concluded from this comparison is that there does not 
seem to be any evidence that mothers of Indian or Bangladeshi ethnic origin live in 
more deprived areas in regions covered by “complete” when compared to 
“incomplete” ethnicity registers and there is therefore a lack of evidence that the 
excess prevalence for Indian and Bangladeshi mothers in the former, should be 
attributed to deprivation. 
 
5.2.2 Conclusions 
 
In a complete case analysis using data from all registers and ignoring missing 
ethnicity data, there was shown to be an excess anencephaly prevalence in mothers 
of Indian (PRR 5.43)  and an excess spina bifida prevalence in mothers of 
Bangladeshi ethnicity (PRR 3.63) when compared to mothers of White ethnicity. 
This excess was found in non-isolated NTDs (other congenital defects are present in 
addition to the NTD) in women of Indian and Bangladeshi ethnicity. The same was 
observed but the effect much more marked for Indian (PRR 7.28) and Bangladeshi 
(PRR 8.45) mothers when compared to mothers of White ethnicity in the complete 
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case analysis using data only from “complete” (>87% completion) ethnicity registers 
(EMSYCAR and SWCAR). Through discussions with CAROBB representatives and 
through linking termination data from BINOCAR with termination data from the 
DH, there were indications of a potential bias for missing ethnicity data in this 
register. Specifically, there seemed to be an excess of missing ethnicity data for 
mothers of Pakistani ethnicity. Although there were no indications of bias for 
missing ethnicity data in NorCAS and CARIS, from either discussions with register 
representatives or the data linkage work, the excess of missing ethnicity data for 
anencephaly cases observed in the NTD dataset could have resulted in an under 
representation of mothers of Indian ethnicity in the analyses. Additionally, there 
would be decreased precision in prevalence estimates for registers with 
“incomplete” (<68% completion) ethnicity information (NorCAS; CAROBB and 
CARIS), due to there being more missing in the numerator (NTD cases) than the 
denominator (births). Therefore, because of these identified problems, and due to 
there being a lack of evidence that Indian and Bangladeshi mothers from 
“complete” ethnicity registers live in more deprived areas (greater deprivation is 
associated with a higher NTD prevalence) than mothers of the same ethnicity for 
the “incomplete” registers, further complete case analyses have been conducted 
using data only from “complete” ethnicity registers (EMSYCAR and SWCAR). It is 
also of importance to note that, as shown, the area covered by EMSYCAR is more 
ethnically diverse than that covered by SWCAR and therefore observed outcomes 
by ethnicity are unlikely to be over inflated.  
 
Restricting analyses by ethnicity to the “complete” ethnicity registers does have its 
limitations as there were identified regional differences for NTD prevalence 
explorations in Chapter 4 and maternal BMI is only recorded with sufficient 
completeness in NorCAS. An in-depth discussion of this is included in the final 
chapter of this thesis. 
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 NTD prevalence in ethnic communities in EMSYCAR and SWCAR 5.3
 
5.3.1 Isolated and Non-Isolated NTDs  
 
As described in section 4.4.7.1.1, a classification system that enables isolated and 
non-isolated NTDs to be distinguished, based on EUROCAT’s multiple congenital 
anomaly algorithm, has been applied to all NTD affected pregnancies obtained in 
the BINOCAR dataset. All analyses detailed in this thesis so far that have involved 
stratification by whether the NTD is isolated or not, have been based on this 
classification system. However, changing the focus to EMSYCAR and SWCAR only 
and ethnicity in particular, numbers start to become quite small in some groups. 
 
It was described how there is strong agreement between classification of cases 
based on the EUROCAT algorithm and a local aetiological variable, only available 
for CAROBB and EMSYCAR. Comparing the number of NTDs classified as isolated 
and non-isolated using the two classification systems for EMSYCAR only, 28 cases 
classified as non-isolated and 7 cases classified as isolated using the EUROCAT 
algorithm are re-classified as isolated and non-isolated, respectively, using the 
aetiological classification system (Table 44). Using the kappa statistic, a measure of 
inter-rater agreement, agreement is shown to be strong (93.15%) (p<0.001).  
However, the strong inter-rater agreement will be influenced by the higher 
proportion of isolated cases and when looking only at non-isolated cases for groups 
with small numbers, observed study outcomes could be altered by relatively few 
categorisation changes.   
 
Table 44: Comparing aetiological vs. EUROCAT algorithm classification for isolated and 
non-isolated NTD cases in EMSYCAR 
Aetiological classification 
EUROCAT algorithm 
Isolated Non-isolated 
Isolated 387 28 
Non-isolated 7 89 
 
It was described in the previous section (section 5.2) how it was specifically for non-
isolated NTDs (determined using the EUROCAT algorithm) that there was found to 
be an excess NTD prevalence in mothers of Indian and Bangladeshi ethnicity when 
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compared to mothers of White ethnicity. Anomaly subgroup codes obtained from 
BINOCAR, which give an indication of what other conditions a fetus might have, 
were explored for the twelve non-isolated NTDs (based on the EUROCAT 
algorithm) to Indian mothers and five non-isolated NTDs to Bangladeshi mothers 
across EMSYCAR and SWCAR. For two of “non-isolated” NTD affected 
pregnancies to Bangladeshi mothers, club foot was the only condition specified in 
addition to the NTD. However, club foot is thought to occur as secondary to the 
NTD, rather than independent of it, and thus, if truly the only other condition in 
addition to the NTD, the case should be coded as isolated. It was confirmed through 
both discussions with the BINOCAR database manager and looking at the local 
aetiological variable, that these two cases should have been categorised as isolated. 
Furthermore, comparing aetiological and EUROCAT algorithm classification 
systems for mothers of White, Indian and Bangladeshi ethnicity for both isolated 
and non-isolated cases in EMSYCAR, 2 out of 7 Bangladeshi mothers; 4 out of 23 
Indian mothers and 14 out of 372 White mothers are re-classified using the 
aetiological system (Table 45). NTD cases are more likely to be re-classified from 
non-isolated to isolated than the other way round (Table 45). 
 
Table 45: Comparing aetiological and EUROCAT algorithm classification systems for 
mothers of White, Indian and Bangladeshi ethnicity in EMSYCAR 
Ethnicity 
Aetiological classification EUROCAT algorithm 
Isolated Non-isolated Isolated Non-isolated 
White 305 67 291 81 
Indian 16 7 12 11 
Bangladeshi 4 3 2 5 
 
If prevalence is calculated for non-isolated and isolated NTD affected pregnancies 
separately, just using EMSYCAR data and the aetiological classification system, the 
NTD prevalence for Indian mothers when compared to White mothers is more 
marked for non-isolated NTDs (PRR 3.58; 95% CI: 1.64, 7.79) (p=0.001). However, 
the difference is also shown to be statistically significant for isolated NTDs (PRR 
1.80; 95% CI: 1.09, 2.97) (p=0.022). As described, the inclusion of data from SWCAR 
is important in order not present an over inflated view for ethnicity outcomes.  
It is unfortunate that a local aetiological classification system is not available for 
SWCAR. However, as detailed, NTD cases are more likely to be re-classified from 
non-isolated to isolated and there is only 1 mother of Indian ethnicity, and no 
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mothers of Bangladeshi ethnicity, in the non-isolated category using the EUROCAT 
algorithm in SWCAR. Any re-classifications for mothers in the White ethnic group 
in SWCAR are also likely to have little impact due to the size of the population and 
strong agreement between the two classification systems. It is also of importance to 
note that the majority of NTD cases re-classified from non-isolated to isolated when 
going from the EUROCAT algorithm to the aetiological classification system, had 
no other anomaly subgroup selected in the dataset obtained (17 out of 28). 
Therefore, to conduct some further exploratory analyses, the aetiological 
classification system was used for EMSYCAR data and all non-isolated NTD cases 
in SWCAR where no additional anomaly subgroups had been selected, were re-
classified as isolated (to ensure that the NTD prevalence in mothers of White 
ethnicity for isolated cases in this register is theoretically as high as possible to 
explore ethnic differences). It was found that although the effect for non-isolated 
NTD affected pregnancies was more marked: the PRR for non-isolated cases for 
Indian mothers when compared to mothers of White ethnicity was 2.93 (95% CI: 
1.43, 5.98) (p=0.003) and 5.28 for Bangladeshi mothers when compared to mothers 
of White ethnicity (95% CI: 1.68, 16.58) (p=0.004), an ethnic difference in prevalence 
was also observed for isolated cases. Specifically, for isolated cases, Indian mothers 
were 1.60 times more likely (95% CI: 1.00, 2.56) (p=0.05) and Bangladeshi mothers 
were 2.56 times more likely (95% CI: 1.15, 5.73) (p=0.02) to have an NTD affected 
pregnancy than mothers of White ethnicity. 
 
5.3.1.1 Conclusions 
 
The EUROCAT multiple congenital anomaly algorithm is an effective and replicable 
tool for categorising congenital anomaly cases as isolated and non-isolated in 
analyses with groups unaffected by small numbers. However, when numbers do 
start to become small in certain groups, analyses using the EUROCAT algorithm 
categorisation system should be conducted with caution. As shown, analyses based 
on the EUROCAT algorithm found that it was specifically for non-isolated NTDs 
that there was an excess NTD prevalence in mothers of Indian and Bangladeshi 
ethnicity when compared to mothers of White ethnicity. However, this is likely to 
be a distortion of the true picture, with indications that ethnic differences would 
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also be observed for isolated cases. As detailed, misclassifications may arise as not 
all potential multiples will be reviewed by clinicians and geneticists. Dolk and 
colleagues describe how one of the reasons why cases might be assigned as 
potential multiples and in fact be isolated is that there is an additional malformation 
that is not independent of the primary malformation that hasn’t been included in 
the algorithm (135). As shown from the explorations here, a specific example of this 
is when club foot is the only condition specified in addition to the NTD. Although it 
could be argued that the way in which the local aetiological variable is generated is 
less standardised and less widely applicable, its classification of isolated and non-
isolated NTD cases is more accurate. It is a shame that a local aetiological variable is 
not collected by SWCAR and, therefore, in future multivariable analyses around 
ethnicity, whether the NTD is isolated or not will only be explored in sub-analyses 
using the EMSYCAR data. There are limitations of this as these sub-analyses will be 
underpowered and will only be focused on one geographical area, which is very 
ethnically diverse.  
 
5.3.2 Univariable explorations for ethnicity in the NTD dataset (EMSYCAR and 
SWCAR) 
 
In preliminary explorations of NTD prevalence using the BINOCAR dataset 
(Chapter 4) it was found that NTD prevalence was higher in mothers living in more 
deprived areas and in mothers in the under 20 and 40+ age groups. There were also 
indications of a discrepancy by sex of fetus, although this is something which is 
difficult to explore as the majority of anencephaly cases, where specifically a female 
excess has been previously observed (3), are terminated before sex determination is 
accurate. Initial univariable explorations around ethnicity and these three variables 
were conducted primarily in the NTD, pregnancy level, dataset with reference to 
the denominator dataset where appropriate. Typically, the Chi-Squared Test, and 
Fischer’s Exact Test when cell sizes became too small, were performed in STATA to 
explore associations. 
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5.3.2.1 Ethnicity and Deprivation 
 
Results from the 2011 census showed that all ethnic minority groups were more 
likely to live in more deprived areas than those from the White British ethnic group; 
deprivation was highest for those of Bangladeshi or Pakistani ethnic origin with 
more than a third of individuals from these ethnicities living in deprived areas. 
Those of Indian ethnicity, in contrast, were the least deprived of the ethnic minority 
groups after White Irish (155). Looking at the birth denominator data obtained from 
ONS for the study (where deprivation quintile 1 is the most deprived and quintile 5 
the least deprived), mothers of Indian ethnicity are concentrated in both quintile 1 
and quintile 2 for both the region covered by EMSYCAR and SWCAR. Bangladeshi 
mothers are concentrated in quintile 1 in the region covered by EMSYCAR; 
however, for SWCAR, although there are still significantly more births to 
Bangladeshi mother in the quintile 1 than any other quintile, there is less of a 
discrepancy between quintile 1, 2 and 3.  
 
Looking just within the BINOCAR NTD dataset, White mothers are more evenly 
distributed across the different deprivation quintiles in contrast to Pakistani, 
Bangladeshi, Black Caribbean and Black African mothers who are clearly 
concentrated in quintile1 (most deprived), although half of White mothers are still 
within quintile 1 and 2. Indian mothers are concentrated in quintile 1 and 2 
(p=0.004). No statistically significant differences are detected between maternal 
ethnicity and deprivation of maternal residence, when breaking the analyses down 
for anencephaly (p=0.106) and spina bifida subtypes (p=0.193). However, this could 
be due to small numbers.  
 
5.3.2.2 Ethnicity and maternal age 
 
Within the NTD dataset, mothers of Indian ethnicity are concentrated in the 25-29 
age group and Pakistani mothers in the 25-29 and 30-34 age groups. In contrast, 
although mothers of White ethnicity aged between 25 and 29 have the highest 
number of NTD affected pregnancies, there are only slightly less affected 
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pregnancies in the 20-24 and 30-34 age groups.  However, the association between 
maternal age and ethnicity doesn’t reach statistical significance (p=0.09).  
 
Exploring the association between maternal age and ethnicity for anencephaly and 
spina bifida subtypes separately, for anencephaly affected pregnancies a similar 
pattern is observed, although the difference still doesn’t reach statistical significance 
(p=0.09). For spina bifida, no statistically significant difference is detected (p=0.27). 
Despite the fact that there was not found to be a statistically significant association 
between maternal age and ethnicity, it was still considered an important variable to 
include in the multivariable model, particularly due to its association with other key 
variables. 
 
5.3.2.3 Deprivation and maternal age 
 
For NTD affected pregnancies, older mothers are more likely to live in less deprived 
areas than younger mothers (p<0.001). The same effect is observed when looking at 
anencephaly (p=0.001) and spina bifida affected pregnancies (p=0.001) individually. 
 
5.3.2.4 Ethnicity and sex of baby 
 
A breakdown of the proportion of males and females by maternal ethnicity for 
pregnancies where the gestation length is eighteen weeks or more in the NTD 
dataset is given in Table 46. No statistically significant association (p=0.92) between 
sex and ethnicity is detected, despite the fact that there are equal numbers of males 
and females born to mothers of White ethnicity in contrast to mothers from most 
other ethnic groups, where there seems to be a female excess. There is also no 
statistically significant association for anencephaly affected pregnancies (p=0.67), 
despite the fact that the sex discrepancy for Indian mothers is more marked, and 
also for spina bifida affected pregnancies (p=0.66) where the discrepancy for 
Bangladeshi and Pakistani mothers is more marked. It is a problem that numbers 
become very small in these analyses. Due to the findings from these explorations 
and the greatly reduced dataset (particularly for anencephaly affected pregnancy) 
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that would result from including sex of baby in the analyses, it was not deemed 
appropriate to include it in the multivariable analyses. 
 
Table 46: Breakdown of sex of baby by maternal ethnicity for NTD affected pregnancies 
in EMSYCAR and SWCAR, where sex is known and the gestation length is 18 weeks or 
longer 
Ethnicity Male (%) Female (%) Total 
White 50.36 49.64 100 
Indian 35.71 64.29 100 
Pakistani 40 60 100 
Bangladeshi 40 60 100 
Black Caribbean 33.33 66.67 100 
Black African 50 50 100 
Other ethnic group 45.45 54.55 100 
Total 48.94 51.06 100 
 
5.3.3 Multivariable model exploring the association between ethnicity and NTD 
prevalence 
 
To explore the mitigating impact of maternal age and deprivation of maternal 
residence on any observed association between ethnicity (main independent 
variable) and NTD prevalence (dependent variable) in EMSYCAR and SWCAR, 
variables were initially added iteratively into a binomial regression model to 
explore their impact. White, deprivation quintile 1 and maternal age group 25-29 
are taken as the reference groups, as in previous analyses. As both deprivation and 
maternal age were shown to influence observed outcomes, they were adjusted for in 
the “final” model. To further investigate the complex relationship between ethnicity 
and deprivation, deprivation quintile was taken out the model as a cofactor and 
analyses were stratified by deprivation quintile. The model was also stratified by 
whether the NTD was anencephaly or spina bifida, as the excess NTD prevalence in 
mothers of Indian ethnicity was shown to be specifically for anencephaly affected 
pregnancies and in Bangladeshi mothers, for spina bifida affected pregnancies. The 
model was then further stratified by whether the NTD was isolated or not, in sub-
analyses using only the EMSYCAR data (as the aetiological variable is not collected 
by SWCAR). This analysis was conducted as there were indications that the NTD 
prevalence discrepancy by ethnicity is more marked for non-isolated cases.  Finally, 
sensitivity analyses were conducted (using EMSYCAR and SWCAR data) to explore 
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the impact of removing NTD affected pregnancies that occurred as part of a 
multiple set from the model. 
 
5.3.3.1 Final “all in” model 
 
Table 47 gives both unadjusted prevalence rate ratios e.g. association between 
ethnicity and NTD prevalence without taking into account other variables and 
adjusted prevalence rate ratios e.g. the association between ethnicity and NTD 
prevalence, adjusted for maternal age and deprivation of maternal residence. There 
is little change to observed associations between ethnicity and NTD prevalence 
between unadjusted and adjusted models, although there is a slight attenuation of 
the effect for Bangladeshi mothers in the latter. Specifically, after adjusting for 
maternal age and deprivation, Indian mothers are still 1.84 times more likely (95% 
CI: 1.24, 2.73) (p=0.002) and Bangladeshi mothers 2.86 times more likely (95% CI: 
1.48, 5.53) (p=0.002) than White mothers to have an NTD affected pregnancy. 
Holding everything else constant, in the adjusted model, the NTD prevalence in 
mothers living in deprivation quintile 3, 4 and 5 is statistically significantly lower 
than mothers living in quintile 1 (most deprived) and deprivation is highly 
significant in the adjusted model as a whole (p<0.001).  
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Table 47: Binomial regression model to explore the association between ethnicity and 
NTD prevalence, unadjusted and adjusted for IMD quintile and maternal age for 
EMSYCAR and SWCAR 
Variable 
Unadjusted 
PRR 95% CI 
P-
value 
Adjusted 
PRR 95% CI 
P-
value 
White (ref)     
0.019 
    
0.003 
Indian 1.86 
1.26-
2.75 1.84 
1.24-
2.73 
Pakistani 1.30 
0.80-
2.11 1.12 
0.68-
1.85 
Bangladeshi 3.10 
1.61-
5.97 2.86 
1.48-
5.53 
Black Caribbean 1.25 
0.52-
3.02 1.10 
0.46-
2.66 
Black African 1.17 
0.69-
1.99 1.04 
0.61-
1.77 
Other ethnic 
group 0.47 
0.31-
0.72 0.42 
0.27-
0.66 
IMD quintile 1 
(ref) 
 
  
<0.001 
    
<0.001 
IMD quintile 2 0.87 
0.72-
1.05 0.87 
0.71-
1.06 
IMD quintile 3 0.74 
0.60-
0.91 0.70 
0.56-
0.87 
IMD quintile 4 0.67 
0.54-
0.83 0.68 
0.53-
0.85 
IMD quintile 5 0.70 
0.56-
0.87 0.69 
0.54-
0.88 
25-29 (ref)     
0.378 
    
0.367 
<20 1.32 
1.02-
1.72 1.31 
0.99-
1.74 
20-24 1.03 
0.84-
1.26 1.01 
0.81-
1.25 
30-34 0.94 
0.78-
1.14 1.04 
0.85-
1.28 
35-39 1.07 
0.87-
1.33 1.23 
0.98-
1.55 
40+ 1.14 
0.78-
1.65 1.32 
0.90-
1.94 
 
5.3.3.2 Stratifying by deprivation quintile 
 
When deprivation quintile is removed from the model as a covariate and stratified 
by, despite births to mothers of Indian ethnicity in the geographical regions covered 
being concentrated in deprivation quintile 1 and 2, the biggest discrepancy in NTD 
prevalence between Indian and White mothers is observed in quintile 3 (PRR 2.83; 
95% CI: 1.15, 6.93) (Table 48). This accentuates how in order to understand the 
discrepancy in NTD prevalence between mothers of Indian and White ethnicity, 
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explorations solely around deprivation are not enough. It is difficult to say anything 
definitely for Bangladeshi mothers after stratifying by deprivation quintile, due to 
the small numbers involved. 
 
Table 48: Binomial regression model to explore the association between ethnicity and 
NTD prevalence, stratified by deprivation quintile and adjusted for maternal age for 
EMSYCAR and SWCAR 
Variable 
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 
Adjusted 
PRR (95% 
CI) 
Adjusted 
PRR (95% 
CI) 
Adjusted 
PRR (95% 
CI) 
Adjusted 
PRR (95% 
CI) 
Adjusted 
PRR (95% 
CI) 
White (ref)           
Indian 
1.96 (1.00-
3.85) 
2.29 (1.21-
4.36) 
2.83 (1.15-
6.93) 
0.61 (0.09-
4.40) 
0.52 (0.07-
3.76) 
Pakistani 
1.34 (0.72-
2.46) 
0.59 (0.15-
2.39) 
2.32 (0.74-
7.31) 0.00 0.00 
Bangladeshi 
2.91 (1.20-
7.08) 
2.66 (0.66-
10.74) 0.00 
9.46 (2.35-
38.12) 0.00 
Black 
Caribbean 
1.43 (0.53-
3.85) 
1.10 (0.15-
7.87) 0.00 0.00 0.00 
Black African 
0.98 (0.50-
1.92) 
0.40 (0.06-
2.83) 
2.50 (0.62-
10.09) 
2.02 (0.28-
14.45) 
1.36 (0.19-
9.77) 
Other ethnic 
group 
0.18 (0.07-
0.49) 
0.74 (0.36-
1.51) 
0.63 (0.23-
1.72) 
0.60 (0.19-
1.88) 
0.36 (0.09-
1.48) 
25-29 (ref)           
<20 
1.64 (1.06-
2.54) 
0.88 (0.47-
1.66) 
1.58 (0.75-
3.34) 
1.57 (0.73-
3.39) 
0.99 (0.30-
3.27) 
20-24 
1.18 (0.82-
1.70) 
0.87 (0.57-
1.34) 
1.31 (0.77-
2.23) 
0.77 (0.41-
1.43) 
0.95 (0.47-
1.91) 
30-34 
1.07 (0.69-
1.64) 
1.06 (0.71-
1.60) 
1.23 (0.76-
1.99) 
0.82 (0.51-
1.32) 
0.94 (0.57-
1.55) 
35-39 
2.03 (1.30-
3.17) 
1.33 (0.83-
2.12) 
1.17 (0.66-
2.05) 
0.75 (0.43-
1.30) 
0.99 (0.57-
1.71) 
40+ 
1.13 (0.41-
3.13) 
1.49 (0.67-
3.28) 
2.82 (1.41-
5.63) 
0.67 (0.24-
1.88) 
0.72 (0.25-
2.07) 
 
5.3.3.3 Stratifying by whether the NTD is anencephaly or spina bifida 
 
Carrying out the multivariable binomial regression for anencephaly and spina 
bifida NTD sub-types separately, as shown in Table 49, after adjusting for 
deprivation of maternal residence and maternal age, the anencephaly prevalence is 
still statistically significantly higher in Indian (PRR 2.57; 95% CI: 1.52, 4.34) 
(p<0.001) and the spina bifida prevalence still statistically significantly higher in 
Bangladeshi (PRR 3.86; 95% CI: 0.72, 8.69) (p=0.001) mothers, than mothers of White 
ethnicity. 
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Holding everything else constant, deprivation of maternal residence is also highly 
significant in both the anencephaly and spina bifida models overall (p=0.001). 
Markedly, for spina bifida affected pregnancies, the prevalence is statistically 
significantly lower in mothers living in deprivation quintile 2 (PRR 0.70; 95% CI: 
0.52, 0.94) (p=0.017), 3 (PRR 0.58; 95% CI: 0.42, 0.81) (p=0.001), 4 (PRR 0.61; 95% CI: 
0.44, 0.85) (p=0.004) and 5 (PRR 0.63; 95% CI: 0.45, 0.89) (p=0.008) when compared 
to quintile 1 (most deprived). 
 
Holding maternal ethnicity and deprivation of maternal residence constant, for 
anencephaly affected pregnancies, the prevalence is statistically significantly higher 
in the 40+ age group when compared to those aged 25-29 (PRR 2.02; 95% CI: 1.20, 
3.38) (p=0.008) and for spina bifida affected pregnancies, in the 35-39 age group 
when compared to those aged 25-29 (PRR 1.42; 95% CI: 1.03, 1.97) (p=0.033). It was 
stated in preliminary analyses (Chapter 4) that an excess NTD prevalence in older 
mothers is accounted for by chromosomal cases (based on EUROCAT algorithm 
classification) and when these are removed, an excess is no longer observed. 
Comparing the aetiological and EUROCAT algorithm classification systems in 
EMSYCAR specifically for chromosomal cases, there is agreement in all cases. If 
chromosomal cases from EMSYCAR and SWCAR (n=42) are therefore dropped 
from the analyses, the excess prevalence in the 35-39 age group when compared to 
those aged 25-29 for spina bifida affected pregnancies is no longer statistically 
significant (PRR 1.27; 95% CI: 0.90, 1.78) (p=0.168). This is also true for the excess 
prevalence in the 40+ age group when compared to those aged 25-29 for 
anencephaly affected pregnancies (PRR 1.45; 95% CI: 0.81, 2.62) (p=0.213). 
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Table 49: Binomial regression model to explore the association between ethnicity and 
NTD prevalence, stratified by whether the NTD is anencephaly or spina bifida and 
adjusted for IMD quintile and maternal age for EMSYCAR and SWCAR 
Variable 
Anencephaly Spina bifida 
Adjusted 
PRR 95% CI 
P-
value 
Adjusted 
PRR 95% CI 
P-
value 
White (ref)     
0.037 
    
0.023 
Indian 2.57 
1.52-
4.34 1.02 
0.48-
2.16 
Pakistani 1.00 
0.44-
2.26 0.98 
0.46-
2.09 
Bangladeshi 1.50 
0.37-
6.04 3.86 
0.72-
8.69 
Black Caribbean 0.51 
0.07-
3.63 1.79 
0.66-
4.81 
Black African 1.06 
0.47-
2.41 0.87 
0.38-
1.96 
Other ethnic group 0.43 
0.22-
0.84 0.37 
0.19-
0.72 
IMD quintile 1 
(ref)     
0.001 
    
0.001 
IMD quintile 2 0.93 
0.68-
1.26 0.70 
0.52-
0.94 
IMD quintile 3 0.72 
0.51-
1.01 0.58 
0.42-
0.81 
IMD quintile 4 0.61 
0.42-
0.88 0.61 
0.44-
0.85 
IMD quintile 5 0.66 
0.45-
0.97 0.63 
0.45-
0.89 
25-29 (ref)     
0.604 
    
0.383 
<20 1.34 
0.86-
2.09 1.37 
0.91-
2.05 
20-24 1.20 
0.87-
1.66 0.95 
0.69-
1.31 
30-34 1.02 
0.74-
1.41 1.15 
0.86-
1.55 
35-39 1.19 
0.83-
1.72 1.42 
1.03-
1.97 
40+ 2.02 
1.20-
3.38 0.86 
0.43-
1.72 
  
When deprivation quintile is removed from the anencephaly only model as a 
cofactor and instead this variable is stratified by, the excess anencephaly prevalence 
for Indian when compared to White mothers is only observed in quintile 2 (PRR 
3.88; 95% CI: 1.77, 8.50) (p=0.001). It is presumably in part a reflection of the 
underlying population that the excess for Indian mothers is observed in quintile 2, 
although, as previously detailed, in the ONS birth denominator data mothers of 
Indian ethnicity were shown to be concentrated in both quintile 1 and 2. 
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5.3.3.4 Stratifying by whether the NTD is isolated or not and whether the NTD is 
anencephaly or spina bifida using only EMSYCAR data 
 
The multivariable binomial regression models for isolated and non-isolated NTD 
affected pregnancies in EMSYCAR, which are further stratified by whether the NTD 
is anencephaly or spina bifida are shown in Table 50 and Table 51. It is difficult to 
say anything conclusively about the NTD prevalence discrepancy between mothers 
of Bangladeshi and White ethnicity, particularly for non-isolated NTDs, due to the 
analyses being underpowered and the very small number of mothers in the former 
group. The analyses do however indicate an excess of isolated spina bifida affected 
pregnancies in Bangladeshi mothers when compared to White mothers, after 
stratifying by maternal age and deprivation of maternal residence (PRR 4.12; 95% 
CI: 1.52, 11.19) (p=0.005). For mothers of Indian ethnicity, the outcomes in the 
multivariable model are very interesting: Although for both isolated and non-
isolated anencephaly affected pregnancies there is a clear prevalence excess for 
Indian mothers when compared to White mothers, for the non-isolated group (PRR 
7.52; 95% CI: 2.82, 20.09) (p<0.001) the excess is more marked than for the isolated 
group (PRR 2.44; 95% CI: 1.23, 4.81) (p=0.01). 
 
Holding everything else constant, it is only in the isolated, spina bifida model that 
deprivation of maternal residence is statistically significant (p=0.002).   
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Table 50: Binomial regression model to explore the association between ethnicity and 
NTD prevalence for isolated NTDs, stratified by whether the NTD is anencephaly or 
spina bifida and adjusted for IMD quintile and maternal age for EMSYCAR 
Variable 
Anencephaly Spina bifida 
Adjusted 
PRR 95% CI 
P-
value 
Adjusted 
PRR 95% CI 
P-
value 
White (ref)     
0.163 
    
0.054 
Indian 2.44 
1.23-
4.81 0.91 0.34-2.47 
Pakistani 0.69 
0.22-
2.18 1.11 0.49-2.54 
Bangladeshi 0.00 
 
4.12 
1.52-
11.19 
Black Caribbean 0.78 
0.11-
5.62 1.32 0.33-5.34 
Black African 0.63 
0.16-
2.57 0.99 0.36-2.71 
Other ethnic 
group 0.61 
0.28-
1.30 0.29 0.11-0.79 
IMD quintile 1 
(ref)     
0.166 
    
0.002 
IMD quintile 2 0.97 
0.64-
1.47 0.81 0.55-1.20 
IMD quintile 3 0.66 
0.40-
1.11 0.46 0.27-0.77 
IMD quintile 4 0.73 
0.44-
1.24 0.64 0.40-1.04 
IMD quintile 5 0.78 
0.46-
1.31 0.54 0.32-0.91 
25-29 (ref)     
0.965 
    
0.664 
<20 2.07 
1.17-
3.66 1.65 0.95-2.87 
20-24 1.33 
0.82-
2.15 1.19 0.76-1.85 
30-34 1.25 
0.78-
2.01 1.41 0.92-2.17 
35-39 1.86 
1.12-
3.08 1.59 0.97-2.60 
40+ 1.15 
0.41-
3.26 1.02 0.36-2.86 
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Table 51: Binomial regression model to explore the association between ethnicity and 
NTD prevalence for non-isolated NTDs, stratified by whether the NTD is anencephaly or 
spina bifida and adjusted for IMD quintile and maternal age for EMSYCAR 
Variable 
Anencephaly Spina bifida 
Adjusted 
PRR 95% CI 
P-
value 
Adjusted 
PRR 95% CI 
P-
value 
White (ref)     
0.980 
    
0.382 
Indian 7.52 
2.82-
20.09 1.06 0.14-7.80 
Pakistani 2.74 
0.63-
11.83 0.98 0.13-7.34 
Bangladeshi 7.79 
1.03-
58.60 5.70 
0.76-
42.57 
Black Caribbean 0.00 
 
3.85 
0.52-
28.68 
Black African 1.91 
0.25-
14.57 1.33 
0.18-
10.00 
Other ethnic 
group 0.51 0.07-3.77 0.00 
 IMD quintile 1 
(ref)     
0.186 
    
0.815 
IMD quintile 2 1.69 0.69-4.13 0.98 0.39-2.47 
IMD quintile 3 1.25 0.43-3.59 0.44 0.12-1.59 
IMD quintile 4 1.15 0.37-3.59 0.93 0.33-2.64 
IMD quintile 5 0.47 0.10-2.24 1.09 0.40-2.99 
25-29 (ref)     
0.102 
    
0.105 
<20 0.94 0.20-4.39 0.36 0.05-2.87 
20-24 0.97 0.37-2.58 0.75 0.27-2.08 
30-34 0.59 0.20-1.73 0.99 0.40-2.47 
35-39 0.70 0.19-2.57 1.40 0.53-3.73 
40+ 6.45 
2.32-
17.93 1.78 0.39-8.20 
 
5.3.3.5 Removing multiples from the analyses 
 
When the 35 multiple affected pregnancies (22 in EMSYCAR and 13 in SWCAR) are 
removed from the analyses, there is shown to be very little change to the observed 
association between ethnicity and NTD prevalence. The NTD prevalence is still 
statistically significantly higher in Indian (PRR 1.87; 95% CI: 1.25, 2.79) and 
Bangladeshi (PRR 3.02; 95% CI: 1.56, 5.84) mothers than mothers of White ethnicity, 
after adjustment for maternal age and deprivation (Appendix D: Table D 7). 
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5.3.4 Conclusions 
 
Even after adjusting for maternal age and deprivation, the NTD prevalence is still 
statistically significantly higher in mothers of Indian (p=0.002) and Bangladeshi 
(p=0.002) ethnicity, than mothers of White ethnicity. This is due to an excess of 
anencephaly affected pregnancies for Indian mothers and an excess of spina bifida 
affected pregnancies for Bangladeshi mothers. The small change to the observed 
association between ethnicity and NTD prevalence after adjustment for deprivation 
and what is observed after stratifying by, rather than adjusting for, deprivation 
quintile, suggests that the ethnic discrepancy cannot be explained solely by socio-
economic factors. 
 
Sub-analyses conducted, stratifying by whether the NTD is isolated or not, using 
only the EMSYCAR data (based on the aetiological classification system), indicated 
that discrepancies in anencephaly prevalence for mothers of Indian and White 
ethnicity are likely to be attributed more to an increase in non-isolated than isolated 
cases. It was described in preliminary explorations in Chapter 4 that for non-
isolated NTDs there is not shown to be a prevalence discrepancy by deprivation 
quintile. In the current analyses for ethnicity, stratified by whether the NTD was 
isolated or not and whether the NTD it was anencephaly or spina bifida, 
deprivation of maternal residence was only shown to be significant in the isolated, 
spina bifida model. It has also been reported in the literature that there is a strong 
correlation between deprivation and folic acid use and that non-isolated NTDs are 
not expected to decline with folic acid usage (47;48). Thus, although folic acid 
supplementation is likely to contribute to a reduction in ethnic discrepancies in 
NTD prevalence, in the population studied, it certainly wouldn’t be expected to 
reduce it entirely.  
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 Natural History of NTD affected pregnancies in EMSYCAR and 5.4
SWCAR for mothers from different ethnic communities 
 
5.4.1 Introduction 
 
This section sought to explore whether the proportion of NTD affected pregnancies 
that result in a termination varies by ethnic group and therefore, how different 
prevalence estimates might distort the picture by ethnicity. However, the reasons 
for carrying out these analyses also went beyond this, namely, to form a basis for 
and complement further exploration, through semi-structured interviews, of why 
women from different ethnic groups decide to continue their NTD affected 
pregnancy or not. 
 
As described in the introduction to this thesis (Chapter 2), previous research has 
shown that mothers of Pakistani ethnicity are less likely than mothers of White and 
Indian ethnicity to terminate a pregnancy affected by a congenital anomaly (92). It 
has also been shown that less educated Pakistani mothers would have terminations 
for fewer conditions than White mothers. However, for anencephaly, all women 
were in favour of termination regardless of their ethnicity or education level (91). 
 
Key variables in the analyses in this section, but not introduced previously, are 
detailed in Table 52, with a breakdown of the missing data for each by register. In 
line with analyses in the previous section of this chapter, this section only includes 
data from EMSYCAR and SWCAR. 
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Table 52: Missing data for additional variables by register 
Register name 
(short name)  
Number of 
NTD cases 
notified 
between 
2006 and 
2011 
(based on 
Feb 2014 
EUROCAT 
update) 
% missing for NTD cases 
Birth type  
Gestation 
length in 
complete 
weeks  
Timepoint 
of discovery 
Gestational 
age at 
discovery, 
if 
prenatally 
diagnosed  
East Midlands 
and South 
Yorkshire 
Congenital 
Anomalies 
Register 
(EMSYCAR) 511 0 0.59 2.15 2.49 
Northern 
Congenital 
Abnormality 
Survey 
(NorCAS) 288 0 0.35 0 1.43 
Congenital 
Anomaly 
Register for 
Oxfordshire, 
Berkshire and 
Buckinghamshire 
(CAROBB) 216 0 0.93 0.46 0 
South West 
Congenital 
Anomaly 
Register 
(SWCAR) 326 0 1.84 5.52 9.12 
Congenital 
Anomaly 
Register and 
Information 
Service for Wales 
(CARIS) 303 0 0.33 0 0.7 
 
5.4.2 Preliminary analyses 
 
5.4.2.1 Birth type 
 
Looking within the BINOCAR NTD dataset, a breakdown of the proportion of 
pregnancies resulting in each of the different pregnancy outcomes (live birth, still 
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birth, late miscarriage, TOPFA) is given in Figure 23. Mothers of Indian, Pakistani 
and Bangladeshi ethnicity have been combined as “Asian” and mothers of Black 
Caribbean and Black African ethnicity combined as “Black” which is an 
oversimplification but demonstrates the proportion of pregnancies resulting in still 
birth or late miscarriage for these aggregated ethnic groups. However, as shown in 
Table 53, across the EMSYCAR and SWCAR there are only 5 NTD affected 
pregnancies that result in a late miscarriage and only 22 that result in a stillbirth and 
so it is not possible to draw definite conclusions about ethnic variation.  
 
 
Figure 23: NTD pregnancy outcomes by maternal ethnicity 
 
Table 53: Breakdown for different pregnancy outcomes in the NTD dataset for 
EMSYCAR and SWCAR 
Birth type         Number (%) 
Live birth 155 (18.52) 
Still birth (24+ weeks) 22 (2.63) 
Late miscarriage (20-23 weeks) 5 (0.60) 
TOPFA 655 (78.26) 
Total 837 (100) 
 
To facilitate further analysis, the NTD dataset was dichotomised into pregnancies 
that resulted in TOPFA and those that did not. This was due to small numbers for 
still births and particularly late miscarriages. Moreover, in more than 90% of 
pregnancies that result in a termination, the NTD has been detected by 21 weeks 
gestation and since 90% of these are terminated within 2 weeks of being detected, 
pregnancies that result in a stillbirth (from 24 weeks) are most likely to occur once 
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the decision has been made to continue the pregnancy. Additionally, although the 
majority (n=777; 93%) of NTD affected pregnancies are discovered prenatally, there 
are some that are discovered at birth (n=30; 4%); one postnatally and 29 cases where 
the time point of discovery is unknown. Therefore, only the 777 discovered 
prenatally in EMSYCAR and SWCAR have been included in subsequent analyses in 
this section. 
 
5.4.2.2 NTD type 
 
A breakdown of the number and proportion of different NTD subtypes resulting in 
TOPFA or not in the BINOCAR dataset is given in Table 54. Anencephaly affected 
pregnancies are more likely to be terminated than spina bifida affected pregnancies 
(p<0.001). This is not surprising as anencephaly is a more severe phenotype and not 
compatible with life after birth. Anencephaly also tends to be detected earlier than 
spina bifida with a peak in detection for the former around the 12 week scan and a 
peak for the latter around the 20 week scan. However, TOPFA rates for spina bifida 
affected pregnancies are still high (79% terminated) (Table 54).  
 
Table 54: Number and proportion of prenatally detected NTD affected pregnancies that 
are terminated or not for different NTD subtypes in EMSYCAR and SWCAR 
NTD  Not TOPFA n (%) TOPFA n (%) 
Anencephaly 34 (9.74) 315 (90.26) 
Encephalocele 15 (19.48) 62 (80.52) 
Spina bifida 73 (20.80) 278 (79.20) 
Total 122 (15.70) 655 (84.30) 
 
Therefore, as in previous analyses, primarily, outcomes have been presented for 
total NTD cases (anencephaly, encephalocele and spina bifida) and then for 
anencephaly and spina bifida subtypes separately, where appropriate.  
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5.4.3 Univariable analyses for an exploration of the association between 
maternal ethnicity and whether an NTD affected pregnancy is terminated or 
not  
 
In addition to Smith and colleagues finding an ethnic discrepancy in whether 
individuals terminated a pregnancy affected by a congenital anomaly or not, as 
detailed in section 5.4.1, they also found that maternal deprivation, maternal age 
and gestation at which the anomaly is detected affected the outcome (92). Thus, 
univariable analyses were conducted exploring the association between ethnicity, 
whether the NTD affected pregnancy was terminated or not and these other factors 
using the EMSYCAR and SWCAR data, to explore their likely impact in the 
multivariable model. Explorations around sex of fetus were also conducted using 
data from both registers and explorations around whether the NTD was isolated or 
not were conducted using the aetiological variable in the EMSYCAR dataset. As in 
previous univariable analyses, typically the Chi-Squared Test, and Fischer’s Exact 
Test when cell sizes became too small, were performed in STATA to explore 
associations. 
 
A breakdown of the proportion of NTD affected pregnancies that result in TOPFA 
or not for individual ethnic groups is shown in Figure 24. Mothers of Pakistani and 
Black African ethnicity are statistically significantly less likely to terminate their 
pregnancy than mothers of White ethnicity (p<0.001). Looking at spina bifida and 
anencephaly affected pregnancies separately, the discrepancy between Pakistani 
and White mothers is statistically significant for both subtypes but most marked for 
spina bifida, where 33% of mothers of Pakistani ethnicity terminate an affected 
pregnancy when compared to 81% of mothers of White ethnicity (p=0.003). For 
anencephaly, 71% of mothers of Pakistani ethnicity and 92% of mothers of White 
ethnicity terminate an affected pregnancy (p=0.017). However, numbers do start to 
become quite small in these sub-analyses. 
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Figure 24: Proportion of NTD affected pregnancies resulting in TOPFA or not for 
different ethnic groups in EMSYCAR and SWCAR 
 
5.4.3.1 Deprivation 
 
As previously described, there is a strong association between ethnicity and 
deprivation in the NTD dataset (p=0.005) with mothers of Pakistani and Black 
African ethnicity clearly concentrated in areas with greater deprivation. No 
statistically significant differences were detected when looking at anencephaly and 
spina bifida subtypes specifically; however, as argued, this could be due to small 
numbers. 
  
The association between deprivation and whether the NTD affected pregnancy is 
terminated or not, is also statistically significant, with mothers living in areas of 
greater deprivation less likely to terminate their pregnancy than mothers living in 
areas of less deprivation (p<0.001); e.g. 93% of mothers living in quintile 5 (least 
deprived) decided to terminate their NTD affected pregnancy in contrast to 76% of 
mothers in quintile 1 (most deprived) This pattern is strongly apparent for the spina 
bifida subtype particularly (p=0.011); for the anencephaly subtype, although there is 
a statistically significant difference, the difference between mothers living in 
quintile 5 (least deprived) and quintile 1 (most deprived) is less marked (p=0.041). 
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5.4.3.2 Gestation, in weeks, at which the NTD is discovered 
 
There are no statistically significant differences in the mean age of discovery, in 
weeks, between any of the ethnic groups.  
 
However, the mean age of discovery is statistically significantly earlier in 
pregnancies that result in TOPFA (16.30; 95% CI: 15.99, 16.61) than those that do not 
(19.94; 95% CI: 19.04, 20.84). This is more pronounced for anencephaly ((TOPFA – 
13.77 (95% CI: 13.42, 14.12) and not TOPFA – 17.67 (95% CI: 15.61, 19.73)) than spina 
bifida ((TOPFA – 19.21 (95% CI: 18.86, 19.56) and not TOPFA – 20.87 (95% CI: 19.93, 
21.81)).   
 
5.4.3.3 Gestation, in weeks, at which the NTD is discovered and deprivation of maternal 
residence 
 
The mean age of discovery, in weeks, is statistically significantly earlier in mothers 
living in quintile 5 (least deprived) (15.87; 95% CI: 15.08, 16.66) when compared to 
those living in quintile 1 (most deprived) (17.33; 95% CI: 16.75, 17.91). This statistical 
difference is observed in anencephaly affected pregnancies only ((Quintile 5 - 13.02 
(95% CI: 12.20, 13.84) and Quintile 1 - 14.91 (95% CI: 14.09, 15.73)) and no 
statistically significant differences are observed for spina bifida.  
 
5.4.3.4 Maternal age 
 
No statistically significant association is detected between maternal ethnicity and 
age for all NTDs or for anencephaly and spina bifida subtypes separately. 
  
There is also no statistically significant association between maternal age and 
whether the NTD affected pregnancy is terminated or not (p=0.313)), and this is also 
observed when looking at anencephaly (p=0.155) and spina bifida (p=0.609) 
subtypes separately. 
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5.4.3.5 Maternal age and deprivation of maternal residence 
 
As previously stated, there is a strong association between maternal age and 
deprivation of maternal residence, with older mothers living in less deprived areas 
(p<0.001); for example, 16% of mothers aged 40+ live in quintile 1 (most deprived) 
when compared to 52% of mothers under 20. Looking at anencephaly (p=0.002) and 
spina bifida (p=0.004) affected pregnancies individually, the same pattern is 
observed. 
 
5.4.3.6 Sex of baby 
 
As described for previous analyses, sex of baby is very difficult to explore in the 
current dataset as there is a high proportion of missing data, a disproportionate 
amount of which is anencephaly due to the earlier detection. No association is 
detected between ethnicity and sex of baby, in line with what was found previously, 
in a dataset restricted to cases discovered prenatally and only those of known sex 
reaching a gestation length of 18 weeks or longer (when sex determination is better) 
(p=0.866). There is also no association detected when looking at anencephaly and 
spina bifida subtypes individually. 
 
No statistically significant association is detected between sex of baby and whether 
the pregnancy is terminated or not (p=0.560). This is also true when looking at spina 
bifida (p=0.338) and anencephaly affected pregnancies (p=0.622) individually. Due 
to the lack of association and a markedly reduced dataset that would result from 
including sex, it has not been included in multivariable analyses. 
 
5.4.3.7 Whether the NTD is isolated or not 
 
Using the aetiological classification system within EMSYCAR, there is no 
statistically significant association between whether the NTD is isolated or not and 
whether the pregnancy is terminated or not (p=0.595). This is also observed when 
looking at anencephaly (p=0.299) and spina bifida (p=0.554) subtypes separately. 
Using this restricted dataset, there is not shown to be any association between 
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maternal ethnicity and whether the NTD is isolated or not for all NTD subtypes 
combined (p=0.239). This is also the case for spina bifida affected pregnancies 
specifically (p=0.977), and there is only 1 Indian mother, 1 Pakistani mother, 1 
Bangladeshi mother, 1 Black Caribbean mother and 1 Black African mother in the 
non-isolated spina bifida group. For anencephaly affected pregnancies, the 
association is of borderline statistical significance (p=0.062) with 36% of Indian 
mothers having a non-isolated anencephaly affected pregnancy when compared to 
15% of White mothers.  
 
5.4.4 Multivariable analyses exploring the association between ethnicity and 
whether an NTD affected pregnancy is terminated or not using a logistic 
regression model 
 
For multivariable analyses, a logistic regression model, with effect sizes expressed 
as an odds ratio (OR), using the EMSYCAR and SWCAR data, was built up with 
whether the pregnancy was terminated or not as the binary outcome variable and 
maternal ethnicity as the main independent variable. To explore the mitigating 
impact of maternal deprivation, maternal age, NTD type (anencephaly, 
encephalocele or spina bifida) and gestational age at which the NTD was 
discovered, on this association, these variables were first added iteratively into the 
logistic regression model. White maternal ethnicity and maternal age group 25-29 
were taken as reference groups as per previous analyses. For NTD type, spina bifida 
was taken as the reference group as it is the most common NTD.  Due to the strong 
association between maternal deprivation and maternal age and maternal 
deprivation and gestational age at discovery of the NTD, as described, interaction 
terms were placed between these two sets of variables and explored. The “final” 
multivariable model was then built-up, with further stratification by whether the 
NTD was anencephaly or spina bifida, due to the differences in outcome for the two 
NTD types observed in the univariable analyses. Sub-analyses using only the 
EMSYCAR data and stratifying by whether the NTD was isolated or not (based on 
the aetiological variable) were conducted where it was deemed appropriate and 
was feasible. Finally, sensitivity analyses were conducted using data from both 
registers to explore the impact of removing NTD affected pregnancies that occurred 
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as part of a multiple set from the model (there were 34 multiple pregnancies across 
EMSYCAR and SWCAR in which the NTD was diagnosed prenatally).  
 
5.4.4.1 An Iterative model 
 
Of importance to note in the iterative explorations, is that the addition of maternal 
deprivation to a maternal ethnicity and whether the pregnancy was terminated or 
not only model, was shown to improve it (p=0.007) (based on a likelihood ratio test 
used to explore model fit with and without deprivation). However, there was only a 
slight attenuation in the observed association between ethnicity and whether the 
pregnancy was terminated or not, when maternal deprivation was added. The 
addition of gestational age at which the NTD was discovered to the model, was also 
shown to improve it (p<0.001) (again based on a likelihood ratio test comparing 
model fit with and without this variable). The addition of gestational age of 
discovery was actually shown to mildly increase the ethnic discrepancy in 
pregnancy outcome. Although neither NTD type nor maternal age were shown to 
improve the model fit when added (p=0.780 and p=0.200, respectively, using a 
likelihood ratio test) both were included in the final model as they are important 
variables. 
 
5.4.4.2 Exploring variable interactions 
 
The addition of an interaction term between deprivation and maternal age, 
comparing a model with the interaction term and one without it, using the 
likelihood ratio test, was not shown to improve it (p=0.583). Doing the same for 
deprivation and age of discovery, an interaction term is not shown to improve the 
model in any way (p=0.996). 
 
Putting an interaction term between ethnicity and deprivation (due to the strong 
association) was not possible as many outcomes are omitted due to the strong 
collinearity. 
 
Therefore, in the final model, no interaction terms have been included. 
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5.4.4.3 Final model 
 
Table 55 gives both unadjusted odds ratios e.g. association between maternal 
ethnicity and whether the pregnancy was terminated or not without taking into 
account other factors and adjusted odds ratios e.g. the association between ethnicity 
and whether the pregnancy was terminated or not, adjusted for maternal 
deprivation, maternal age, NTD type (anencephaly, encephalocele or spina bifida) 
and gestational age at discovery (in weeks).  In the adjusted model, Pakistani (OR 
0.16; 95% CI: 0.05, 0.52) (p=0.002) and Black African (OR 0.14; 95% CI: 0.04, 0.49) 
(p=0.002) mothers are statistically significantly less likely to terminate their 
pregnancy than White mothers. The effect sizes for Pakistani and Black African 
mothers differ very little between unadjusted and adjusted models and in fact are 
slightly stronger in the latter. In the adjusted model, holding everything else 
constant, mothers living in deprivation quintile 4 are more likely than mothers 
living in quintile 1 (most deprived) to terminate an NTD affected pregnancy (OR 
2.75; 95% CI: 1.18, 6.41) (p=0.019). Maternal deprivation is shown to be highly 
significant in the adjusted model as a whole (p=0.001). The same is true of 
gestational age at discovery of the NTD (p<0.001), with pregnancies in which the 
NTD is discovered earlier being more likely to be terminated (OR 0.82; 95% CI: 0.77, 
0.88). Although maternal age is not shown to be significant in the multivariable 
model overall (p=0.387), there is weak evidence that mothers aged 20-24 are less 
likely than mothers aged 25-29 to terminate an NTD affected pregnancy (p=0.048). 
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Table 55: Logistic regression model exploring the association between maternal ethnicity 
and whether the NTD affected pregnancy is terminated or not, unadjusted and adjusted 
for NTD type; maternal age; age, in weeks, at which the NTD is discovered; and 
deprivation of maternal residence for EMSYCAR and SWCAR 
Variable 
Unadjusted 
Odds Ratio 
95% 
CI 
P-
value 
Adjusted 
Odds Ratio 
95% 
CI 
P-
value 
White (ref)     
0.001 
    
0.007 
Indian 0.63 
0.23-
1.73 1.31 
0.32-
5.35 
Pakistani 0.20 
0.07-
0.56 0.16 
0.05-
0.52 
Bangladeshi 0.55 
0.11-
2.72 0.61 
0.11-
3.36 
Black Caribbean 0.24 
0.04-
1.44 0.19 
0.02-
1.74 
Black African 0.16 
0.05-
0.46 0.14 
0.04-
0.49 
Other ethnic group 0.63 
0.21-
1.94 0.81 
0.20-
3.26 
Spina bifida (ref)     
<0.001 
    
0.672 
Anencephaly 2.43 
1.57-
3.77 1.08 
0.59-
1.96 
Encephalocele 1.09 
0.58-
2.02 0.77 
0.35-
1.69 
25-29 (ref)     
0.114 
    
0.387 
<20 0.82 
0.39-
1.75 1.28 
0.49-
3.39 
20-24 0.59 
0.34-
1.03 0.51 
0.26-
0.99 
30-34 1.02 
0.58-
1.79 1.02 
0.51-
2.02 
35-39 1.14 
0.59-
2.22 1.04 
0.46-
2.34 
40+ 0.86 
0.31-
2.41 1.40 
0.28-
7.02 
Age, in weeks, at 
discovery 
0.82 
0.78-
0.87 
<0.001 
0.82 
0.77-
0.88 
<0.001 
IMD quintile 1 (ref)     
<0.001 
    
0.001 
IMD quintile 2 1.69 
1.02-
2.81 1.61 
0.85-
3.05 
IMD quintile 3 1.7 
0.98-
2.95 1.40 
0.71-
2.76 
IMD quintile 4 2.85 
1.46-
5.59 2.75 
1.18-
6.41 
IMD quintile 5 4.05 
1.85-
8.86 2.49 
0.96-
6.50 
 
5.4.4.4 Stratification by NTD type 
 
The multivariable logistic regression outcomes for anencephaly and spina bifida 
subtypes separately (with NTD type removed as a cofactor) are shown in Table 56. 
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It is in the anencephaly (p=0.048) rather than spina bifida (p=0.190) only model that 
ethnicity is shown to be significant overall. However, this is misleading as it is in 
fact spina bifida affected pregnancies that are statistically significantly less likely to 
be terminated by mothers of Pakistani (OR 0.15; 95% CI: 0.02, 0.93) (p=0.042) and 
Black African (OR 0.15; 95% CI: 0.02, 0.93) (p=0.042) ethnicity than  mothers of 
White ethnicity. The effect sizes for Pakistani and Black African mothers are still 
quite large for anencephaly affected pregnancies, and the OR for Black African 
mothers for anencephaly (0.13) is actually very similar to that for spina bifida (0.15) 
affected pregnancies. Again the lack of significance could be due to small numbers, 
although there are a similar number of affected pregnancies in the anencephaly and 
spina bifida subgroups and there is a stronger OR for Pakistani mothers in the 
latter.  
 
Holding everything else constant, pregnancies where the NTD is discovered earlier 
are more likely to be terminated in both the anencephaly (p<0.001) and spina bifida 
(p=0.007) model.  Deprivation of maternal residence is significant only in the spina 
bifida model (p=0.003), with mothers living in quintile 5 (least deprived) being 
more likely to terminate their pregnancy than mothers living in quintile 1 (most 
deprived) (OR 4.16; 95% CI: 1.12, 15.45) (p=0.033). The effect size for age of 
discovery is greater in the anencephaly (OR 0.79; 95% CI: 0.70, 0.89) than spina 
bifida (OR 0.88; 95% CI: 0.80, 0.97) model and when adding in variables iteratively 
to the spina bifida model, it has little impact on the observed association between 
ethnicity and whether the pregnancy is terminated or not. As previously described, 
there is no detected association between ethnicity and age at which an NTD is 
discovered. Also, the mean age of discovery is only statistically significantly earlier 
in those living in more deprived areas when compared to those living in less 
deprived areas, for anencephaly and not spina bifida affected pregnancies. Age of 
discovery, therefore, seems to provide little insight into why Pakistani and Black 
African mothers are less likely to terminate a spina bifida affected pregnancy than 
White mothers.  
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Table 56: Logistic regression model exploring the association between ethnicity and 
whether the NTD affected pregnancy is terminated or not, stratified by whether the NTD 
is anencephaly or spina bifida and adjusted for maternal age; age, in weeks, at which the 
NTD is discovered and deprivation of maternal residence for EMSYCAR and SWCAR 
Termination   
Anencephaly Spina bifida 
Adjusted Odds 
Ratio 
95% 
CI 
P-
value 
Adjuste
d Odds 
Ratio 95% CI 
P-
valu
e 
White (ref)     
0.048 
    
0.19 
Indian 1.55 
0.17-
14.34 1.00 
 
Pakistani 0.23 
0.03-
1.86 0.15 0.02-0.93 
Bangladeshi 0.18 
0.00-
13.75 1.17 0.13-10.92 
Black Caribbean 1.00 
 
0.18 0.01-2.18 
Black African 0.13 
0.01-
1.54 0.15 0.02-0.93 
Other ethnic group 0.31 
0.04-
2.29 1.94 0.20-18.48 
25-29 (ref)     
0.302 
    
0.889 
<20 5.19 
0.49-
55.51 0.82 0.25-2.69 
20-24 0.62 
0.20-
1.99 0.59 0.23-1.47 
30-34 2.23 
0.48-
10.33 0.73 0.30-1.78 
35-39 1.94 
0.35-
10.71 0.79 0.29-2.16 
40+ 3.15 
0.25-
39.26 1.03 0.11-9.55 
Age, in weeks, at 
discovery 0.79 
0.70-
0.89 <0.001 0.88 0.80-0.97 0.007 
IMD quintile 1 (ref)     
0.136 
    
0.003 
IMD quintile 2 1.31 
0.41-
4.18 1.86 0.80-4.33 
IMD quintile 3 1.41 
0.38-
5.22 1.57 0.64-3.87 
IMD quintile 4 1.00 
 
2.07 0.80-5.32 
IMD quintile 5 1.45 
0.26-
8.06 4.16 1.12-15.45 
 
5.4.4.5 Isolated spina bifida affected pregnancies in EMSYCAR 
 
As described in the univariable analyses, looking at the aetiological variable in the 
EMSYCAR dataset, there are very few mothers in ethnic groups other than White 
for the non-isolated spina bifida affected pregnancies. In the multivariable non-
isolated spina bifida model all cells for mothers of non-White ethnic groups when 
compared to mothers of White ethnicity have an odds ratio of 1 and there is no 
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confidence interval (as there is only 1 mother in each of these non-White ethnic 
groups). Therefore, only the isolated spina bifida multivariable model is shown in 
Table 57. 
 
After adjusting for gestational age at discovery, maternal age and deprivation of 
maternal residence, Pakistani mothers are statistically significantly less likely to 
terminate an isolated, spina bifida affected pregnancy than White mothers (OR 0.07; 
95% CI: 0.01, 0.75) (p=0.028). The difference for Black African and White mothers is 
not statistically significant, although the effect size is still quite large (OR 0.17). 
Holding everything else constant in the model, the discrepancy between quintile 5 
and quintile 1 in whether the isolated, spina bifida affected pregnancy is terminated 
or not is only of borderline statistical significance (OR 6.97; 95% CI: 0.80, 60.92) 
(p=0.079). However, this could be due to small numbers. Interestingly, gestational 
age at discovery is not statistically significant in this model. 
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Table 57: Logistic regression model exploring the association between ethnicity and 
whether the isolated, spina bifida affected pregnancy is terminated or not, and adjusted 
for maternal age; age, in weeks, at which the NTD is discovered and deprivation of 
maternal residence for EMSYCAR 
Termination   
Spina bifida (isolated) 
Adjusted Odds Ratio 95% CI P-value 
White (ref)     
0.052 
Indian 1.00   
Pakistani 0.07 0.01-0.75 
Bangladeshi 1.01 0.09-11.52 
Black Caribbean 1.00   
Black African 0.17 0.01-2.00 
Other ethnic group 0.90 0.06-12.97 
25-29 (ref)     
0.317 
<20 1.04 0.18-6.11 
20-24 0.38 0.10-1.45 
30-34 0.53 0.14-2.04 
35-39 0.41 0.09-1.80 
40+ 0.27 0.02-3.92 
Age, in weeks, at discovery 0.90 0.78-1.03 0.116 
IMD quintile 1 (ref)     
0.016 
IMD quintile 2 2.76 0.90-8.43 
IMD quintile 3 3.95 0.73-21.46 
IMD quintile 4 1.98 0.56-7.07 
IMD quintile 5 6.97 0.80-60.92 
 
5.4.4.6 Removing multiples pregnancies from final multivariable model using EMSYCAR 
and SWCAR data 
 
No major changes to the final multivariable model are observed when multiple 
pregnancies are removed from the analyses, apart from the difference between 
deprivation quintile 5 and quintile 1 (most deprived) now becomes significant 
(p=0.046) (Appendix D: Table D 8). 
 
5.4.5 Conclusions 
 
It has been shown in the multivariable logistic regression model, using EMSYCAR 
and SWCAR data, that Pakistani (OR 0.16; 95% CI: 0.05, 0.52) (p=0.002) and Black 
African (OR 0.14; 95% CI: 0.04, 0.49) (p=0.002) mothers are less likely than White 
mothers to terminate their pregnancy, when it is discovered that their child has an 
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NTD. This is after adjustment for maternal age, NTD type, age of discovery and 
deprivation quintile of maternal residence. NTD prevalence estimates that do not 
include terminations are therefore likely to distort the picture for ethnicity, for 
settings such as the UK, as well as greatly underestimating the “true” prevalence.  
 
When stratifying the analyses by whether the NTD was spina bifida or 
anencephaly, in line with what was reported by Hewison and colleagues (91), for 
anencephaly no statistically significant differences on the basis of ethnicity or 
deprivation were observed. However, Black African mothers had TOPFA rates of a 
similar magnitude lower than White mothers for both spina bifida and anencephaly 
affected pregnancies, although only for the former was the difference statistically 
significant (p=0.042). Although small numbers could play a part in this, it also could 
indicate that mothers of Black African ethnicity are less likely to terminate a 
pregnancy affected by a fetal anomaly, regardless of the severity of the condition. 
For spina bifida affected pregnancies, which have a less severe phenotype and are 
usually compatible with postnatal survival, TOPFA rates were also statistically 
significantly lower in Pakistani than White mothers (p=0.042) and in those living in 
the most deprived when compared to the least deprived quintile (p=0.033). 
 
When stratifying spina bifida affected pregnancies into those that are isolated and 
non-isolated, using only the EMSYCAR data, although it was not possible to say 
anything about the non-isolated cases, due to the small numbers, the isolated model 
was very interesting. Holding everything else constant, it was solely Pakistani 
mothers who were shown to be statistically significantly less likely to terminate an 
isolated spina bifida affected pregnancy than mothers of White ethnicity (p=0.028). 
Additionally, the discrepancy between the most deprived and least deprived 
deprivation quintile in this model was only of borderline statistical significance 
(p=0.079) and critically, although highly statistically significant in all previous 
explored models, in this model gestational age at discovery was not significant.  
Although strongly associated with whether a NTD affected pregnancy is terminated 
or not, the timing of provision of information about an NTD diagnosis seems to 
provide little explanation for ethnic variations in pregnancy outcome. It is difficult 
to disentangle the complex relationship between ethnicity and deprivation, due to 
the strong collinearity between the two variables. However, the fact that ethnic 
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differences in whether a pregnancy is terminated or not are still observed when 
maternal deprivation is added to the regression model, which is particularly 
strongly apparent in the isolated spina bifida model, indicates that factors other 
than maternal deprivation underlie ethnic variations. 
 
The decision around whether to continue an NTD affected pregnancy has been 
explored in further depth in the qualitative research (Chapter 6). 
 
 Chapter Summary and Important Points to Take Forward 5.5
 
 Due to a high proportion of missing ethnicity data in NorCAS, CAROBB and 
CARIS, and due to indications of bias/imprecision that would be introduced 
into the analyses if missing data was simply ignored, complete case analyses 
were only carried out using EMSYCAR and SWCAR. 
 
 There was shown to be a clear NTD prevalence excess in Indian 
(anencephaly) and Bangladeshi (spina bifida) mothers when compared to 
mothers of White ethnicity, after adjusting for maternal age and deprivation 
of maternal residence. It was also hypothesised, based on the limited 
available literature, that there would be an excess in Pakistani mothers but 
this was not detected (and was not attributed to small numbers). 
 
 There were also indications that the anencephaly prevalence excess for 
Indian mothers was particularly marked for non-isolated NTDs, which are 
unlikely to decrease with folic acid supplementation. 
 
 Maternal BMI is not collected with sufficient completion by either 
EMSYCAR or SWCAR and therefore could not be explored further. 
 
 Mothers of Pakistani and Black African ethnicity were shown to be less 
likely than mothers of White ethnicity to terminate their pregnancy when it 
was discovered that their child had an NTD, after adjusting for NTD type, 
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maternal age, gestational age at which the NTD was discovered and 
deprivation of maternal residence. 
 
 After stratifying by whether the NTD is anencephaly or spina bifida and 
adjusting for all other factors, it is specifically for spina bifida affected 
pregnancies that mothers of Pakistani and Black African ethnicity are less 
likely to terminate their pregnancy. After further stratification, for isolated 
spina bifida affected pregnancies (those that do not occur in association with 
other defects), the difference is only statistically significant for Pakistani 
mothers. Age of discovery does little to explain observed ethnic 
discrepancies and socio-economic factors are unlikely to be the whole story. 
 
 Explorations around folic acid use and decisions around whether to 
continue an NTD affected pregnancy or not has been explored further in the 
qualitative study detailed in Chapter 6. 
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6 Exploring the pre-pregnancy and pregnancy knowledge, 
attitudes and health behaviour of South Asian mothers with 
a previous neural tube defect (NTD) affected pregnancy 
 
 Introduction 6.1
 
Several studies have been conducted exploring the knowledge and peri-
conceptional use of folic acid of women of childbearing age in diverse populations. 
Poor knowledge of the benefits of taking folic acid, specifically its role in NTD 
prevention, in women of childbearing age is consistently reported in the literature 
(37;97;102;156). The pregnancy being unintended; young maternal age; being of a 
low socio-economic status and being of non-White/non-Western ethnicity are 
typically described as being associated with low knowledge and use 
(22;37;93;103;157-161). Previous research conducted as part of this doctoral thesis 
(22), a systematic review exploring knowledge and use of folic acid in women from 
different ethnic communities in the UK (Appendix A), found, from the limited 
available evidence, that mothers of South Asian ethnicity have lower knowledge 
and peri-conceptional use of folic acid than mothers of Caucasian1/White ethnicity. 
A synthesis of results in a meta-analysis found that mothers of Caucasian/White 
ethnicity are more than three times more likely to take folic acid before conception 
than mothers of non-Caucasian/non-White ethnicity (22). A further study 
conducted in the UK after this systematic review was published, also found that 
mothers of Caucasian ethnicity were more likely to take folic acid before pregnancy 
than mothers of non-Caucasian ethnicity (103). 
 
No previous research in the UK, or elsewhere based on an extensive literature 
search, has been conducted into the pre-pregnancy knowledge and health 
behaviours, particularly with regards to folic acid, of individuals with a previous 
NTD affected pregnancy. Preliminary findings from a quantitative study, exploring 
NTD epidemiology in different ethnic communities in the UK and conducted 
                                                          
1
 Caucasian is the term typically used throughout the systematic review and equates to “White” in the 
British Isles Network of Congenital Anomaly Registers (BINOCAR) data used for the quantitative 
study for this thesis. 
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concurrently with this qualitative research (results are described in depth in 
Chapters 4 and 5) found an increased prevalence in mothers of Indian and 
Bangladeshi ethnicity when compared to mothers of White ethnicity using data 
from the East Midlands and South Yorkshire Congenital Anomalies Register 
(EMSYCAR) and South West Congenital Anomaly Register  (SWCAR) (detailed in 
Chapter 5). No explorations around folic acid knowledge and use were possible in 
this study due to insufficient data quality. An increased NTD prevalence in mothers 
of Pakistani ethnicity has also been previously reported by Tonks and colleagues for 
another region of the UK (82).  
 
Perceived quality of life/severity of condition (162-167) involvement of the CNS 
(92;168); religious or personal belief (163;169-171); feeling a strong prenatal 
attachment ((169;172); gestation at which anomaly is detected (92;173); maternal age 
(168); maternal education (91); maternal deprivation ((92;165) and maternal 
ethnicity (92) have all been described as important factors affecting a decision of 
whether to continue a pregnancy or not when a fetal anomaly is detected. Smith and 
colleagues (92), when exploring outcomes for pregnancies affected by congenital 
anomalies using data from the EMSYCAR, found that Pakistani mothers have lower 
rates of TOPFA than White British and Indian mothers.  In the second set of 
analyses exploring ethnicity in the quantitative study for this thesis (detailed in 
Chapter 5), it was found that mothers of Pakistani and Black African ethnicity were 
less likely than mothers of White ethnicity to terminate a spina bifida affected 
pregnancy. This difference was statistically significant, even after adjusting for 
maternal age and deprivation and gestation at which the anomaly was detected.   
 
The aim of the qualitative research was to conduct more in-depth explorations 
around the pre-pregnancy and pregnancy views and experiences of mothers with a 
previous NTD affected pregnancy. The research was focused specifically on 
mothers of South Asian (Indian, Bangladeshi and Pakistani) ethnicity. Mothers of 
Indian and Bangladeshi ethnicity were included in the qualitative study, due to the 
detected increased NTD prevalence in the quantitative research. Pakistani mothers 
were included due to the increased NTD prevalence in this ethnic group reported in 
the literature and the fact that Pakistani mothers were less likely than White 
mothers to terminate an NTD affected pregnancy in the quantitative study. 
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Restricting the qualitative study to mothers of South Asian ethnicity meant that in-
depth interviews could be conducted with ethnic communities where a high NTD 
prevalence has been detected and also the importance of specific cultural and 
dietary factors could be explored. 
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 Methodology 6.2
 
6.2.1 Background 
 
As stated in Chapter 3, the grounded theory method was used to conduct and 
analyse the qualitative research. The grounded theory method is inductive, it is 
routed in the data and everything comes from the data. It is concerned not only 
with the “how” but also the “why”(174). The method involves being iterative, 
moving between collecting data and analysis and coding the data in a constant 
comparative fashion (data are continually compared with data). The development 
of coding and initial categories are further developed and fine-tuned through going 
back to the field and collecting more data from existing or new participants. 
Ultimately, core conceptual categories are raised to a theoretical level (175).  
 
In her book “Constructing Grounded Theory” Kathy Charmaz distinguishes 
between Objectivist and Constructivist Grounded Theory. Classical objectivist 
grounded theory is described as adhering strictly to grounded theory steps and 
erasing the social context underlying the data. The researcher also remains separate 
and distant from research participants and doesn’t take an interpretive stance. 
Constructivist  Grounded Theory, on the other hand, acknowledges that resulting 
theory is interpretation and depends on the researcher’s view;  it emphasises the 
importance of context and reflexivity about own (researcher) interpretations. 
Charmaz underlines how she draws comparisons for clarity’s sake, and that in 
reality “theorizing means being eclectic, drawing on what works, defining what 
fits.” (175). Mills and colleagues describe a traditional (Glaser) and evolved (Strauss 
and Corbin) grounded theory, with the latter not believing there is a pre-existing 
reality, stressing the importance of context and the involvement of the researcher 
(176). They describe how Constructivist Grounded Theory can be traced from the 
work of Strauss and Corbin and subsequently through the work of Charmaz. They 
argue, as Charmaz does, that “all variations of grounded theory exist on a 
methodological spiral and reflect their epistemological underpinnings”(176). 
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In their defence of the classical objective stance, Breckenridge and colleagues argue 
that it is not that participants’ perspectives are not important but are incorporated 
into the research as more data to be analysed and explored with the aim of raising 
them to a conceptual level (177). It is described how Glaser accuses constructivist 
grounded theory of making the researcher more important than the participants 
and that the “objective” stance so often criticised in classical theory is in fact about 
putting the concerns of the participant over the researcher. He also criticises 
constructivist theory for always using a pre-defined lens to analyse data (178). The 
authors conclude by saying that researchers must be clear on the path they decide to 
take (classical or constructivist) rather than picking and choosing from the two 
(177). This conclusion seems to be a bit of a contradiction, based on the fact that it is 
argued that everyone should start a study with an open theoretical perspective. 
Moreover, as described, and as Charmaz delineates, it is not a one size fits all and 
she emphasizes the importance of being “eclectic” when theorizing (175). It seems 
through exploring the literature that many of the criticisms levelled at “classical” or 
“constructivist” grounded theory are due to misinterpretation. 
 
6.2.2 Aligning research with theory 
 
In the current study, although it is recognised there are multiple truths, multiple 
voices and perspectives and the importance of looking at context, a key unifying 
conceptual category was identified in relation to the knowledge and use of folic acid 
for the prevention of NTDs. A central category was also determined regarding 
detailed experiences when the spina bifida was detected in interviewees’ children 
and around decisions to continue their pregnancy. These over-arching categories 
are rendered all the more meaningful and only of practical applicability when all 
the nuances are taken into account, but it is also believed that they go to the heart of 
the interviewees detailed experiences.  
 
In line with a constructivist viewpoint, it is believed that searching for assumptions 
underlying meanings and actions is vital and the researcher is viewed in the current 
study as an integral part of the research process. Breckenridge and colleagues (177) 
argue that although in classical grounded theory the importance of an objective 
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researcher is emphasised, the perspective of the researcher is not ignored but 
incorporated as more data to be analysed, as described. Here, the researcher is not 
viewed as simply contributing more data but to a certain extent, influencing the 
data collected from study participants. I like the idea put forward by Breckenridge 
and colleagues (177) that in classical theory emphasising researcher objectivity, they 
are placing the concerns of the participant above the researcher. However, I believe 
that it is still possible to place the concerns of the participant above the researcher, 
whilst recognising that it is never possible for a researcher to be wholly objective. 
The researcher having a certain amount of influence over the data collected is 
unavoidable, accentuating the importance of being reflexive about potential impact. 
However, having an influence does not necessarily mean unduly “leading” the data 
that is generated and arguably, it can actually help to open it up. It is believed that 
through showing empathy and humanity to participants, as one human being to 
another and not in the authoritarian figure of researcher over participant, as it is 
human experience that is being detailed, that the data will be richer and more 
meaningful. 
 
To conclude, do I ultimately believe that theory is construction and is based on 
interpretation or do I see it as an objective truth? Perhaps I sit somewhere in the 
latter half of the methodological spiral with a stronger constructivist leaning. The 
constant comparative method has been adhered to quite stringently, as detailed 
below and the main literature review was conducted after writing a first draft of the 
findings. However, it was not possible (and also would have been undesirable) to 
start from a completely blank page. Through using grounded theory method I 
believe the data collected from participants have been placed at the centre, but that 
it is impossible for such data to be devoid of researcher influence, in line with a 
constructivist perspective, as a researcher is a human being with their own research 
leanings and ideologies and not a computer that can be programmed to certain 
settings. Nevertheless, as stated, I do not believe this reduces the worth or 
applicability of the outcome and that a researcher with both humanity and 
reflexivity can be part of research that is meaningful and has depth. 
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6.2.3 Statement about researcher involvement 
 
I am a 31 year old, White British, PhD student with a background in Infectious 
Disease epidemiology. During the course of my PhD I have volunteered with the 
Spina Bifida, Hydrocephalus, Information, Networking, Equality (SHINE) 
association and spoken to a number of families with children with spina bifida 
about their experiences. These discussions have not been viewed as extraneous to 
the research and have been commented on below. I have also been to a number of 
spina bifida clinics at Great Ormond Street Hospital (GOSH) to recruit women for 
the study and have again spoken to many families and seen many children living 
with spina bifida in this setting. I do not believe these experiences have biased me in 
any way when conducting the research and in fact have helped to open my eyes 
and enrich it. When conducting the interviews, although a general topic guide was 
used, this was in no way prescriptive and it was the women’s story that was of 
interest. Some interviewees spoke more openly than others which could have led 
certain interviewees down a specific path due to the necessity of asking more 
questions. However, in applying grounded theory methodology, both what was 
and was not said were considered and the emphasis was on actions.  
 
6.2.4 Participant recruitment 
 
The inclusion criteria for the study were women of South Asian (Indian, 
Bangladeshi, Pakistani) ethnicity who were 18 years or older and had a previous 
NTD affected pregnancy. There were no restrictions based on language and 
materials were translated and an interpreter was present where required. The study 
was advertised in a variety of different ways, including an advertisement on a spina 
bifida parent support group on facebook; through SHINE; through GOSH, where 
the study was introduced to mothers during the spina bifida clinic they attended 
with their child and through the Asian Parent Carer’s project in Manchester. 
Participation in the study was completely voluntary. Although the study was 
targeted at both mothers who did and did not continue their NTD affected 
pregnancy, only mothers of children living with spina bifida took part in the study. 
This was largely because identifying an effective method for recruiting women who 
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chose TOPFA proved extremely difficult. SHINE is a charity which helps 
individuals and families affected by spina bifida, whether the decision is made to 
continue the pregnancy or not. However, only one interviewee was recruited 
through this method and she had a child living with spina bifida. The remainder of 
interviewees were recruited though the spina bifida clinic at GOSH which was 
attended by children with NTDs and their parents/carers. It would not be expected 
that not including mothers who chose TOPFA would bias what is observed about 
pregnancy behaviours and attitudes before diagnosis. However, it did mean that 
the second part of the analysis was focused specifically on mothers deciding to 
continue their pregnancy. There were also no anencephaly affected pregnancies 
included. However, this is an in-depth qualitative study and is not intended to be 
representative. Moreover, what was revealed specifically about spina bifida affected 
pregnancies where the decision was made to continue the pregnancy, was very 
striking.  
 
Individuals who expressed an interest in taking part in the study and who met the 
inclusion criteria, were given an information sheet about the study (a copy of the 
information sheet can be found in Appendix E). The contact details of potential 
interviewees were also taken at this time and they were contacted after a week to 
see whether, after taking some time to consider the information they had been 
given, they would like to take part. It was emphasised throughout that participation 
in the study was completely voluntary and that women did not have to answer any 
questions they did not want to and were free to withdraw from the study at any 
time. 
 
Recruitment took place over twelve months, between December 2013 and December 
2014, and eight women took part in the study. Interviews were in-depth and having 
a sample size of eight was viewed as both sufficient and necessary to enable an 
exploration of the pre-pregnancy and pregnancy views and experiences of South 
Asian mothers who had a child with spina bifida using grounded theory 
methodology as part of a mixed methods study. 
 
Key self-reported information for the eight interviews of South Asian ethnicity (four 
of Bangladeshi ethnicity and two of Pakistani and Indian ethnicity) is given in Table 
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58. It was not the purpose of the qualitative research to quantify certain outcomes; 
however, it was useful to underline certain key factors e.g. reports of previous 
miscarriage/TOPFA.  
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Table 58: Key self-reported participant characteristics 
Patient 
ID 
Country of 
Birth Ethnicity Religion 
Age 
group 
Maternal health 
conditions 
Planned/un
-planned 
pregnancy 
Pre-
pregnancy 
folic acid 
use 
Previous 
miscarriage/TOPFA 
reported 
Older 
siblings (n) 
1 UK Indian N/A 35-39 
Gestational 
diabetes; blood 
clotting issue Planned Yes Yes  N/A 
2 UK Bangladeshi Muslim 25-29 
Vitamin D 
deficiency Unplanned No No 2 
3 UK Bangladeshi Muslim 25-29 Anaemia 
Semi-
planned No Yes   2 
4 Unknown Bangladeshi Muslim 30-34 
Vitamin D and 
iron deficiency* Unplanned Yes No 
4 (1 with 
congenital 
condition) 
5 Pakistan Pakistani Muslim 30-34 
Anaemia; brain 
tumour Unplanned No No 1 
6 UK Bangladeshi Muslim 20-24 
Vitamin D and 
iron deficiency Unplanned No Yes 1 
7 Pakistan Pakistani Muslim 25-29 
Vitamin D 
deficiency and 
on aspirin  Planned Yes Yes 1 
8 UK Indian N/A 30-34 
Beta thalassemia 
trait;  UTI and 
exposed to 
rotavirus during 
pregnancy* Unplanned Yes Yes 2 
*Severe morning sickness also reported 
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6.2.5 Interview procedure 
 
At the beginning of each interview the study aims, confidentiality, the voluntary 
nature of participation and the participant’s right to withdraw from the study at 
any time were again described and emphasised. Written informed consent was 
obtained prior to each interview (A copy of the consent form is included in 
Appendix E). Interviews were in-depth and a topic guide was followed (the original 
topic guide is included in Appendix E) but were flexible and the interviews were 
participant led. The topic guide was adapted after each interview in line with the 
constant comparative method, as detailed below. All interviews were audio-taped 
and lasted between 22 and 70 minutes. 
 
6.2.6 Data collection and analysis 
 
6.2.6.1 Summary 
 
All interviews were transcribed verbatim and coded using NVivo software. 
Analysis consisted of informal coding and memoing (reflective notes) during the 
interview stage, then line-by-line coding (with an emphasis on actions), memoing, 
development of focused codes and initial conceptual categories from interviews 
then theoretical sampling and further coding, memoing and raising focused codes 
to conceptual categories and raising conceptual categories to a theoretical level in 
the final stage. 
 
6.2.6.2 Using the constant comparative method: Coding and memoing 
 
Preliminary coding and memoing was conducted after each interview which 
dictated the direction of subsequent interviews and the topic guide was adapted 
accordingly. After all interviews had been carried out, analyses were conducted in a 
constant comparative fashion i.e. line-by-line coding was conducted for the first 
interview, then line-by-line coding was carried out for the second interview, a 
memo was then used to examine codes within and between the two interviews and 
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more focused codes started to be developed. Line-by-line coding was then 
conducted for the third interview, which was then examined and compared with 
coding in the first two interviews etc. The process of developing focused codes was 
described to two supervisors and there was discussion around this.  
 
Focused codes were raised to preliminary conceptual categories through constant 
comparison and reflection through further memo writing and diagramming. The 
process of developing a core conceptual category for the study, based on 
interviewees’ detailed accounts, using the constant comparison method is described 
in section 6.2.6.4. 
  
6.2.6.3 Theoretical sampling 
 
Following later interviews which identified some health professionals (HPs) as 
giving a bleak picture for spina bifida when the condition was detected, in line with 
the inductive process of grounded theory, I went back to previous interviewees. 
These further interviews were then coded and constantly compared with data 
already collected, in the same way as described above. Through doing this, it 
emerged that only those who did not routinely see children with spina bifida or 
indicated they had little understanding of the complexity of the condition tended to 
give a worst case scenario as inevitability. 
 
6.2.6.4 Emergence of giving meaning through detail and emphasis vs. gaining meaning 
through experience as a core conceptual category 
 
After coding and constantly comparing the first four interviews, key focused codes 
that seemed to be emerging centred on timing: Investing time; the limiting nature of 
time; the torturing nature of time. However, it kept bothering me that these codes 
somehow fell short, or at least were insufficient on their own, at getting to the heart 
of what was happening. Something said by one interviewee when asked what pre-
pregnancy care means to her, kept resonating in my mind: 
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After #child's name# it means a lot. Before #child's name# nothing. It didn’t occur to me, I 
didn’t even, I’d heard about it but didn’t think it was important. So after #child's name# 
it’s a lot (Interviewee 2). 
 
After going back to this statement several times and this particular interview, it was 
detailed in a memo how although timing was of course important here, it was 
through the particular circumstance of having a baby with spina bifida that pre-
pregnancy care now meant so much. This lead to the development of two further 
focused codes: Meaning through circumstance and meaning through emphasis, 
with the two being interlinked and a tension existing between gaining meaning 
through learning; through being told and gaining meaning through a lived 
experience. These codes were further scrutinised and developed in the process of 
coding subsequent interviews and going, of course, back over previous ones in a 
constant comparative fashion and were ultimately raised as a core conceptual 
category. 
 
6.2.7 Presentation of findings 
 
In-line with the grounded theory methodology, reference to the literature and 
discussion is interspersed throughout the findings section. There are two main sub-
sections presented: The first surrounds the core conceptual category identified 
regarding folic acid knowledge and use and the second around the decision to 
continue a spina bifida affected pregnancy. There is further discussion with a 
stronger researcher overview towards the end of each sub-section.  
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 Findings 6.3
6.3.1 Pre-pregnancy knowledge and health behaviours, particularly with regards 
to folic acid: Giving meaning through detail and emphasis vs. gaining 
meaning through experience 
 
A sense of information being given and understood in sufficient detail and with 
sufficient emphasis in contrast to a sense of learning through a lived experience is at 
the heart of the analysis. The fact that information about the benefits of taking folic 
acid has been given in sufficient detail and with sufficient emphasis, does not 
necessarily mean this information will be acted on, as there are several factors 
involved. Even if this health message is adhered to before and during pregnancy, it 
does not mean that the pregnancy will not be affected by an NTD as their aetiology 
is complex and poorly understood. A pregnancy where folic acid is taken, can still 
be affected by an NTD and of course, one where it isn’t will usually not be affected 
by an NTD (approximately 1 in a 1000 pregnancies are affected(4)) (Figure 25).  
 
 
Figure 25: Possible pathways for “knowing” and “not knowing” about folic acid benefits 
and pregnancy outcomes 
 
However, folic acid is a clear prevention tool for NTDs and it would be difficult to 
dispute the importance of informing all prospective mothers of its benefits. Sadly, 
all mothers in this study only fully appreciated the importance of peri-conceptional 
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folic acid use for NTD prevention through their lived experience of having an NTD 
affected pregnancy. This was brought into sharp focus by what one mother said 
when asked what the term pre-pregnancy care means to her: 
 
After #child's name# it means a lot. Before #child's name# nothing. It didn’t occur to me, I 
didn’t even, I’d heard about it but didn’t think it was important. So after #child's name# 
it’s a lot (Interviewee 2). 
 
Meaning failed to be imbued previously due to inadequate information that lacked 
emphasis; when she had been told about folic acid in her previous pregnancies she 
described how it was just said as “a passing comment.” It hadn’t even been 
mentioned at all when she went to see the GP after finding out she was pregnant 
with her child who was later discovered to have spina bifida. Meaning couldn’t fail 
to be imbued through her experience of having a child with spina bifida. 
 
One mother had been trying to get pregnant for ten years, had six previous 
miscarriages and her pregnancy with her daughter who had spina bifida was fully 
planned. Despite taking folic acid for many years, she only found out that neural 
tube closure occurs early in pregnancy when her daughter was born and the 
condition was detected. She described the importance of receiving more 
information on why folic acid should be taken: 
 
And even maybe a bit more information on why you should take folic acid. I mean yeah it 
says to avoid spina bifida but it doesn’t, it wasn’t until after she was born that they 
explained that that condition happens so early on and that’s why you have to take it before 
pregnancy (Interviewee 1). 
 
This interviewee also emphasised the importance of enough information being 
given but not too much: 
 
It’s the amount of information and what information and obviously generally a lot of people 
don’t need to know the ins and outs, the background, they just need to know you need to take 
this because it avoids this (Interviewee 1). 
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Another interviewee also spoke about the importance of emphasising how taking 
folic acid can help your baby but not ‘overdoing’ the advice: 
 
They should explain why.  I’m not talking that you show them the difficult picture – at least 
you should tell them that ‘Look this is very important for your baby’.  Yeah (Interviewee 5).  
 
6.3.1.1 Knowing in time 
 
As described, interviewee 1, despite taking folic acid for many years, was only fully 
aware of the benefits of taking folic acid before pregnancy once it was discovered 
that her daughter had spina bifida. When advice is given, is critical to this concept 
of gaining knowledge through detail and emphasis rather than through a lived 
experience. Folic acid is a prevention tool for NTDs and can only be of benefit if 
taken before pregnancy as neural tube closure will occur by about day 28 of 
pregnancy, before many women know they are pregnant (4). The most important 
time to be aware of its benefits is therefore before pregnancy. For all mothers in the 
current study, the spina bifida was detected in their children at the 20 week scan at 
the earliest. One mother described how it was when the spina bifida was detected in 
her child that she learnt when folic acid needs to be taken: 
 
I think during that time when I found out spina bifida, that you’re supposed to take folic acid 
3 months before and 3 months after (Interviewee 6). 
  
Another mother detailed how it was the first time that she heard the word spina 
bifida when it was discovered that her child had the condition: 
 
When I was pregnant with her and the doctors told me about her, I just heard first time that 
word ‘spina bifida’ I didn’t heard before (Interviewee 7). 
 
Interviewee 8 also stated that when she was told her daughter had spina bifida at 
the 20 week scan, she had “no idea what neural tube defects were.” 
 
As shown in Table 58, 4 out of the 8 interviewees started taking folic acid before 
they became pregnant with their child who had spina bifida, however in no case 
were they sufficiently aware of why until the condition had been detected. 
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6.3.1.2 Respecting/emphasising responsibility of Health Professionals (HPs) to advise 
 
Interviews were only conducted with mothers and not with HPs and so the 
perspective of the HP cannot be taken into account here. However, all mothers 
described how it was the GP/Midwife (in most cases the GP) who they respected 
and trusted most to give them pre-pregnancy health advice. This supports previous 
research conducted with pregnant British Pakistani mothers, where pregnancies 
were unaffected by an NTD, who emphasised the important role of the GP in giving 
them pre-pregnancy advice (100). In the current study one mother said she would 
prefer to receive advice from the GP “because they’re more experienced, they know 
about it (Interviewee 2).” Another mother described the doctor as "knowing 
everything (Interviewee 5)" and one mother described getting information from the 
GP as being far superior to getting information through a leaflet: 
 
Cos people, if people give leaflet, some people they won’t bother innit. They will just say I 
will read it and they don’t read it. They forget about it. If the doctor talks, the information 
will go through to them. They can take something in and it’s better like that (Interviewee 3). 
 
They not only respected GPs as informers, but thought they had a responsibility to 
inform. One mother stated that: 
 
Because new mums who are having the baby first time, so it has to be the doctor’s 
responsibility to tell them, inform them at the GP’s (Interviewee 7). 
 
6.3.1.3 Not seeking/not receiving pre-pregnancy care from health professionals 
 
It has been reported by previous studies how the majority of women who are 
advised by their GP to take folic acid, go on to take it (37;102). However, it is also 
reported that the majority of women taking folic acid based on a HPs advice, don’t 
start until after they become pregnant (102). It was interesting in the current study 
how the role of the GP/midwife was largely discussed by mothers with regards to 
when they became pregnant. The GP was seen as the person you go and see when 
you find out you are pregnant and not before. However, it was assumed by one 
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interviewee that GPs would give the same advice before pregnancy as they do 
when you go and see them when pregnant. She said: 
 
If you go and see your GP I assume they will give you a whole load of paperwork to look 
through cos they give you wads and wads of stuff when you are pregnant so it would be the 
same before you are trying to get pregnant (Interviewee 1). 
 
As stated, interviews were only conducted with mothers and so the perspective of 
the HP cannot be given. However, some very interesting research conducted by 
Stephenson and colleagues involved interviewing HPs, including GPs and 
midwives, about their views on pre-pregnancy guidelines and whether they 
thought it was their responsibility to offer pre-pregnancy care. It was found that 
knowledge was hazy and many of the interviewees did not see it as their 
responsibility to offer this service. It was described how one GP said “I don’t do 
pre-pregnancy care – I tend to leave that for the antenatal appointments” (179). 
Another GP described that, “We often get people saying do I need to see a 
Gynaecologist about having a baby and you say well no, go and get pregnant and 
then come back to me” (180). 
 
6.3.1.4 Planning pregnancy vs. not planning pregnancy 
 
GPs might not regard it as their responsibility to provide pre-pregnancy care and it 
seems to be the “norm” for mothers to visit the GP once they are pregnant, therefore 
even for the pregnancy “planners” this presents a bit of a predicament. In Stockley 
and colleagues (93) systematic review of research specifically encouraging women 
who were young and of lower socio-economic status to take peri-conceptional folic 
acid, it was reported that the biggest factor associated with low folic acid use was 
the pregnancy being unintended. However, use is still low in the pregnancy 
“planners” and a European wide survey exploring awareness and use of folic acid 
by women of reproductive age (37) found that only 28% of those who described 
their pregnancy as planned, took folic acid. Interestingly, most of the women 
planning their pregnancy did not consult a HP before stopping their method of 
contraception, which probably impacted the low rate of use in the planners as the 
majority of women who were advised to take folic acid by a HP, as previously 
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reported, went on to take it (37). This is supported by previous research that found 
that whether the HP was consulted before planning, predicted awareness and use of 
folic acid (157). However, it is very difficult to dichotomise pregnancies into those 
that are planned/intended and those that are not planned/unintended and doing 
so is probably over simplistic. Described limitations of many studies exploring 
pregnancy intendedness include that the terms planned and intended can mean 
different things to different women (181) and that there is not necessarily a 
congruence between intentions and behaviour (182). 
 
As stated previously, it is not the purpose of the qualitative research to quantify 
certain outcomes and only eight mothers were interviewed. However, two mothers 
in the current study described how their pregnancy with their child who had spina 
bifida was planned; four that the pregnancy definitely wasn’t; one said it wasn’t 
planned but in less definite terms, “I wasn’t so much planning” (Interviewee 6) and 
one mother that it was “sort of like planned” (Interviewee 3). For the two mothers 
who described their pregnancy as planned, both took folic acid before pregnancy. 
One of these mothers had had six previous miscarriages and had researched 
extensively in order to have a successful pregnancy. She had built up knowledge 
and gradually adopted health behaviours over a significant period of time. For the 
other mother, she had to have a termination for her previous pregnancy as her 
baby’s brain hadn’t formed properly and she had been consistently taking folic acid 
since that point: 
 
They just give me folic acid.  I was taking folic acid when I’ve got … you know the abortion 
before her pregnancy … I was taking folic acid from that time to when she born on that time 
(Interviewee 7). 
 
In two of the “non-planners” folic acid was already being routinely taken before 
pregnancy, in one case due to an absorption problem and in another due to 
pregnancy vitamins being taken routinely for beta-thalassemia trait. In the mother 
whose pregnancy was “sort of like planned” she didn’t take folic acid until she went 
to see her GP after she found out she was pregnant and he advised her to, as was 
the case with her previous pregnancies. She described how she didn’t take folic acid 
before she became pregnant as she wasn’t sure when it was going to happen: 
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Cos I didn’t know when I was gonna fall pregnant so I didn’t know when to take folic acid 
(Interviewee 3). 
 
6.3.1.5 Previous pregnancies setting norms 
 
A sense of earlier pregnancies setting norms and impacting practices during later 
pregnancies, was very striking in the study. Interviewee 3 also described how: 
 
Afterwards, when I find out, doctor prescribed me and then I take it straight away. It’s like 
normal pregnancy isn’t it, when you go to the doctor they give you folic acid (Interviewee 3). 
 
A “normal pregnancy” for this mother, and what had occurred for her previous 
pregnancies, was that the doctor was visited once pregnant and it was then that 
folic acid was given. It was very interesting in this study that every mother 
interviewed had a gravidity of at least one before becoming pregnant with their 
child who had spina bifida i.e. they all had previous pregnancies. A few of the 
mothers in the study who hadn’t planned the pregnancy where their baby had 
spina bifida also indicated that at least one of their previous pregnancies had been 
planned and that they had taken folic acid. It is reported how the second pregnancy 
to a mother that results in a birth is likely to be the most planned and the third 
pregnancy and any subsequent pregnancies that result in a birth are likely to be 
least planned (182). In the current study, out of the six “un-planned” pregnancies 
where the child had spina bifida, four mothers had two or more older children. The 
importance of receiving advice from the GP/midwife was strongly emphasised by 
mothers during the interviews; yet it does not seem to be routine, in the case of a 
pregnancy being planned, for women to visit their GP or the GP to give them pre-
pregnancy advice. Even if they did visit their GP before pregnancy and were given 
pre-pregnancy advice to take folic acid, which is a strong motivator for use, their 
knowledge of the benefits of taking folic acid are likely to be low. Women are likely 
to take folic acid if their GP advises them to, even if they don’t have a full 
understanding of the benefits (37). However, it has been shown that those who do 
not know about the benefits of taking folic acid are less likely to initiate folic acid 
use pre-conception (102). 
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6.3.1.6 Wanting to have a healthy pregnancy 
 
In the current study it was strongly apparent that all mothers interviewed loved 
their children and didn’t want them to suffer. Interviewees spoke of their deep 
shock and distress when they found out that their baby had spina bifida and the 
very difficult time that followed for their family. One mother described how 
depressed she became: 
 
When she was born actually I was in deep shock – every night I start crying, because I don’t 
know what’s this ... why it’s happened to me, and why she is like this ... I was so depressed 
(Interviewee 5). 
 
Another mother described how she couldn’t cope and veered between two states: 
 
And then literally I had two states, either sleeping or crying – I had no in between, I just 
couldn’t cope with anything else (Interviewee 8). 
 
Mothers also described how when you become pregnant you do everything you can 
to ensure the baby will be healthy: 
 
If they’re not thinking about theirself they should have to think about the baby, something 
little inside.  Yeah.  Yeah it’s alive something inside (Interviewee 7). 
 
You have more fruit, you have more yoghurt and have more milk and you know you’re 
trying to take care of them, because ... that’s the way I am, I just think this is my 
responsibility just going to try and make sure that they come out healthy (Interviewee 8).  
 
As detailed in Figure 25, some women who take folic acid before and during 
pregnancy will still go on to have an NTD affected pregnancy. Indeed, 4 out of the 8 
interviewees in this study reported starting taking folic acid before getting 
pregnant. Despite the uncertainty, however, in all cases, when mothers knew what 
the harm might be, they weighed up the simple act of taking a supplement against 
the small but important risk of an NTD. All mothers interviewed, took folic acid for 
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subsequent pregnancies after their pregnancy with their child who had spina bifida. 
Interviewee 1 described how, despite not planning a subsequent pregnancy, she 
had been taking the high dose folic acid since she had given birth to her daughter: 
 
So at the moment we’re not planning but in case I was to fall pregnant without knowing or 
when I do start planning to fall pregnant. Since she’s been born I’ve just been taking the 
high dose (Interviewee 1). 
 
Semi-structured interviews were conducted by Tedstone and colleagues (97) with 
mothers, including those from Black and Minority Ethnic (BME) communities, to 
explore knowledge of NTDs and folic acid. It was interesting that avoiding harm to 
their baby was described as a strong motivator for making lifestyle changes but 
promoting general health was not.  Not smoking and drinking was seen as 
preventing harm but taking folic acid wasn’t, as there was very little awareness of 
the association between folic acid and NTD prevention (97). Information that folic 
acid can help to prevent harm to your baby, like not smoking and not drinking, and 
details of exactly what it could prevent and when it needs to be taken to be 
effective, is information that no mother with a strong protective instinct for her 
child, would take lightly. If the benefits were more clearly explained when seeking 
and receiving pre-pregnancy advice when this occurs, or failing this, when a mother 
goes to visit a GP once she is pregnant, in the latter scenario it might not be able to 
help the current pregnancy but it could help subsequent pregnancies. 
 
It is therefore theorized that giving sufficient information about the benefits of 
taking folic acid, including when it needs to be taken and with sufficient emphasis 
is important before pregnancy. “Before pregnancy” also encompasses “before 
subsequent pregnancies” and information given in an earlier pregnancy could help 
to protect a later one. However, it was also emphasised in this study that there are 
key misconceptions and situational factors that need to be addressed; taken into 
consideration or utilised as further opportunities to improve peri-conceptional use 
of folic acid. 
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6.3.1.7 Healthy eating is not enough 
 
It was indicated by some mothers in the current study that we can slip into thinking 
that healthy eating is enough linked to a lack of awareness of the greater 
bioavailability of folate in its synthetic form, folic acid. One interviewee whose GP 
didn’t even mention folic acid to her once she became pregnant, said how she didn’t 
go back to check with her GP as she thought she was probably getting enough of 
what she needed from her food: 
 
I mean that’s in one sense that’s what I was thinking where cos we have a lot of spinach, we 
have a lot of the vegetables so I think that’s another reason why I didn’t go back to the GP 
thinking I’m having enough anyway (Interviewee 2). 
 
Another interviewee in the current study described how time was a big barrier for 
her to go out and get more vitamin supplements and that due to the fact that she 
had a healthy diet, and would think this is enough, she probably would not do so: 
 
Because for me to try and get the time to go and get some more vitamins for myself because 
these ones are not given out anymore would be a bit difficult – I probably wouldn’t do it.  I 
think you know what, I’m okay, I’m a healthy person, I don’t need it (Interviewee 4). 
 
When asked what the term pre-pregnancy care means to her, as previously stated, 
interviewee 2 said “After #child's name# it means a lot. Before #child's name# 
nothing.” Many mothers described pre-pregnancy care as including both healthy 
eating and taking folic acid supplements at the time of the interview and after their 
experience of having a child with spina bifida: 
 
That would mean eating lots of healthy food, vegetables, fruits and taking folic acid and 
tablets and things, yeah vitamins (Interviewee 4). 
 
You have to eat healthy food and … yeah.  And folic acid specially (Interviewee 7). 
 
In the study by Prue and colleagues (183) one of the reasons given by mothers for 
not taking folic acid, was that they believed healthy eating was enough. This is also 
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a misconception that has previously been reported to be held by HPs and after a 
training programme that aimed to disseminate information about folic acid, it was 
found the knowledge of the fact that getting enough folate from diet is extremely 
difficult, was increased (184). 
 
6.3.1.8 Having a previous healthy pregnancy 
 
A sense of previous pregnancies setting norms for current pregnancies and 
individuals having a strong motivation to have a healthy pregnancy, was described 
in previous sections. It was also described how it is essential that earlier pregnancies 
are utilised as opportunities for relaying important information for later 
pregnancies. However, if earlier pregnancies are healthy it could impact the 
perceived importance of any health information that is given. One of the 
interviewees in the study described how she really struggled to eat well during a 
previous pregnancy: 
 
Yeah the first one I wasn’t even eating properly.  It’s like I would get up and have a crisp, I 
would go to bed having a crisp ... just living on crisps.  But she came out healthy. She did 
(Interviewee 6). 
 
The mother struggled to eat properly in her previous pregnancy and everything 
was fine and so healthy eating was not significant to her. It was really striking that 
out of the 4 mothers who took folic acid before pregnancy, one had multiple “non-
healthy” previous pregnancies that resulted in miscarriage; one had to have a 
termination due to a congenital anomaly and one interviewee had an older child 
with a congenital condition. 
   
It has been reported by some studies that use of folic acid is lower among mothers 
who have had a previous healthy pregnancy (183;185). Prue and colleagues (183) 
described how mothers who believed that they didn’t need to take folic acid gave 
the fact that they had had a previous healthy child as their reason. It is reported that 
knowledge of the benefits of taking folic acid are higher in mothers who have given 
birth to a child when compared to those who haven’t; however, specific knowledge 
that folic acid can reduce NTDs, is currently very low in both groups (19% in the 
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former and 13% in the latter). Moreover, these findings must be treated with caution 
as information on benefits of taking folic was also given at the end of the 
questionnaire, which could have biased results (37). 
 
6.3.1.9 Reporting a previous miscarriage 
 
The number of mothers in the study (four out of eight) who reported having at least 
one miscarriage before they had their child with spina bifida, was striking. A high 
spontaneous abortion rate has previously been reported in pregnancies preceding a 
NTD affected pregnancy (186).  However, as described, none of the mothers in the 
study were fully aware of the benefits of taking folic acid until the spina bifida was 
detected in their child. Interviewee 1 who had six previous miscarriages, was only 
put on the higher (5mg) dose folic acid once she gave birth to her daughter who had 
spina bifida. Interviewee 8, who was taking folic acid as part of a pregnancy vitamin 
she had been routinely taking for beta thalassemia trait, described how she had lost 
one twin in her previous pregnancy. For the two interviewees, interviewee 3 and 6, 
who were carrying singletons when they miscarried and both reported one 
miscarriage, both became pregnant again soon afterwards. Neither received 
counselling about folic acid at this point and neither were taking folic acid in the 
peri-conceptional period when pregnant with their child who had spina bifida. 
Interviewee 7 who had to terminate her previous pregnancy as the baby’s brain 
“hadn’t formed properly” (suspected anencephaly), was only placed on the normal 
dose (400 µg) folic acid at the time of the termination. Six months later, she became 
pregnant with her daughter who had spina bifida.  
 
6.3.1.10 Considering higher dose (5mg) folic acid 
 
As stated, interviewee 7 was only taking the normal dose folic acid when she fell 
pregnant with her daughter who had spina bifida. It was only at this point that she 
was put on the high dose (5mg) folic acid for her subsequent pregnancy with her 
son who didn’t have an NTD: 
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they said continue this whatever you’re taking, they didn’t give me on that time 5mg, no.  
The normal I was taking, that’s it I was taking yeah… They didn’t give me on her time, but 
when the boy was … so then they increased the dose (Interviewee 7).  
 
This sense of folic acid dose is really critical and another striking factor in the 
research was the number of mothers (seven out of the eight interviewees) who 
reported some form of vitamin absorption problem (this included vitamin D and 
iron deficiency as shown in Table 58). Interviewee 1 was the only mother who 
didn’t report an absorption problem and after being placed on the high dose folic 
acid once her daughter with spina bifida was born, she still went on have another 
miscarriage and ectopic pregnancy.  One of the mothers (interviewee 4) who 
reported an absorption problem described how she had routinely been taking the 
high dose folic acid before and whilst pregnant with her daughter who had spina 
bifida: 
 
Yeah cos I was low so I was on 5mg ... just generally I was on that.  And when I found out I 
was pregnant I was still on that as well.  Like it didn’t increase or anything, it just stayed on 
the same level (Interviewee 4).  
 
Folic acid is very clearly not everything, yet, as described, interviewee 7 had a 
healthy pregnancy when she was taking the high dose folic acid and interviewee 6 
who hadn’t been taking folic acid and then was put on the higher dose, went on to 
have two subsequent healthy pregnancies.  
 
6.3.1.11 Religious observance during pregnancy 
 
As shown in Table 58 above, for the two mothers of Indian ethnicity, interviewee 1 
stated that she would not describe herself as following any particular religion but 
would participate in things due to tradition: 
 
Well obviously I don’t follow it, don’t practise it but I participate in things when I go to my 
parents’ house but not really on an everyday basis (Interviewee 1). 
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Interviewee 8 did not state that she followed any particular religion. All mothers of 
Pakistani (n=2) and Bangladeshi (n=6) ethnicity described themselves as Muslim. 
Fasting during Ramadan is one of the five pillars of Islam and involves not eating or 
drinking between dawn and dusk. Islamic law states that pregnant women do not 
have to fast, although many still choose to do so (187). The impact of fasting during 
pregnancy on fetal outcomes is inconclusive (188). From the mothers who described 
themselves as Muslim, two detailed that they had fasted during pregnancy and 
three that they didn’t (with one mother it was not discussed). For the two 
interviewees that did fast, it fell towards the end of their pregnancy. One of these 
mothers stated: 
 
I can’t remember but yeah I’m sure cos it fell in the month so and I usually fast in my 
pregnancies. So yeah I must have fasted...It would have been late pregnancy, late as in 6 
months. It was 6 months (Interviewee 2). 
 
One of the mothers who didn’t fast described how “even when you’re pregnant 
during Ramadan you don’t fast anyway.” However, she went on to clarify that “it 
depends on yourself … cos I get light headed quite quickly” (Interviewee 6). 
Another mother detailed how she couldn’t fast as the fasts were long and she had 
bad morning sickness: 
 
I would have, but they were like really long fasts, because at that time the fasts finished at 
9pm.  And also I was very sick (Interviewee 4). 
 
6.3.1.12 NTDs being an act of God 
 
Mothers spoke about how they found support through their faith in God.  One 
mother described how she prayed during her pregnancy with her daughter with 
spina bifida and her gratitude to God that she was ok: 
 
Yeah and I was praying over my pregnancy about her and I was thinking I don’t know what 
will happen… But she is all right, I thank God all the time.  She’s all right, she’s doing very 
well (Interviewee 7). 
 
Another mother spoke about her belief that everything happens for a reason: 
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I mean I do believe everything is, what we believe is everything is planned by God anyway 
so if it was gonna happen it was gonna happen (Interviewee 2). 
 
However, she also stated that the GP “didn’t do her job” by not mentioning folic 
acid to her. There were also indications by interviewees that they felt a certain 
degree of guilt about their child having spina bifida and they feared being blamed. 
Although the GP didn’t do her job by not informing her about folic acid when she 
was pregnant, it was very sad as no-one had explained to interviewee 2 that it 
would have been too late for her to take folic acid anyway by that point, and she 
had ongoing guilt that she should have gone back and asked or just started taking 
it. Interviewee 1, who had been taking folic acid for many years, felt a sense of guilt 
that there was something she had done wrong to result in her child having spina 
bifida as her friends hadn't taken folic acid and their children didn't have an NTD:  
 
Cos I’ve had friends obviously when we were discussing things that obviously I feel guilty 
that you know we’ve taken the folic acid and they say ooh I didn’t even know I was pregnant 
so I didn’t start taking folic acid until after and their child’s completely fine. Obviously 
you’re just in that lucky, yeah (Interviewee 1). 
 
Husain (189) conducted semi-structured interviews with mothers of children with 
spina bifida, focusing on coping and stress in the period after birth and argued that 
HPs have an important role in addressing mothers’ beliefs that they are to blame. In 
the current study, in some cases, rather than addressing feelings of blame, HPs 
seemed to reinforce it. Despite the fact that none of the interviewees had been 
sufficiently informed of the benefits of taking folic acid before the NTD was 
detected in their child, when the NTD was detected, the link with folic acid seemed 
to be readily stated; guidance was given by HPs in “diagnosis” rather than 
“prevention” mode. One mother’s response when she was asked if she was taking 
folic acid when the NTD was detected was: 
 
I said yes I was because a lot of people say, people with her condition is because they haven’t 
realised they are pregnant and haven’t being taking the folic acid cos it happened so early on 
(Interviewee 1). 
181 
 
 
Another mother was told: 
 
Continuously I was taking but they said to me in your body is folic acid less, that’s why it’s 
happened (Interviewee 7). 
 
NTDs seemed to be attributed to people “failing” to take folic acid or having lower 
levels in their body. In one case, a strong sense of ignorance about the condition and 
presumption was emphasised: 
 
oh the midwife there said ‘Oh spina bifida ... so you weren’t taking any folic acid then? 
(Interviewee 8)’  
 
Al-Gailani (190) in his article tracing the history of folic acid in Britain makes a very 
interesting point: 
 
If epidemiology in the tradition of social medicine encouraged NTDs to be understood in 
relation to social problems of poverty and malnutrition, by the end of the century they were 
more likely to be attributed to individual women’s failure to respond appropriately to expert 
guidance 
 
As stated, folic acid is a prevention tool for NTDs, but it is not the complete picture. 
NTDs are never caused by a “failure” on the part of the mother, even if “expert 
guidance” is given in a timely manner, which was not the case here.  From the 
comments of the interviewees, it seemed that in some cases there was ignorance on 
the part of the HPs about the complexity of NTDs. It was actually quite striking that 
one of the doctors who had a better understanding of the condition, emphasised 
that the mother was not at fault: 
 
He said ‘Are mum and dad related?’ and we’re like ‘No’.  And he’s like ‘Any family 
history?’ I’m like ‘No.  And then he just went through and said it’s just an act of God.’  And 
that’s the way I liked it to be referred to - it’s an act of God. You weren’t at fault 
(Interviewee 8). 
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6.3.1.13 Targeting education campaigns 
 
After conducting a systematic review exploring the knowledge and peri-
conceptional use of folic acid by mothers from different ethnic communities, as part 
of this doctoral thesis, it was recommended that carefully targeted and innovative 
campaigns need to be implemented in combination with a mandatory fortification 
programme for different ethnic communities (22). For mothers of South Asian 
ethnicity who were interviewed in the current study, it was GPs/midwives who 
were most commonly stated as the people they respect/feel they have a 
responsibility to give them pre-pregnancy health advice. It was also detailed how 
none of the interviewees were sufficiently aware of the benefits of taking folic acid, 
until it was discovered that their child had spina bifida. It cannot be assumed that 
GPs will play such a vital role for all South Asian mothers, with the term ethnicity 
itself being a social construct (149;150). However, it is striking that both South Asian 
mothers interviewed by Jessa and Hampshire (100) and South Asian mothers in this 
study, emphasised GPs/midwives as their preferred information source. Moreover, 
across different ethnic groups, both the media, such as newspapers and television, 
and HPs are the most commonly cited desired sources of information on folic acid 
(22). It was theorized based on the responses of interviewees that giving sufficient 
information about the benefits of taking folic acid with sufficient emphasis is 
essential for impacting early and later pregnancies. It would therefore seem that the 
best initial stage to try to increase the likelihood that South Asian mothers receive 
this information is targeting culturally sensitive education campaign at HPs. 
  
Interviewees detailed how some HPs had a real lack of understanding of the 
complexity of NTDs and thus increasing awareness about the condition and its 
complex aetiology should be a crucial part of the campaign. Giving sufficient 
information on why folic acid should be taken, whilst giving information in a 
sensitive way that helps to lessen rather than perpetuate any ensuing sense of self-
blame, should also be addressed. Based on the responses of interviewees, there 
were also further factors which need to be understood by HPs and addressed when 
giving individuals pre-pregnancy health advice. A key factor is the misconception 
that we can get sufficient folate from diet alone. Folate is far more bioavailable in its 
synthetic form, folic acid, and emphasising the importance of both eating healthily 
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and taking folic acid supplements, is critical. In addition to describing the benefits 
of taking folic acid in combination with having a healthy diet, based on the 
responses of interviewees, it is also important to emphasise that having an earlier 
healthy pregnancy that is unaffected by an NTD, does not necessarily mean this will 
be the case for subsequent pregnancies. Seven out of the eight interviewees reported 
some form of vitamin absorption problem: It is also recommended that this is taken 
into account when counselling mothers, including a consideration of the added 
therapeutic benefits of being on the high dose folic acid (5mg). One of the mothers 
reported she had Beta thalassemia trait and the National Institute for Health and 
Care Excellence (NICE) guidelines currently recommends that those with 
thalassemia take the higher dose folic acid (191). Finally, it is striking that four of the 
eight interviewees reported at least one previous miscarriage and one reported a 
previous TOPFA. This strongly suggests that another potentially vital time to 
inform about the benefits of taking peri-conceptional folic acid, is soon after a 
miscarriage or after a pregnancy is terminated due to fetal anomaly. 
 
As described, a European wide survey found that the majority of women planning 
their pregnancy did not consult a HP before stopping their method of 
contraception, which probably impacted the low rate of folic acid use (28%) in the 
planners. Therefore, ensuring that women planning their pregnancy visit the GP in 
the first place is problematic. Two mothers in the current study suggested that 
another important way to inform about folic acid benefits, which would ensure 
individuals are made aware before pregnancy, is through sex education in schools. 
One mother said: 
 
But then before that, even school. Bringing out all the sex education and this, that and the 
other, surely that should be a part of it. I don’t think that comes into it at all. I don’t think, 
you know. Yeah because we learn a lot in school and it gets drummed in at that time so 
surely this, having the folic acid when you’re pregnant or this will happen, could happen 
(Interviewee 2). 
 
This emphasises the high degree of receptivity of young people at school and the 
amount of information that is absorbed and retained during this period of life. To 
increase awareness about NTDs as early as possible, an additional future targeted 
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education campaign could therefore be at those providing sex education classes at 
schools. Consequently, sex education classes could be extended to describe NTDs 
and prevention by folic acid in sufficient detail to young women. The importance of 
visiting the GP for tailored advice when planning pregnancy could also be 
emphasised. 
 
6.3.1.14 Further discussion 
 
There has been a real paucity of qualitative research into the peri-conceptional 
knowledge and use of folic acid by different ethnic communities and, as described 
in the Introduction to this chapter, this qualitative study was the first to specifically 
explore the pre-pregnancy and pregnancy knowledge and behaviours of 
individuals with a previous NTD affected pregnancy in the UK. Jessa and 
Hampshire (100) in their qualitative research with pregnant mothers of Pakistani 
ethnicity from Nottingham in the UK, found that none of the mothers had been 
informed by the GP about the benefits of taking folic acid but they stated that they 
believed it was the duty of the GP to give them this advice. This was also the case 
for the South Asian mothers interviewed in this study, as described. However, this 
research with mothers with a child with spina bifida, went beyond looking at 
mothers’ knowledge and peri-conceptional use of folic acid and was concerned with 
mothers’ experiences both before and after the condition was detected in their child. 
It was thus underlined by mothers how HPs did not sufficiently detail the benefits 
of folic acid in “prevention” mode, before pregnancy, but stated its association with 
NTDs in “diagnosis” mode, when the spina bifida had been detected. The over 
assertion of the link between NTDs and folic acid, by some HPs, as described, could 
indicate a lack of understanding about the condition. This could be linked to the 
“invisibility” of NTDs. One mother in the study described how she felt a 
responsibility to tell other prospective mothers about the importance of taking folic 
acid: 
 
I told whoever I know. Whoever I know now, even when they’ve just got married or 
whatever I’m like make sure when you’re planning your pregnancy, have your folic acid and 
I do tell people, I do tell them (Interviewee 2). 
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She had a child who had spina bifida, who was wonderful, but the condition was 
very far from being invisible for her and she felt a duty to inform others. It is 
believed that making NTDs less invisible for HPs could only be a good thing. 
  
Additionally, further situational factors were discussed, or brought to light through 
the in-depth discussions, which could impact whether individuals receive sufficient 
folate/folic acid in the peri-conceptional period. It was the practices and views of 
South Asian mothers that were specifically explored here and this enabled specific 
recommendations to be generated for both information received by GPs and other 
HPs through education campaigns and the mothers themselves when learning of 
the benefits of folic acid. Valuing an individual’s religious belief is of paramount 
important, including recognising the support and strength this might give them, 
whilst also, with great sensitivity, considering the impact that certain practices, such 
as fasting early in pregnancy, might have on them and their baby. The high 
proportion of interviewees who reported some form of vitamin absorption problem 
was very striking. None of the interviewees specifically reported that they were B12 
deficient, and all self-reported that they were not vegetarian. However, evidence 
suggests that those who are vegetarian might be at higher risk of B12 deficiency 
(192) and there has been shown to be an increased risk of NTDs in mothers who are 
B12 deficient (42). This should be taken into consideration when counselling 
communities where vegetarianism is more common. 
 
The generated theory from this analysis, being given sufficient information, with 
sufficient emphasis, about the benefits of folic acid to impact current and future 
pregnancies, focuses on the strong protective effect of folic acid: the 1991 Medical 
Research Council (MRC) double blind randomised controlled trial showed an 
approximately 70% reduction in NTD recurrences in women taking folic acid 
supplements (17). However, the fact that taking folic acid before and during early 
pregnancy will not prevent all NTDs, introduces uncertainty into the equation. As 
described, some mothers in this study reported that they had started taking folic 
acid before they became pregnant with their child who had spina bifida. And, as 
described in the Introduction to this chapter, a key reason for this research being 
conducted with mothers of South Asian ethnicity was that the NTD prevalence was 
shown to be particularly elevated in mothers of Indian and Bangladeshi ethnicity in 
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the quantitative study (Chapter 5). However, there were indications that this 
elevation was most marked for Indian mothers for non-isolated NTDs, NTDs 
occurring in combination with other defects, which are unlikely to decrease with 
folic acid usage (47). 
 
Coupled with this uncertainty about the benefits of taking folic acid is a 
consideration of the risk of having an NTD affected pregnancy in the first place. 
Approximately 1 in a 1000 pregnancies in the UK are affected by NTDs (4). 
However, as findings from the quantitative study showed, the NTD prevalence can 
be as high as 2 in a 1,000 for Indian mothers and 3 in a 1,000 for Bangladeshi 
mothers. In the current study, when aware of the potential harm, despite the 
uncertainty of benefit, all mothers weighed up the simple act of taking a 
supplement against a small but important risk of an NTD. It is described how 
information that folic acid can help to prevent harm to your baby is information that 
no mother with a strong protective instinct for her child would take lightly. 
However, in no way does this indicate that a mother who does routinely take folic 
acid when aware of its benefits is any better or loves her child any more than a 
mother who does not. In previous studies, other stated reasons by mothers for not 
taking folic acid include busy lives, competing priorities for concern and poor 
memory (193). We all have a multitude of life demands competing for our attention 
and the routine of taking tablets is something that is not necessarily easy to stick to. 
One interviewee described the problem of sticking to the routine of tablet taking: 
 
I don’t know. It’s just the routine of taking tablets.  Yeah you can’t keep up with it 
(Interviewee 6). 
 
Moreover, having a child with spina bifida was something that was very real and 
tangible for all mothers interviewed in the current study. Hearing about the risk of 
NTDs, and being given details of what the condition is, is very different to having a 
direct experience of it. Therefore, it cannot be automatically assumed that as all 
mothers in the current study took folic acid after they had a child with spina bifida 
that mothers who have not had an NTD affected pregnancy, will take folic acid 
when aware of the benefits. Although not explored in this study, it was very 
interesting that in the qualitative study conducted by Jessa and Hampshire (100) 
187 
 
with pregnant British Pakistani women, individuals stated that they preferred their 
GP to prescribe folic acid rather than to simply buy it over the counter. This 
supports earlier research comparing the views of Asians and non-Asians towards 
certain medications being made available over the counter, with the former group 
showing much less desirability for this than the latter (194). Higher dose (5mg) folic 
acid is currently prescribed by GPs but the normal dose (400 µg) is not. If the 
normal dose was also prescribed by GPs for those who have a preference for it, then 
they would be further “endorsing” its use: it would not just be a vitamin bought 
across the counter but something with the stamp of approval from the doctor, like a 
medicine, to take. 
  
6.3.1.15 Key conclusions and recommendations 
 
In conclusion, mothers of South Asian ethnicity interviewed in this study only fully 
appreciated the benefits of taking folic acid when it was discovered that their child 
had spina bifida; they found out in “diagnosis” rather than “prevention” mode. 
However, all mothers indicated that it was their GP/midwife who they respected 
most/felt they had a responsibility to give them adequate advice about folic acid 
benefits. It does not seem routine for many women to visit a HP before they get 
pregnant when planning their pregnancy and HPs do not necessarily view it as 
their role to provide pre-pregnancy counselling. Yet what was striking was that for 
all women interviewed, their pregnancy with their child who had spina bifida was 
not their first. Half of the interviewees reported previous miscarriages and one 
mother a previous TOPFA. There was also a sense in the study of previous 
pregnancies setting norms for current ones. Therefore, although it is best to inform 
mothers of the benefits of taking folic acid before pregnancy to protect that 
pregnancy, if this is not possible or does not occur, giving information about 
benefits as early as possible within that pregnancy could help to protect future 
pregnancies. Moreover, the information does not just need to be given once as 
mothers can be informed again at antenatal clinics and soon after a miscarriage or 
TOPFA occurs is also a critical point to provide information. It is recommended that 
a culturally sensitive education campaign is targeted at HPs to ensure they have an 
adequate understanding of NTDs and their complexity, to tailor counselling for 
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South Asian mothers for specific circumstances and to ensure that information is 
given in a sensitive way that helps to lessen rather than perpetuate any ensuing 
sense of self-blame. Another suggested method to inform young women before they 
become pregnant is through sex education classes at school. 
 
6.3.2 Deciding to continue a spina bifida affected pregnancy: Seeing the whole 
picture (with human eyes) 
 
In the current study, for two interviewees the spina bifida was not detected in their 
child until birth (interviewee 1 and 3) and in two detection was late (for interviewee 
6 this was at 36 weeks and in interviewee 5 this was at 24 weeks; the latter was 
detected and the child was born in Saudi Arabia where termination is only 
permitted up until 120 days after conception (164)). For three interviewees the NTD 
was detected at 20 weeks (interviewee 2; 7 and 8) and the parents made the decision 
to continue the pregnancy and in one interviewee (interviewee 4), it was unknown 
when the NTD was detected.  
 
Therefore, when exploring around decisions to continue a spina bifida affected 
pregnancy only data from interviewee 2, 7 and 8 can be included.  Although the 
number of interviewees was limited, the in-depth interviews resulted in a rich 
dataset for qualitative analysis. Many of the points raised were striking and are 
important to detail here. Comments from discussions with parents of children with 
spina bifida are also included where necessary and where appropriate, in 
accordance with the grounded theory methodology, regardless of ethnic 
background. Ahmed and colleagues (163), in their research exploring the views of 
parents from different ethnic backgrounds towards prenatal testing and termination 
of pregnancy for sickle cell disorders and thalassemia major, found that even for 
those mothers who believed that termination was prohibited by their religion, many 
would consider termination to avoid their child suffering. Therefore, regardless of 
ethnicity or religious belief, it was perceived severity of the condition/quality of life 
of the child that was shown to be the most important factor when deciding to 
continue the pregnancy or not. This led the authors to conclude that there is a real 
need to move away from stereotypical views based on faith and ethnicity, towards 
looking at the beliefs of individuals (163).  This has been strongly apparent in the 
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current study and has been key to how this second part of the qualitative study has 
evolved. 
 
The importance of seeing the whole picture is central to this part of the analysis. It 
was described towards the end of the last section how the “invisibility” of NTDs 
could contribute towards breeding ignorance about their complexity. From 
discussions with mothers about their experiences when the spina bifida was 
detected in their child, it seems that this invisibility could affect HPs perceptions of 
the severity of the condition and what is consequently communicated to parents 
about it. However, based on the detailed experiences, this seems to go further than 
not seeing and communicating the whole picture, in some cases, to a lack of 
humanity and recognition that the decision of whether to continue the pregnancy or 
not, lies with the parents.   
 
6.3.2.1 Giving a worst case picture and driving TOPFA 
 
From the responses of some interviewees (and discussions with mothers more 
widely) it seemed that not routinely seeing children living with spina bifida, 
inclined HPs towards presenting a much bleaker picture of the condition. 
Interviewee 2 and 8 spoke about how the doctors they saw prenatally and scanned 
them during their pregnancy gave them a worst case picture when the spina bifida 
was detected in their child as how things would be; not as a possibility. One mother 
described how the doctor said: 
 
He’ll be blind, deaf, dumb. He won’t be able to talk, he’ll have bowel problems (Interviewee 
2) 
 
Such a bleak picture was given despite the fact that it could be detected at the 20 
week scan that the defect was lower down. For interviewee 8 a similarly bleak 
picture was presented: 
 
So they were talking about the brain, and basically made out that the whole life was just 
going to be one surgery after another, too much suffering, many disabilities (Interviewee 8). 
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Being given such a bleak picture by some HPs came simultaneously with what was 
perceived as a strong drive behind terminating the pregnancy. Several parents of 
children living with spina bifida from SHINE, also commented on this. Interviewee 
8 described how she felt “badgered” to terminate her pregnancy. After one scan 
with a doctor who didn’t allow her to ask questions, she described how she "had 45 
minutes of grilling and badgering" by another doctor who subsequently told her 
"Do you understand what the effects of this is. Your baby is going to be completely 
retarded," which again appeared to reflect ignorance about the condition. This 
mother emphasised that these were the exact words used, and her experience was 
not dissimilar to other mothers. One mother I spoke to who was not of South Asian 
ethnicity said that the same term, “mentally retarded” had been used when 
describing how her child would be. 
 
The same doctor who “badgered” interviewee 8 to terminate her pregnancy also 
said "We don't have many cases of spina bifida nowadays." Interviewee 2 described 
how she felt pressurised to end her pregnancy and despite her decision to continue 
after the condition was detected at 20 weeks, on every subsequent scan 
(approximately monthly) termination was discussed: 
 
he’d say you know you’ve still got the option to have an abortion. We could set it up now, 
we could do this, we could do that (Interviewee 2). 
 
This mother also described how the doctor who carried out each of her scans, and 
spoke about termination on every one, cared for her until birth but didn’t see her 
son again after that: 
 
this doctor he was, right through from the beginning till the end. The end meaning he gave 
birth, cos I had a caesarean. After the operation he disappeared, I didn’t see him after that. 
He didn’t see #child’s name# (Interviewee 2).  
 
6.3.2.2 The paradox of choice 
 
This sense of feeling “badgered (Interviewee 8)” by HPs to terminate their 
pregnancy accentuated how even if they did believe the outcome to be the worst 
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case scenario that they presented, based on this limited picture, they were not 
completely leaving the decision of whether to continue the pregnancy or not to the 
parents. When discussing their experiences of TOPFA, women describe how it is 
never a real choice as their agency is restricted and with either decision, no-one 
really “wins” (195). Parents emphasise the importance of being supported in their 
decision to continue their pregnancy when a congenital anomaly is detected, if this 
is the decision they come to (170;196;197). A qualitative study exploring around 
parents’ pregnancy decisions when holoprosencephaly was detected in their child, 
found that many women felt unsupported to continue their pregnancy and that the 
emphasis was very much on termination (171).  
 
In the current study, in addition to feeling pressurised to end their pregnancy, 
mothers felt unsupported by HPs when they decided to continue and were even 
made to feel guilt for doing so. Both interviewee 2 and 8 described how they were 
made to feel guilty for the impact having a child with spina bifida would have on 
their relationship with their husband and other children: 
 
He was basically talking about my family, how we wouldn’t have a family structure, how 
my other kids would be affected, that I wouldn’t have any time for them (Interviewee 2). 
 
I’m going to ruin my marriage, I’m going to ruin my life, I’m going to ruin my kids’ life, 
and I’m also being incredibly cruel by bringing in such you know an unworthy life into this 
world (Interviewee 8). 
 
Interviewee 2 described how she felt completely unsupported to continue the 
pregnancy and that she would have felt much more support if she had decided to 
end it: 
 
I found a lot of support through, if you want an abortion, we’re here, we’re gonna help you. 
We’ve got this, we’ve got that to support you. Yeah there was a lot of support through that 
way. Which was traumatic (Interviewee 2). 
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Interviewee 8 also described how she felt unsupported to continue her pregnancy 
by some HPs and in one instance was asked over and over again whether she was 
sure: 
 
So the baby’s got spina bifida, and I hear that you’re planning to go ahead with the 
pregnancy’.  I was like ‘Yes’.  And he asked me so many times if I was sure ‘Do you know 
what it involves?  Are you absolutely sure?  Have you thought about it?  Are you sure?’  
Like how many times do I have to say ‘sure’? (Interviewee 8) 
 
She also emphasised how there seemed to be little appreciation of and sensitivity 
towards the multitude of factors that can affect the decision of whether or not to 
continue a pregnancy. Spina bifida is typically detected around the 20 week scan 
and therefore, in some cases, feticide will be necessary to end the pregnancy. It has 
been shown by previous research that the psychological pain associated with 
terminating a pregnancy due to fetal anomaly, is difficult to overcome and this is 
particularly the case when feticide is involved (195). Interviewee 8 described how 
when the process of feticide was described to her, she was horrified and she 
couldn’t even contemplate doing it: 
 
there’s no way I can go into a room and watch them inject her heart, I just can’t do that 
(Interviewee 8) 
 
She described how having to take a pill would be less traumatic but having the late 
termination was completely inconceivable. Despite the mother’s reaction, she was 
still subsequently “grilled and badgered” to end the pregnancy.  
 
It was also automatically assumed that interviewee 8 was deciding to continue the 
pregnancy because of religion: 
 
And then she said can I ask are you saying no for religious reasons. I was like no, I’m saying 
no because it’s my baby and I actually love her (Interviewee 8). 
 
Her reason for continuing was for love not religion and she went on to describe 
how she had loved her baby since her pregnancy was known: 
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even though I haven’t met her, I actually love this baby, because she’s my child (Interviewee 
8).  
 
She stated that as soon as she knew she was pregnant “it’s like it’s my baby.” 
Mothers have reported already loving their baby and feeling a strong bond with 
them as reasons for continuing their pregnancy affected by a fetal anomaly in 
previous research (169;172). There is little evidence to support an assumption that 
mothers of a particular ethnicity will choose to continue their pregnancy for 
religious reasons. As stated, work by Ahmed and colleagues (163) exploring the 
views of parents towards prenatal testing and termination of pregnancy for sickle 
cell disorders and thalassemia major found that perceived severity of the condition 
was shown to be a more important factor than religion or faith when deciding to 
continue the pregnancy or not (163). This was supported by subsequent work by the 
same authors (162) conducted in Yorkshire comparing the views of European and 
Pakistani women who either had a child with a congenital anomaly or terminated 
their pregnancy because of one, towards prenatal testing and termination for 30 
different fetal conditions. It was found overall that there were more similarities than 
differences between the two groups and that the most important factor in the 
decision was a perception of the child’s quality of life. Again, although Pakistani 
women said that Islam didn’t allow termination, they came to the personal decision 
that TOPFA is justified for serious conditions as it would be wrong to bring a child 
into the world that isn’t going to have any quality of life (162). 
 
Every situation is different and each individual unique. Interviewee 7 described 
how she had to have a termination for her previous pregnancy as her baby's brain 
hadn't formed properly and how when it was detected that her daughter had spina 
bifida in her subsequent pregnancy and she was offered a termination, she said no: 
 
And when they told me about her condition which the baby maybe can’t walk and maybe 
have lots of operations and this and that.  My husband was with me also, the doctors told me 
about terminate the pregnancy, but I said no.  Because before her I’ve got a miscarriage and 
that baby was also not good.  They said … when the first scan they said its brain not proper 
make and something … I don’t know what they were saying after that.  And they said you 
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have to terminate the pregnancy because the baby can die inside maybe 6 months pregnancy 
or 7 months … but that time you get more difficulties (Interviewee 7).   
 
This mother didn’t speak further about her decision to continue her pregnancy and 
this wasn’t probed further due to the mother having had to have a previous 
termination and it being a very sensitive situation.  
 
6.3.2.3 Taking off the clinical mask 
 
HPs having sensitivity and compassion when giving information about a fetus with 
a congenital anomaly has previously been described as essential by parents, with 
one parent remarking that the HP should “take off the clinical mask and see the 
person as a person” (197). In the current study interviewee 8 described how there 
was a real lack of empathy, realisation that it was a human that they were speaking 
about and humans that they were speaking to, when the condition was described. 
She remarked how "you know you need to realise that this life’s over here, it’s not 
just a picture on a scanner," and how "I think its routine for them, they don’t realise 
that there’s emotions attached." It was also quite poignant what she subsequently 
said: 
 
I think over here there’s that lack of humanity, there really is.  When it comes to doctors, 
there really is a lack of humanity (Interviewee 8). 
 
In addition to feeling unsupported and guilty for continuing her pregnancy and 
pressurised to end it, interviewee 2 commented on how everything “was just so 
negative. It was horrible.” It was very interesting as this mother spoke about how 
when the condition had been detected she went away to research on the internet 
and to look on YouTube and that it tended to be the "good things" that were on 
there: 
 
Yeah I think on youtube parents put the videos up when they reach a goal; when they’re 
happy about something. It’s the good things I could see that were on youtube (Interviewee 
2). 
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She then described that there would "be the negative parts or the medical parts" on 
websites. Remarks from interviewee 2 about the negative/medical things she saw 
on websites and negativity of some of the HPs point to an interesting point about a 
too medicalised picture being presented. Although interviewee 2 described how 
being given such a bleak picture was beneficial for her: 
 
I actually benefited from having a bleak picture cos then I woke myself up, I got myself 
prepared for the worst (Interviewee 2). 
 
For her husband the opposite was true and she described how “he didn’t deal with 
that part, the negativity.” It was also really sad what she described what she 
expected to see when her child was born: 
 
So when I gave birth I couldn’t even look at him, I was scared. Cos I was imagining this 
monster (Interviewee 2). 
 
This contrasted sharply with what she actually saw: 
 
And then when I saw him I was like, oh, he’s normal. He looks fine (Interviewee 2).  
 
In previous research exploring parents’ experiences when a fetal anomaly is 
detected, individuals have emphasised the importance of the HP providing them 
with detailed and unbiased information about the condition, including giving both 
a best and worst case picture; for them to acknowledge uncertainty where this is the 
case and to give information through a variety of methods, including verbal, 
written and using visual illustration (170;171;195-198). Based on interviewees’ 
responses in the current study, some HPs in fact gave biased information, only a 
worst case picture and didn’t acknowledge uncertainty. 
 
6.3.2.4 A few angels 
 
Receiving conflicting views from different HPs (196) and different HPs holding 
different views towards TOPFA (199), has been reported in the literature. 
Interviewees in the current study did not describe all doctors as driving termination 
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so strongly and as interviewee 8 said, "if you come across so many awful … you 
need a few angels as well." She described how a doctor early on advised her of her 
pregnancy options but did not pressurise her in any way: 
 
he said look I’m not suggesting you do this, it’s entirely your decision, but legally I’m 
obliged to tell you that if you want a termination then you can have one.  So there was no 
pressure on me to do that (Interviewee 8). 
 
This was the same doctor discussed in the section above who seemed to have a 
better understanding of spina bifida (and did not immediately attribute it to folic 
acid not being taken) and described it as just being “an act of God”, having no clear 
cause. 
 
Interviewee 2 described how the neurosurgeon at GOSH gave a much more 
balanced view and how this resulted in it being a much less traumatic experience: 
 
She was A’s neurosurgeon from the beginning. They referred, when I was pregnant they 
referred me to go to GOSH. And she, when I spoke to her, she gave both sides…I remember 
that appointment not being so traumatic (Interviewee 2). 
 
6.3.2.5 Dispelling ignorance 
 
As previously described, it is the views of mothers of children with spina bifida that 
have been explored here and so everything detailed is from their perspective. Also, 
no individuals were interviewed who decided to end their pregnancy and so it is 
specifically the views of those that decided to continue that have been included. 
Nevertheless, the discrepancies in mothers’ detailed experiences about 
consultations with doctors who do not routinely see children with spina bifida 
when compared to those that do, was striking. The perceived “negative”, over 
medicalised picture with a strong onus on termination seemed to come from the 
prenatal team and the more “positive”, less traumatic and balanced view came from 
the neurosurgical team. It was also those who seemed to know more about the 
condition that had the most sensitivity about it and as one mother said, “when 
people do know (about the condition), they’re just so much more different” 
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(Interviewee 8). It was described at the end of the last section how targeting 
education campaigns at HPs to improve their knowledge about NTDs was essential; 
explorations throughout this section have shown that this should also include HPs 
who routinely scan and counsel mothers about their pregnancy options. Previous 
research has shown that although the probability of TOPFA tended to be associated 
with the severity of the condition, at similar levels of severity, CNS anomalies were 
more likely to result in a termination (168). This is a very interesting finding and a 
possible postulated reason for this was that the impact of having a CNS anomaly is 
being communicated to parents differently (168). This needs to be addressed. 
 
A lack of exposure to individuals living with NTDs might not be the whole picture 
here. Interviewee 2 spoke about how she thought that money was the reason that 
termination is driven so hard: 
 
I know a lot is to do with money. Cos these kids, there’s a lot of money behind them, the 
NHS. So I think that’s more why, you know why they try to push towards a termination cos 
there is a lot of money behind them (Interviewee 2). 
 
However, what is strongly apparent is that there are women who are not receiving 
the complete picture about spina bifida when it is detected that their child has the 
condition, which means that they do not have sufficient information in order to be 
able to make an informed decision. In some cases the decision women come to is 
not being respected, including reports of them being treated with very little 
humanity.  
 
It has been observed in other qualitative research, involving both parents and 
clinicians, that neonatal surgeons can sometimes be over optimistic when 
counselling mothers when a fetal anomaly is detected (200). However, it has been 
shown that neurosurgical teams working more closely with fetal medicine 
specialists can help to ensure that parents receive a more balanced picture about a 
fetal anomaly from the outset (201). It is recommended that this setup is strongly 
considered more widely. 
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6.3.2.6 Further discussion 
 
Numerous studies have been conducted exploring mothers’ experiences when a 
fetal anomaly is detected. Lafarge and colleagues conducted a systematic review of 
qualitative research exploring women’s experiences of TOPFA. The authors 
described how mothers who had a TOPFA went through the experience of their 
world being shattered; a sense of losing control and re-gaining it again. They also 
described how the women emphasised the importance of HPs giving them detailed 
and unbiased information. However, above all else, women valued their HP 
showing them empathy and compassion (195). The current study was the first 
qualitative study in the UK to focus specifically on the experiences of South Asian 
mothers who have had a previous pregnancy affected by an NTD. As described in 
the Methodology section of this Chapter, it was only mothers who had a child living 
with spina bifida that decided to take part. Yet it is striking how the views of 
mothers who decided to continue their NTD affected pregnancy in this study, and 
mothers who had a TOPFA across 14 studies synthesised in a meta-ethnography by 
Lafarge and colleagues, coalesced: All went through a process of their world falling 
apart and then went through a cycle of regaining a sense of control again. And 
critically, all emphasised the importance of being given clear and unbiased 
information from their HPs whilst also being treated with humanity and supported 
in the decision that they come to.  
 
The described over-clinical way in which mothers felt the information about their 
child’s condition was relayed to them by some HPs was quite poignant. As one 
mother said, their child is “not just a picture on a scanner (Interviewee 8).” The 
‘clinical’ approach that the women described did not recognize their baby as a 
“person” but the mothers did. When a fetus becomes a human is a contentious 
issue, however, it might be missing the point slightly to focus too heavily on this 
and instead look at the emotional bond that mothers described as having with their 
baby when they were 20 weeks pregnant. For the past five months their child had 
been growing inside of them and they had grown to love them, whether they were 
technically a “person” or not. An over-clinical picture was not described as being 
given by the neurosurgical team, people who would routinely see children with the 
condition. Perhaps this reflects different priorities and previous research conducted 
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in the US, comparing the views of maternal fetal medicine and fetal paediatric care 
specialists, has shown that the latter were more likely to see the well-being of the 
fetus and the former the well-being of the mother, as their primary responsibility 
(199). However, based on described accounts in this study for mothers who decided 
to continue their pregnancy, in overlooking the fetus, HPs are hurting the mother as 
they already see the fetus as their baby. 
 
In the previous section for this qualitative research it was detailed how mothers 
interviewed in the study didn’t know about the benefits of taking folic acid and 
many heard the word spina bifida for the first time when it was discovered that 
their child had the condition. In the quantitative study for this thesis, it was 
described how there is a peak in the detection for spina bifida around the 20 week 
scan and for mothers who make the decision to have a TOPFA, they often make the 
decision quite quickly, with 90% of NTDs terminated within 2 weeks of the 
condition being detected. Thus, at the time when the spina bifida is detected and the 
mother is unlikely to know very little about the condition, it is crucial to also 
provide mothers with a positive view of a future with a child with spina bifida so 
they make the decision that is “right” for them. The bleak view of the condition that 
was described as being presented by some HPs, contrasted sharply with many of 
the interviewees descriptions of their child’s life. One mother described how her 
child is doing everything as normal: 
 
No as far as I’m concerned she’s doing everything like a normal child. Nobody can tell 
anything’s wrong with her until I say something (Interviewee 3). 
 
Another mother described how her daughter still has the same mentality as 
everyone else: 
 
They still have that normal mentality ... still same feelings as everyone else (Interviewee 6).   
 
One interviewee also described how well her daughter was doing: 
 
But she is all right, I thank God all the time.  She’s all right, she’s doing very well 
(Interviewee 7).  
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There will also be children with the worst case spina bifida presented by HPs and 
one interviewee described how this was the case for the daughter of someone she 
knew: 
 
Yeah well she had an awful time and she lived until she was about 8 I think (Interviewee 2). 
 
However, based on the interviewees’ detailed experiences, there will also be 
individuals for whom this will be very far from the truth and parents need to be 
given all possibilities. 
 
It is argued that not understanding the complexity of spina bifida sufficiently and 
not routinely seeing children with spina bifida, might not be the sole reason for HPs 
presenting such a bleak picture of the condition. However, one has to ask whether it 
would be morally and legally permissible to present the condition in such a bleak 
light if it was not believed this is how things will be. As described, one mother said 
she thought it had more to do with monetary reasons that termination was driven 
so strongly; however, again, when would this ever be an ethically acceptable 
reason? Furthermore, regardless of other factors, it is troubling that termination is 
perceived to be driven at all as it at best reflects a lack of regard for the parents’ 
right to decide whether to continue the pregnancy or not. 
 
6.3.2.7 Key conclusions 
 
In conclusion, based on detailed experiences of mothers who have a child with 
spina bifida, those HPs who do not routinely see many children living with spina 
bifida seem to be more inclined to give a worst case picture as the diagnosis, rather 
than appreciating the complexity of the condition. Consequently, mothers may not 
be presented with a balanced picture in order to be able to make an informed 
decision about whether to continue the pregnancy or not. It appears that some HPs 
place more of an onus on TOPFA in their counselling and do not respect the 
mothers’ decision to continue their pregnancy when it is discovered that their child 
has spina bifida. The inhumane way in which some women described that they 
were treated, was shocking. HPs that routinely see children with spina bifida were 
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described by interviewees as giving a more balanced and “positive” view of the 
condition. It is therefore recommended that neurosurgical teams work more closely 
with fetal medicine specialists to ensure a more balanced view of fetal anomalies is 
given from the outset and it is seriously considered the types of individuals that are 
permitted to scan and counsel vulnerable women.  
 
 Chapter summary and important points to take further 6.4
 
Grounded theory methodology was used to explore the pre-pregnancy and 
pregnancy views and experiences of South Asian mothers of children with spina 
bifida. Being inductive in nature, grounded theory methodology ensures the study 
outcomes are routed in the data; it is from the mother’s detailed experiences that 
theory is generated.  
 
All mothers interviewed in the current study were only fully aware of the benefits 
of taking folic acid during the peri-conceptional period, when the spina bifida was 
detected in their baby. They both respected and thought GPs/midwives have a 
responsibility to inform them about folic acid benefits. However, many did not visit 
their GP until they were pregnant and, as indicated from previous research, GPs do 
not necessarily see it as their responsibility to provide pre-pregnancy advice. All 
mothers in the study had previous pregnancies before having their child with spina 
bifida and it was therefore theorised that even if health advice will not be able to 
help current pregnancies, it could help future ones. Targeting culturally sensitive 
education campaigns at the HPs themselves is a crucial first stage in ensuring 
information about the benefits of taking folic acid is more effectively communicated 
to mothers or mothers to be of South Asian ethnicity: Based on interviewees 
accounts, many HPs seemed to be unaware of the complexity of the condition and 
to broach the subject with little sensitivity in “diagnosis” rather than “prevention” 
mode.  
 
A sense of the “invisibility” of NTDs, due to the high prenatal detection and 
termination rate, impacting GPs/midwifes knowledge and sensitivity towards the 
condition, also seemed to impact the way HPs counselled mothers about their 
pregnancy choices when the condition was detected. Typically, HPs who didn’t 
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routinely see children with spina bifida, only gave a worst case picture and the 
emphasis was very much on termination. Some of the detailed consultations 
denoted a real lack of humanity. As neurosurgeons were described as giving a more 
positive view, it is recommended that the paediatric team work more closely with 
the fetal medicine team to ensure a more complete picture about potential outcomes 
for the condition is understood and communicated, in the right way. 
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7 Discussion 
 
 Why is an ethnic discrepancy in neural tube defect (NTD) prevalence 7.1
observed? 
 
In the introductory chapters to this doctoral thesis (Chapter 2 and Chapter 3), it was 
described how there is a lack of robust and up-to-date NTD prevalence estimates by 
maternal ethnicity in the U.K. and a general paucity of epidemiological research in 
this area. Therefore, a central research aim of this PhD was to calculate accurate and 
up-to-date NTD prevalence estimates by ethnicity and to explore the impact of key 
factors, such as socio-economic status. As detailed in Chapter 5, it was shown that 
mothers of Indian and Bangladeshi ethnicity have a statistically significantly higher 
NTD prevalence than mothers of White ethnicity. This was based on data from two 
congenital anomaly registers in the U.K: the East Midlands and South Yorkshire 
Congenital Anomalies Register (EMSYCAR) and the South West Congenital 
Anomaly Register (SWCAR) for the years 2006 to 2011 inclusive. The excess 
prevalence in Indian mothers was shown to be specifically for anencephaly affected 
pregnancies and in Bangladeshi mothers for spina bifida affected pregnancies. No 
excess was detected in Pakistani mothers, and this was not due to a small sample 
size. The region covered by EMSYCAR is much more ethnically diverse than that 
covered by SWCAR and thus, most of the NTD cases in Indian and Bangladeshi 
mothers are from the EMSYCAR register. Apart from the “Other” ethnic group, the 
highest proportion of births, in the region covered by EMSYCAR, are to mothers of 
Pakistani ethnicity after mothers of White ethnicity, and it is unclear why a similar 
NTD excess in Pakistani mothers is not observed. 
 
Variations in classifications systems for isolated and non-isolated NTDs can affect 
results, as discussed under limitations below. However, using only the EMSYCAR 
data, it was still indicated that the anencephaly prevalence discrepancy between 
mothers of Indian and White ethnicity was likely to be attributed more to an 
increase in non-isolated than isolated cases. This is important as it has been argued 
in the literature that non-isolated NTDs are aetiologically distinct from those that 
are isolated (11;45) and that the former are unlikely to decline with folic acid usage 
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(47).  From both preliminary explorations (Chapter 4) and explorations around 
ethnicity (Chapter 5) in the quantitative study key differences between non-isolated 
and isolated NTDs were indicated, even after taking NTD type into account. Folic 
acid usage couldn’t be explored in the quantitative research as discussed in more 
detail below. 
 
Both specifically a high rate of anencephaly affected pregnancies (55) and 
anencephaly affected pregnancies occurring in association with other defects (non-
isolated) (68) have been reported for Indian mothers in the literature. In fact, 
mothers of Indian ethnicity are a very interesting group when it comes to NTD 
prevalence and, as stated in the Introduction to this thesis (Chapter 2), a high NTD 
prevalence is observed in Indian mothers, regardless of where they reside (54). 
Early research in the U.K. found an increased congenital anomaly and perinatal 
mortality rate in mothers of Indian ethnicity in Birmingham (74) and mortality rates 
for stillbirth and infant deaths attributed to NTDs, throughout England and Wales, 
which were higher in Indian (and Bangladeshi) mothers (75). More recent research 
from the North Thames region (which includes London) found an increased NTD 
rate in mothers of Indian ethnicity (81) and this study found an increased 
prevalence in Indian mothers for the region covered by EMSYCAR and SWCAR.  
 
It has previously been reported that it is mainly in the North of India that a high 
NTD prevalence is observed, however, there have also been shown to be pockets of 
increased prevalence in the South (55;58). In the North, the marked NTD prevalence 
is particularly among the Sikh population but also among Hindus in certain areas 
(55). It was not possible to explore religion in the quantitative study for this PhD. 
However, the majority of Indian mothers with an NTD affected pregnancy in the 
study came from Leicester. The largest non-Christian religious group in Leicester is 
Hindu (202). Young and Clark in their analysis of lethal malformations and 
perinatal mortality in Leicestershire demonstrated that consanguinity is rare in Sikh 
and Hindu mothers (106). It was also reported in a study conducted in Birmingham 
that although the congenital anomaly and perinatal mortality rate was high in 
mothers of Indian ethnicity, the consanguinity rate was low (74). Therefore, 
although it was not possible to explore either religion or consanguinity in the 
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current dataset, it would not be expected that consanguinity would have a 
significant impact on the excess NTD prevalence to Indian mothers observed.  
 
For Bangladeshi mothers, consanguinity might have been a bigger contributory 
factor (and is discussed further below). There is little existing literature on NTD 
prevalence within Bangladeshi mothers. Only one study has described an excess of 
deaths due to NTDs in Bangladeshi mothers in the U.K (75), however, this study 
presents data for Indian and Bangladeshi mothers as a group and there are no data 
broken down by subgroup (75). Nevertheless, the World Health Organisation has 
reported that Bangladesh is one of the countries in South East Asia (in addition to 
Bhutan, DPR Korea, India and Nepal) with a particularly marked NTD prevalence 
(52) and therefore the NTD excess observed in the current study is not wholly 
unexpected. 
 
It was demonstrated in preliminary explorations in the quantitative study for this 
thesis that there is an excess NTD prevalence in younger mothers for isolated NTD 
cases and in older mothers for non-isolated (specifically chromosomal) cases. The 
addition of maternal age to the regression model was shown to have little impact on 
the observed association between ethnicity and NTD prevalence. This is in support 
of previous research that found that maternal age was not a significant factor in 
congenital anomaly risk for Indian mothers (74). 
 
It was also demonstrated in preliminary analyses that there was an excess NTD 
prevalence in mothers living in more deprived areas, specifically for isolated cases.  
It is known that there is a strong collinearity between maternal ethnicity and 
deprivation which to a certain extent impedes disentangling the complex 
relationship between the two factors. However, after adjustment for maternal 
deprivation, ethnicity remains an independent predictor of NTD prevalence. This 
further accentuates the importance of factors other than maternal deprivation in 
explaining observed discrepancies in NTD prevalence by maternal ethnicity.  
Moreover, the ESRC Centre on Dynamics of Ethnicity (CoDE) briefing, based on the 
2011 Census,  reported that those of Indian (and White Irish) ethnicity live in the 
least deprived neighbourhoods of all ethnic minority groups (155).  
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7.1.1 Quantitative Study Limitations 
 
7.1.1.1 Classification systems 
 
The ONS 2001 census classification on which the ethnic groupings in this study are 
based are quite broad and may not capture relevant aspects of ethnicity associated 
with the aetiology of NTDs. As described as part of the justification for using mixed 
methodology in this study in Chapter 3, ethnic categories will always be socially 
determined, with classifications changing over time, depending on the social or 
political contexts (111).  Ethnic groupings also fail to take into account crucial 
cultural factors. However, a critical aim in this thesis, further enabled through the 
qualitative research, was to investigate the ethnocultural factors influencing why a 
particular difference was observed, including a consideration of the impact of socio-
economic factors, which are often under reported.  
 
As detailed in Chapter 5, for NTD prevalence calculations by ethnicity, in the 
numerator (BINOCAR data) it is ethnicity of mother and in the denominator (ONS 
data) it is ethnicity of the baby. Although there is shown to be strong agreement 
between the two (152;153), this is definitely a limitation of the data that was 
available for the analysis. 
 
Investigations in Chapter 5 emphasised that differences between coding systems 
designating whether an NTD is isolated or not become apparent when groups in 
analyses start to become small, for example in analyses involving ethnicity.  
Therefore, although for preliminary explorations for the quantitative study, 
analyses stratified by whether the NTD was isolated or not produced reliable 
outcomes, when looking at ethnicity, outcomes had to be interpreted with caution 
and analyses were more restrictive.  
 
7.1.1.2 Ethnicity completeness 
 
Analyses of NTD prevalence in relation to ethnicity could only be conducted using 
EMSYCAR and SWCAR due to a high proportion of missing ethnicity data in the 
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other registers and indications of bias or imprecision that would be introduced into 
analyses if missing data were simply ignored (Chapter 5). As detailed in chapter 5, 
ethnicity should be recorded somewhere in the patient’s notes. However, if it is 
difficult to find, it might not be reported to the register. SWCAR retrospectively 
completed all their ethnicity data using patient notes and they had the most 
complete ethnicity data of all the registers, although there will always still be a 
proportion with not stated/not known ethnicity. It would have been important to 
explore whether an ethnic discrepancy was observed in Bangladeshi mothers in  
regions other than those covered by EMSYCAR and SWCAR in the U.K, as this was 
more unexpected (based on the literature) than the observed excess in Indian 
mothers in this study. It also would have been interesting to see whether an NTD 
excess was observed in Pakistani mothers for other geographical regions as an 
increased NTD prevalence in mothers from this ethnic group has been reported in 
regions including London (80;81) and the West Midlands (82), whereas this was not 
detected using data from EMSYCAR and SWCAR.  
 
7.1.1.3 Lack of routine data on important co-factors 
 
Folic acid usage couldn’t be explored in the quantitative study as it was poorly and 
imprecisely recorded in the BINOCAR dataset. This is both due to inaccuracies 
during the data extraction process (144) and a high proportion of missing data in 
the computerised and paper prenatal records themselves. The lack of such data in 
routine records is a barrier to understanding the role and impact of folic acid use in 
the U.K in preventing NTDs.  However, maternal deprivation, which seemed to 
have little attenuating effect on the observed association between ethnicity and 
NTD prevalence, has been described as being highly correlated with folic acid usage 
in the literature (101). It was also observed in preliminary analyses (Chapter 4) 
conducted before the main analyses centred around ethnicity, that there was no 
discrepancy in NTD prevalence by maternal deprivation for non-isolated NTD 
cases. Therefore, adjusting for folic acid use in the regression model exploring the 
association between ethnicity and NTD prevalence might have had little impact. 
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Dietary habits, specifically vegetarianism, could not be explored in the study. 
However, it has been reported that in the North of India there is an increased risk of 
NTDs in Hindu mothers who follow a vegetarian diet (63) and this could have been 
a contributory factor in the study. 
 
As described in Chapter 4, it was not possible to explore NTD recurrence in the 
quantitative study, which is a limitation of the current research as the recurrence 
risk is higher than the first time risk for NTDs (10). This could have been of 
particular consequence for mothers of Indian ethnicity due to the high NTD 
recurrence rate in India that has been reported in the literature (62). However, it is 
unlikely to have had a major attenuating effect on the observed NTD prevalence 
excess observed in Indian mothers. 
 
Again, detailed in the preliminary explorations for the quantitative study (Chapter 
4), maternal body mass index (BMI) was only recorded well within NorCAS where 
there were indications that there were an excess of NTD cases for mothers who 
were obese (in accordance with the literature (44)). Maternal BMI would be 
recorded in all prenatal records, however it was only NorCAS that was routinely 
collecting this information for all data years included in the study (2006 to 2011). It 
is a limitation of the current study that the impact of maternal BMI on the 
association between ethnicity and NTD prevalence, could not be explored, 
particularly as obesity levels have been shown to be high in certain ethnic groups 
(84) and the risk of having an NTD affected pregnancy is increased in women who 
are obese (140). However, it is argued that BMI is not always a good measure of 
body fat composition and that mothers of South Asian ethnic origin are more likely 
to have a higher body fat composition than mothers of African ethnic origin for the 
same BMI level (84). 
 
Finally, information on consanguinity could not be collected. This is unlikely to be a 
significant factor for Indian mothers but could influence risk for mothers of 
Bangladeshi ethnicity. In the literature, the importance of consanguinity as a risk 
factor for NTD prevalence in Pakistani mothers has been described (77) and it is 
arguable that this is likely to also be the case for other populations that are 
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predominantly Muslim and who favour first-cousin marriages, such as individuals 
of Bangladeshi ethnicity (203). 
 
7.1.1.4 No congenital anomaly data for London 
 
There was no congenital anomaly register covering any part of London, which has 
significant ethnic and socio-economic diversity. Such data would therefore have 
contributed invaluable information to the analysis. 
 
7.1.2 Conclusions 
 
Based on data from EMSYCAR and SWCAR, including TOPFA cases, with a 
denominator of over half a million births, robust NTD prevalence estimates by 
ethnicity were calculated. The increased NTD prevalence in Indian mothers was 
shown to be specifically for anencephaly affected pregnancies and in Bangladeshi 
mothers for spina bifida affected pregnancies, when compared to mothers of White 
ethnicity. Looking solely at the EMSYCAR data, it was also indicated that the 
anencephaly prevalence discrepancy for Indian and White mothers was likely to be 
attributed more to an increase in non-isolated than isolated cases, which is strongly 
indicative of the involvement of genetic factors. The persistently high NTD 
prevalence in the Indian population, regardless of where they reside, also points 
towards genetics. Although in analyses stratified by whether the NTD was isolated 
or not, numbers became very small for Bangladeshi mothers and no conclusions 
could be drawn, the likely importance of consanguinity for Bangladeshi mothers, 
also suggests the involvement of genetic factors. 
 
Mothers of Indian ethnicity retain their high NTD prevalence wherever they reside 
and previous research in the U.K has reported an increased NTD prevalence in 
mothers from this ethnic group in several geographical areas, therefore it would be 
expected that the excess NTD prevalence observed in Indian mothers in this study 
would be applicable beyond the geographical area studied. For Bangladeshi 
mothers, the findings would be extrapolated to other geographical areas with more 
caution, although it is possible that it is due to small sample sizes and lower 
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precision of estimates that a specific excess in mothers from this ethnic group has 
not been more commonly described in previous studies. An excess NTD prevalence 
in Pakistani mothers was not observed in this study but has been described in 
studies conducted in other regions of the U.K. This could indicate that there is 
geographical variation in NTD prevalence for certain ethnic groups. 
 
Despite the absence of data on dietary habits and folic acid use, it would be unlikely 
that they would be able to explain entirely ethnic discrepancies in NTD prevalence 
observed. For folic acid use, this is further reinforced by there being little change to 
the observed association between ethnicity and NTD prevalence, when maternal 
deprivation is taken into account. The latter observation also highlights the critical 
importance of looking at maternal deprivation when exploring ethnicity in 
epidemiological research, but also the value of including ethnicity as an 
independent variable, beyond a consideration of socio-economic factors. 
  
 What are the best prevention strategies for NTDs in ethnic 7.2
communities? 
 
Increasing folic acid use is a highly effective NTD prevention strategy and it is 
estimated that folic acid can prevent between 50 and 70% of NTDs (15). It has been 
described how pre-conceptional folic acid use is low in mothers of non-White 
ethnicity, with indications that this was particularly true for mothers of South Asian 
ethnicity, when compared to mothers of White ethnicity. However, use is still low 
within White mothers (22;103). Therefore, all populations are seriously lacking in 
suitable folic acid supplementation and increasing its usage would have a beneficial 
effect in all groups, including ethnic groups with a high NTD prevalence, even if it 
is not a key reason for the ethnic discrepancy observed.  
 
The qualitative research was conducted with South Asian mothers, in whom an 
NTD prevalence excess has been described in this thesis and previously. Two 
Indian mothers, four Bangladeshi mothers and two Pakistani mothers who had a 
child with spina bifida were interviewed.  Four out of the eight mothers reported 
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that had taken folic acid before pregnancy. However, two of the mothers were 
taking folic acid routinely for a vitamin absorption problem. 
 
The qualitative study enabled explorations that went beyond a simple 
quantification of whether South Asian mothers took folic acid or not to gaining in-
depth information about why they might not have adequate knowledge of 
supplementation and how both folic acid knowledge and use can best be improved. 
The qualitative research emphasised that although it is important to give 
information about the benefits of taking folic acid before pregnancy, there are also 
benefits in providing such information during pregnancy as this could help to 
protect a future pregnancy. This was particularly striking as all mothers 
interviewed had a previous pregnancy before their NTD affected pregnancy and 
there was a strong sense of earlier pregnancies setting norms for later ones.  It was 
emphasised that GPs or other health professionals (HPs) giving advice on prenatal 
prevention was likely to have the greatest impact as South Asian mothers said that 
they both respected and thought their GP/midwife had a responsibility to provide 
this information. Therefore, it is argued that a culturally sensitive education 
campaign should be targeted at HPs to first improve their understanding about 
NTD prevention, including key situational factors that need to be taken into account 
and misconceptions that need to be addressed (based on responses from 
interviewees). This would be a crucial first stage in increasing knowledge and use of 
folic acid among women from minority ethnic groups, in particular those with high 
rates of NTDs or congenital anomalies. 
 
In the discussion of findings for the qualitative research in Chapter 6 the difficulty 
of the routine of tablet taking was emphasised. It was also detailed that it cannot be 
assumed that mothers who have not had an NTD affected pregnancy will take folic 
acid when aware of its benefits based on the fact that all mothers interviewed in the 
study took folic acid for subsequent pregnancies after having a child with spina 
bifida.  
 
As detailed in Chapter 2, four out of the five studies included in the systematic 
review conducted in the early stages of this doctoral thesis, exploring knowledge 
and peri-conceptional use of folic acid by women from different ethnic communities 
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in the U.K, argued that fortification of food with folic acid is the most effective 
method to improve folate intake (22).A study by Morris and colleagues (204) using 
congenital anomaly data from England and Wales found that if mandatory 
fortification had been adopted between 1998 and 2012 in the U.K at the same level 
as in the USA, 2014 fewer pregnancies would have been affected by an NTD. This 
equates to an approximately 21% reduction in NTD prevalence (204).  
 
It is therefore very strongly recommended that in addition to the targeting of 
culturally sensitive education campaigns at HPs in order to improve their 
understanding of NTDs that, as a matter of urgency, a mandatory fortification 
policy be implemented in the U.K, including the fortification of ethnic minority 
foods. The reality of the situation in the U.K, as described in Morris and Wald’s 
earlier study, published in 2007, that there has been little change in NTD prevalence 
since the late 1980s (32) when compared to the projected impact on prevalence if 
mandatory fortification had been introduced, as detailed in Morris and colleagues 
recent study (204), is stark and shocking. Mandatory fortification is both a safe and 
cost effective method to increase folic acid intake and it is argued that it is a public 
health failure that it has not been implemented in the U.K (204). 
 
7.2.1 Qualitative study limitations 
 
This study was targeted at mothers of South Asian ethnicity with a previous NTD 
affected pregnancy, however, only mothers of children living with spina bifida 
came forward to be interviewed, as described, due to women mainly being 
recruited through Great Ormond Street Children’s Hospital (GOSH). In particular, 
no mothers of Indian ethnicity with a previous anencephaly affected pregnancy 
were interviewed. However, it should be kept in mind that this was a qualitative 
study that was not intended to be representative of all NTD subtypes but rather to 
explore in-depth the pregnancy experiences and decisions of mothers with affected 
babies. 
 
It was stated on the participant information sheet that pre-pregnancy knowledge, 
attitudes and health behaviour would be explored and folic acid wasn’t specifically 
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mentioned as several factors were explored. However, when asked what the term 
pre-pregnancy means to them, all mothers spoke about folic acid. Therefore, 
knowing that folic acid knowledge and use was something that was likely to be 
discussed, could have affected how women recalled information about this in the 
interview. It is also of importance to note that although for the majority of mothers 
interviewed, their child who had spina bifida was a baby or a young child, for two 
interviewees the children were older. The time since their pregnancy with their 
child could have affected recall. However, due to this being a very difficult and 
distressing time for all interviewees, the memory of that time period seemed to be 
very clear and vivid. A further important final consideration is how an individual’s 
current situation might have affected the interpretation of previous events. All 
women interviewed had a child living with spina bifida who they loved very much 
and any previous discussions around termination might have seemed all the more 
horrifying because of this. However, specific details of previous conversations 
around termination still, in some cases, clearly denoted a lack of respect for the 
mother’s decision to continue the pregnancy. 
 
7.2.2 Conclusions 
 
At the end of the systematic review conducted in the early stages of this doctoral 
thesis it was argued that innovative education campaigns should be targeted at 
ethnic communities to improve folic acid use together with a mandatory 
fortification policy. Based on in-depth interviews with mothers of South Asian 
ethnicity with a previous NTD affected pregnancy, this recommendation is altered 
slightly to argue for the targeting of culturally sensitive education campaigns at 
HPs, as these are the individuals from whom women are willing to receive 
information. The recommendation for mandatory fortification still remains. 
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 Why do women decide to continue a spina bifida affected pregnancy 7.3
and how can we ensure it is a fully informed decision 
 
As detailed in Chapter 5, it was shown that mothers of Pakistani and Black African 
ethnicity were statistically significantly less likely to terminate an NTD affected 
pregnancy than mothers of White ethnicity using data from EMSYCAR and 
SWCAR. It has previously been reported in the literature how mothers of Pakistani 
ethnicity are less likely to terminate a pregnancy affected by a congenital anomaly 
than White mothers (92). Also in line with previous research around termination of 
pregnancy for fetal anomaly (TOPFA) for congenital anomalies in general (92), it 
was shown that mothers living in less deprived areas and mothers in which the 
condition is detected earlier are more likely to terminate an NTD affected 
pregnancy. There was also some evidence that TOPFA was less likely in younger 
mothers. However, even after adjustment for all of these factors, an ethnic 
difference in TOPFA rates in the quantitative study was still detected. Ethnic 
differences in TOPFA rates identified are important, however, it is of critical 
importance not to make assumptions beyond the data at hand. One of the mothers 
of South Asian ethnicity in the qualitative study described how a HP counselling 
her automatically assumed she was deciding to continue her pregnancy for 
religious reasons, whereas she stated that in fact she continued because she already 
loved her baby.  
 
Ahmed and colleagues described how the perceived severity of the 
condition/quality of life of the child is the most important factor when deciding 
whether to continue a pregnancy affected by a fetal anomaly or not. They therefore 
argued that there is a real need to move away from stereotypical views based on 
faith and ethnicity, towards looking at the beliefs of individuals (162;163). Ensuring 
a distinction is drawn between perceived severity and actual severity is critical. 
Looking at the quantitative data, the fact that it was specifically for spina bifida (and 
not anencephaly) affected pregnancies that there was an ethnic discrepancy in 
TOPFA rates, could lead to the argument that severity of the NTD is a key factor 
affecting a mothers decision of whether to continue the pregnancy or not. However, 
looking more closely at the data, this argument is inadequate. Although not 
statistically significant, Black African mothers had TOPFA rates of a similar 
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magnitude lower than White mothers for both spina bifida and anencephaly 
affected pregnancies and again, although not statistically significant, the effect size 
for Pakistani mothers in the anencephaly model was also quite strong. Moreover, 
looking at overall TOPFA rates for anencephaly and spina bifida affected 
pregnancies in the BINOCAR dataset, although 90% of anencephaly affected 
pregnancies are terminated, there are still 79% of spina bifida affected pregnancies 
(the less severe phenotype) that are terminated. 
 
The inadequacy of looking at severity of the condition and importance of looking at 
perceived severity of the condition, in a consideration of the factors affecting a 
decision of whether to continue a spina bifida affected pregnancy or not, was 
strongly accentuated through the qualitative research. South Asian mothers who 
were interviewed described how the picture they got of spina bifida was often bleak 
and didn’t emphasise that the prognosis for the condition is actually quite varied. It 
was typically those HPs who do not routinely see children living with spina bifida 
that were described as giving a one-sided view and they were also perceived as 
driving TOPFA quite strongly. It was for this reason that it was argued that the 
invisibility of NTDs could be affecting HPs perceptions of the condition, which is 
something which was also evident in explorations around how and when HPs give 
information about folic acid in the earlier part of the qualitative research. To ensure 
that mothers are able to make a fully informed decision about whether to continue 
their spina bifida affected pregnancy or not, it was therefore recommended that 
those who routinely see children with spina bifida work more closely with those 
who counsel women about the condition but only rarely see affected children, to 
increase both their understanding and sensitivity towards it.  
 
7.3.1 Conclusions 
 
The quantitative research for this thesis was important for highlighting an ethnic 
discrepancy in TOPFA rates for spina bifida affected pregnancies, even after taking 
into account gestational age at discovery and maternal deprivation. However, it is 
important to be cautious when interpreting the results and not taking the 
interpretation beyond the data at hand i.e. assuming that religion is an important 
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factor because of the ethnic difference. This was accentuated through the qualitative 
research and has also been described previously (162;163). Moreover, indicators in 
the quantitative research that severity of condition was inadequate in explaining 
differences in outcomes for anencephaly and spina bifida affected, was further 
developed in the qualitative research which accentuated the critical importance of 
perceived severity. Based on detailed accounts, mothers seem to be given a worst 
case picture of spina bifida as how things will be, rather than as a possible outcome 
by HPs who do not routinely see children with spina bifida. Therefore, it is 
recommended that the prenatal team counselling mothers when a fetal anomaly is 
detected work more closely with the clinical teams who care for children with NTDs 
to ensure mothers are given a more balanced picture from the outset in order to be 
able to make a fully informed decision.  
 
 Appropriateness of using mixed methodology 7.4
 
The outcomes of this doctoral thesis have accentuated the appropriateness of using 
mixed methodology (both quantitative and qualitative) as opposed to solely 
quantitative or qualitative methods to address the research questions. Through the 
quantitative study it was possible to calculate robust NTD prevalence estimates for 
different ethnic groups with a clear indication of the involvement of genetic factors 
in explaining the difference. However, it was only through the qualitative study 
that in-depth information could be obtained to understand the views, knowledge, 
behaviour and attitudes of ethnic groups where a high NTD prevalence has been 
described, before and during their pregnancy affected by an NTD. This enabled a 
clear, informed prevention strategy to be recommended surrounding the best 
prevention tool for NTDs that we have: folic acid supplementation. 
 
Moreover, the integration of qualitative and quantitative components for the 
research exploring women’s decisions to continue an NTD affected pregnancy or 
not, were very revealing and essential to more fully understand the complexity of 
the issue. The ethnic discrepancy in TOPFA rates reported in the quantitative study 
identified important differences, however, the in-depth interviews accentuated that 
there was a need to look beyond simple categories of ethnicity to understand what 
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these represent.  Individuals’ detailed experiences constantly challenged a view 
which it is very easy adhere to without being consciously aware, of ethnic 
distinctions as natural and unchanging. Particularly with regards to the question 
around pregnancy decisions, findings from the qualitative study brought a different 
perspective to the results from the quantitative study and affected interpretation as 
the quantitative study, to a certain extent, affected the focus of the qualitative 
research. 
 
The decision was made to focus on mothers of South Asian ethnicity in the 
qualitative research due to an increased NTD prevalence (Indian and Bangladeshi) 
and lower TOPFA rates (Pakistani) in mothers from this ethnic grouping found in 
the quantitative research (as well as the excess NTD prevalence for Pakistani 
mothers described in the literature). This meant that specific cultural factors could 
be explored and culturally sensitive recommendations proposed to form part of an 
NTD prevention strategy. It also meant that no restrictions needed to be placed 
based on language and that no-one needed to be excluded because on this, which 
could have biased who was interviewed. However, it did mean that the number of 
women interviewed was relatively small and recruitment took place over several 
months. It also meant that the views of women from other ethnic communities 
could not be represented, for example, in the quantitative analysis it was found that 
mothers of Black African ethnicity had low TOPFA rates yet their views could not 
be explored within the scope of this thesis. 
 
 Implications for practice and prevention 7.5
 
The identified problems of using existing coding systems for exploring isolated and 
non-isolated congenital anomalies in analyses, accentuates the need for an 
aetiological-based coding system that is more robust. EUROCAT’s multiple 
congenital anomaly algorithm is an effective and replicable tool for categorising 
congenital anomaly cases that could be implemented across all registers. However, 
it needs further refinement with a greater emphasis on the recording and classifying 
of multiple malformations, before it can be used with confidence in all 
epidemiological analyses. 
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It is also of critical importance that information governance processes for key data 
providers, such as ONS and HES, are more seamless and transparent for 
researchers. Section 251 approval was obtained for the PhD research to enable 
linkage between the HES and ONS data, which was of particular importance in 
matching baby’s ethnicity to mother’s ethnicity. However, due to information 
governance changes, no data could be obtained in the study time frame, which 
spanned several years. This is something that really needs to be addressed to ensure 
that the best possible data are used for analysis. 
 
As shown by the missing ethnicity data, BMI data being only available for one 
register and folic acid usage data that was poorly and imprecisely recorded, there is 
significant room for improving reporting to registers. This is important not only for 
in-depth epidemiological studies but also for routine monitoring. Implementation 
of the new National Congenital Anomaly and Rare Disease Registration Service 
(NCARDRS) began in April 2015 and could help to harmonise reporting across all 
geographical areas. Also, the fact that the NCARDRS will cover the whole of 
England, will mean that London data will also be included. However, the rigorous, 
multi-source reporting to registers that has been built up over several years and 
through the hard work of many individuals is not something that it will be easy to 
replicate overnight at a national scale. Therefore, the quality of data output could 
actually be diminished in the early stages of the national registration service being 
implemented. 
 
Looking to prevention, it is proposed based on the responses of interviewees in the 
qualitative research that culturally sensitive education campaigns should be 
targeted at HPs to ensure they have adequate understanding of the complexity of 
NTDs and can relay information effectively to mothers from ethnic communities 
about the benefits of folic acid. However, considerations also need to be given to 
gaining funding for such an initiative and the allocation of time for GPs, who have 
busy schedules, for the different sessions. 
 
It is also recommended that the fetal medicine team work more closely with the 
neurosurgical team to ensure the former have adequate understanding about spina 
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bifida and give a balanced picture about prognosis when counselling families. This 
is not an untested recommendation and has actually been shown to be highly 
effective in Leicester (201). There seems to be a real need, particularly in London 
based on the responses of the interviewees, to strongly consider this setup. 
 
 Further research 7.6
 
As the impact of obesity on the observed association between ethnicity and NTD 
prevalence could not be explored in the quantitative study, this would be an 
important area for future research.  This is of particular importance due to the 
described association between obesity and NTD prevalence and the fact that obesity 
levels have been found to be high in mothers from certain ethnic communities (84). 
 
It would also be important to conduct the study in other geographical areas of the 
U.K. to explore whether an excess in NTD prevalence for the same ethnic groups is 
observed. This might be possible using NCARDRS data once this system is well-
established. 
 
There is also a real need to better characterise the non-isolated NTDs in Indian 
mothers, where a clear excess is indicated. This includes gene studies to explore 
genetic causation. This research is a crucial first stage before being able to 
implement effective prevention strategies for this particular malformation type. 
 
As described, only South Asian mothers of children with spina bifida were 
interviewed in the qualitative study. There are a number of broader hard-to-reach 
groups whose views would contribute to a better understanding of women’s 
decisions during pregnancy and so to the prevention and management of NTDs. 
These include bereaved mothers and women who decided to terminate the 
pregnancy (including mothers who have an anencephaly affected pregnancy). It 
also would be of importance to explore the views of women from other 
cultural/ethnic groups.  
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 Summary 7.7
 
The described increased NTD prevalence in mothers of Indian (anencephaly) and 
Bangladeshi (spina bifida) ethnicity when compared to mothers of White ethnicity, 
with an indication that the difference is more marked for non-isolated NTDs in 
Indian mothers, is strongly indicative of the involvement of genetic factors. 
However, increasing folic acid supplementation in all populations for NTD 
prevention is essential and a crucial first stage in increasing knowledge and use 
among South Asian mothers, where supplementation seems to be worryingly low, 
is by targeting a culturally sensitive campaign at HPs. Increasing understanding 
among HPs about spina bifida, a largely invisible condition due to the high TOPFA 
rate, in particular is also of critical importance to ensure HPs give a balanced view 
about the condition when counselling mothers about their pregnancy choices. 
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10 Appendix C 
 
Table C 1: Proportion of mothers in the NTD NorCAS dataset falling into the different 
BMI categories, by NTD subtype and excluding missing cases 
Maternal BMI group Anencephaly (%) Spina Bifida (%) Total (%) 
Underweight 2.47 1.72 2.26 
Normal 41.98 48.28 44.8 
Overweight 29.63 24.14 26.70 
Obese 25.93 25.86 26.24 
Total 100 100 100 
 
Table C 2: Proportion of mothers in the NTD NorCAS dataset falling into the different 
BMI categories, broken down by whether the NTD is isolated or not and excluding 
missing cases 
Maternal BMI group Isolated (%) Non-Isolated (%) 
Underweight 2.78 0 
Normal 43.89 48.78 
Overweight 27.78 21.95 
Obese 25.56 29.27 
Total 100 100 
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11 Appendix D 
 
Table D 1: ONS 2001 Census Ethnic grouping 
Ethnic group 
Level 1 Level 2 
White 
White British  
Irish  
Other White background  
All white groups 
Mixed 
White and Black Caribbean  
White and Black African  
White and Asian  
Other mixed background 
Asian or Asian British 
Indian  
Pakistani  
Bangladeshi  
Other Asian background  
All Asian groups 
Black or Black British 
Caribbean  
African  
Other Black background  
All Black groups 
Chinese or Other Ethnic Groups 
Chinese  
Other ethnic group  
All Chinese or Other groups 
All ethnic groups All ethnic groups 
Source: ONS, 2014 (205)  
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Figure D 1: Proportion of isolated and non-isolated NTD affected pregnancies within 
each register 
 
Table D 2: Proportion of births falling into the different deprivation quintiles for Indian 
and Bangladeshi mothers in EMSYCAR 
Deprivation quintile (IMD) 
% births (95% CI) 
Indian Bangladeshi 
1 27.20 (26.31-28.10) 56.83 (54.53-59.11) 
2 28.99 (28.08-29.92) 25.48 (23.50-27.53) 
3 14.77 (14.06-15.50) 8.55 (7.31-9.92) 
4 13.79 (13.11-14.50) 5.50 (4.50-6.64) 
5 15.24 (14.53-15.98) 3.65 (2.84-4.61) 
 
Table D 3: Proportion of births falling into the different deprivation quintiles for Indian 
and Bangladeshi mothers in NorCAS 
Deprivation quintile (IMD) 
% births (95% CI) 
Indian Bangladeshi 
1 35.66 (33.40-37.96) 55.55 (53.00-58.07) 
2 23.85 (21.86-25.92) 28.47 (26.21-30.81) 
3 12.33 (10.82-13.97) 7.40 (6.13-8.83) 
4 10.71 (9.30-12.26) 4.36 (3.39-5.51) 
5 17.45 (15.70-19.32) 4.23 (3.27-5.37) 
 
Table D 4: Proportion of births falling into the different deprivation quintiles for Indian 
and Bangladeshi mothers in CAROBB 
Deprivation quintile (IMD) 
% births (95% CI) 
Indian Bangladeshi 
1 6.26 (5.70-6.85) 15.71 (13.55-18.06) 
2 27.53 (26.49-28.59) 37.26 (34.32-40.27) 
0
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40
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70
80
90
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3 25.74 (24.72-26.77) 22.41 (19.92-25.07) 
4 16.66 (15.80-17.56) 10.25 (8.48-12.25) 
5 23.82 (22.82-24.83) 14.37 (12.30-16.64) 
 
Table D 5: Proportion of births falling into the different deprivation quintiles for Indian 
and Bangladeshi mothers in SWCAR 
Deprivation quintile (IMD) 
% births (95% CI) 
Indian Bangladeshi 
1 27.22 (25.53-28.97) 29.17 (25.81-32.70) 
2 26.88 (25.20-28.62) 21.55 (18.55-24.80) 
3 19.96 (18.45-21.54) 20.69 (17.74-23.89) 
4 12.55 (11.30-13.87) 16.09 (13.44-19.04) 
5 13.38 (12.11-14.75) 12.50 (10.13-15.19) 
 
 
Table D 6: Proportion of births falling into the different deprivation quintiles for Indian 
and Bangladeshi mothers in CARIS 
Welsh Deprivation quintile (WIMD) 
% births (95% CI) 
Indian Bangladeshi 
1 29.67 (27.66-31.75) 52.97 (50.17-55.75) 
2 20.63 (18.86-22.49) 20.27 (18.08-22.59) 
3 14.23 (12.71-15.85) 12.35 (10.59-14.29) 
4 13.01 (11.55-14.57) 6.73 (5.41-8.25) 
5 22.46 (20.63-24.37) 7.68 (6.27-9.29) 
 
Table D 7: Binomial regression model to explore the association between ethnicity and 
NTD prevalence, adjusted for IMD quintile and maternal age, with multiples removed 
Variable Adjusted PRR 95% CI P-value 
White (ref)     
0.009 
Indian 1.87 1.25-2.79 
Pakistani 1.19 0.72-1.96 
Bangladeshi 3.02 1.56-5.84 
Black Caribbean 1.17 0.48-2.82 
Black African 1.10 0.65-1.88 
Other ethnic group 0.45 0.29-0.69 
IMD quintile 1 (ref)     
0.000 
IMD quintile 2 0.88 0.72-1.09 
IMD quintile 3 0.72 0.57-0.90 
IMD quintile 4 0.71 0.56-0.90 
IMD quintile 5 0.70 0.55-0.90 
25-29 (ref)     
0.681 
<20 1.35 1.01-1.80 
20-24 1.04 0.84-1.30 
30-34 1.05 0.85-1.29 
35-39 1.22 0.97-1.55 
40+ 1.20 0.79-1.81 
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Table D 8: Logistic regression model, with multiple pregnancies removed, exploring the 
association between maternal ethnicity and whether the NTD affected pregnancy is 
terminated or not, adjusted for NTD type; maternal age; age, in weeks, at which the NTD 
is discovered and deprivation of maternal residence 
 
Termination Adjusted Odds Ratio 95% CI P-value Overall p-value 
White (ref)       
0.003 
Indian 1.16 0.27-4.95 0.837 
Pakistani 0.13 0.04-0.43 0.001 
Bangladeshi 0.53 0.10-2.94 0.469 
Black Caribbean 0.15 0.02-1.51 0.108 
Black African 0.11 0.03-0.40 0.001 
Other ethnic group 0.75 0.18-3.13 0.694 
Spina bifida (ref)       
0.367 Anencephaly 1.33 0.70-2.54 0.391 
Encephalocele 0.85 0.37-1.95 0.706 
25-29 (ref)       
0.343 
<20 1.30 0.46-3.69 0.625 
20-24 0.50 0.25-1.00 0.051 
30-34 1.06 0.51-2.21 0.877 
35-39 1.19 0.49-2.91 0.698 
40+ 1.08 0.21-5.67 0.926 
Age, in weeks, at discovery 0.80 0.74-0.86 <0.001 <0.001 
IMD quintile 1 (ref)       
0.001 
IMD quintile 2 1.57 0.80-3.10 0.191 
IMD quintile 3 1.29 0.64-2.63 0.479 
IMD quintile 4 2.52 1.06-6.02 0.037 
IMD quintile 5 3.16 1.02-9.80 0.046 
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12 Appendix E 
 
 
 
 
 
 
 
 
 
 
                                 
Birth Defects Research 
Centre 
              UCL Institute of Child Health  
    30 Guilford Street 
              London  
              WC1N 1EH 
 
 
 
 
Prevention of neural tube defects (NTDs) in ethnic 
communities (student research project) 
 
Participant Information Sheet 
 
We would like to invite you to take part in our study which is being supported by 
Dominic Thompson, Consultant Paediatric Neurosurgeon and Clinical Lead and 
Lindy May, Neurosurgical Nurse Consultant at Great Ormond Street Hospital. 
Before you decide we would like you to understand why the research is being 
done and what it would involve for you. You can talk to others about the study if 
you wish and you can take as long as you like to decide whether to take part or 
not. 
 
What is the purpose of the study? 
The study is being carried out, as part of a PhD, to explore the pre-pregnancy 
knowledge, attitudes and health behaviour of women from different ethnic 
communities with a previous neural tube defect (NTD) affected pregnancy.  
 
Why have I been invited to take part? 
This study has been advertised through Great Ormond Street Hospital, 
specialist organisations such as SHINE, community and faith-based 
organisations and through social media to recruit women of Bangladeshi, 
Pakistani or Indian ethnicity who have previously had an NTD affected 
pregnancy, and are happy to be interviewed, about their pre-pregnancy views 
and practices. 
 
Do I have to take part? 
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No. Your participation in the study is entirely voluntary and you are free to 
withdraw from the study at any time. If you decide you do not want to be 
interviewed, or you want to stop the interview part way through you are 
completely free to do so without giving a reason and this will not affect the usual 
standard of care you receive in any way. 
 
 
What will happen to me if I take part? 
Before the interview we will discuss the study with you and answer any 
questions you may have.  If you are happy to take part, we will ask you to sign a 
consent form agreeing to take part in the interview. The interview should last 
about 45 minutes and tea, coffee and biscuits will be provided during this time. We 
would like to record the interview so we have an accurate record of what you tell 
us. The recording will be transcribed and anonymised and then the data will be 
analysed by the study lead.   
 
Expenses and payments 
You will not be paid for taking part in the study but all your travel expenses will 
be reimbursed to you. 
 
What are the possible benefits of taking part? 
It is hoped that findings of the study will provide us with a better understanding 
of potential barriers to NTD prevention in ethnic groups at high risk, and how we 
can overcome them. This will enable us to generate new information that will 
lead to the development of future studies of preventive pre-pregnancy 
interventions and to target NTD prevention interventions to promote the health of 
women and their children. 
 
What are the disadvantages of taking part? 
45 minutes will need to be set aside to complete the interview. However, the 
interview will be conducted at your convenience. Some women may find it 
distressing to discuss pre-pregnancy knowledge and health behaviour when 
they have previously had an NTD affected pregnancy. Remember that you don’t 
have to answer any questions that you don’t want to and are free to withdraw 
from the study at any point without giving a reason and this will not affect your 
normal care.  If you feel you need someone to talk to after the interview process, 
support is available. 
 
Will my participation in the study be confidential? 
Yes. Any information provided by you will be kept strictly confidential. Only those 
at UCL directly involved in the study will have access to any personal details or 
contact details you provide as part of the study, and these will be locked in a 
filing cabinet in a securely locked office environment at UCL. If any of the 
information you have contributed to the study is presented in project reports, 
publications and in the PhD thesis, it will have all identifiers removed to ensure 
you remain anonymous. 
 
Who is funding the research? 
The study is being funded by the UCL Grand Challenges Scheme studentships. 
 
Who has reviewed the study? 
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The study has been reviewed by the NHS Research Ethics Committee—London 
Central. The reference for this study is 12/LO/0890. 
 
What if there is a problem? 
Should you have any complaints about the way in which the study is being 
conducted or you have any queries please discuss with Jordana Peake who is 
leading the study (contact details below). 
 
You can get independent advice from a Hospital’s PALS team and further 
information about NTDs, such as spina bifida, and the support services available 
from SHINE (all contact details are below). 
 
Thank you for taking the time to read this information.  If you are satisfied that 
you understand what the study involves and wish to participate we will now ask 
you to complete the consent form. 
 
 
 
 
 
Contact information 
Study lead:  Jordana Peake 
Institute of Child Health Tel: 020 7905 2612 
Email: j.peake@ucl.ac.uk 
Mobile: 07792113211 
 
 
 
Independent Advice: Patient advice and liaison service (PALS) 
University College London Hospital 
Tel: 020 7691 5834 Email: PALS@uclh.nhs.uk 
 
Great Ormond Street Hospital 
Tel: 020 7829 7862 Email: pals@gosh.nhs.uk  
 
Central Manchester University Hospitals 
Tel: 0161 276 8686 Email: pals@cmft.nhs.uk  
 
SHINE 
Tel: 01733 555988 Email: info@shinechairty.org.uk 
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UCL Project number: 11/054 Patient Identification 
Number 
REC Ref: 12/LO/0890  
 
 
 
Prevention of neural tube defects (NTDs) in ethnic 
communities 
(Student research project) 
 
INTERVIEW CONSENT FORM 
 
Name of Principal Investigator: Jordana Peake 
 
1. I confirm that I have read and understand the information sheet dated 
27.09.13 version 1.3 for the above study.  I have had the opportunity 
to consider the information, ask questions and have had these 
answered satisfactorily. 
 
   
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected. 
 
   
3. I agree to take part in the above study with the understanding that my 
right to confidentiality will be protected at all times, including only 
anonymised information from the study being included in project 
reports, PhD thesis and publications. 
 
 
   
4. I agree to take part in an interview of about 45 minutes about my 
health and my pre-pregnancy knowledge, attitudes and health 
behaviour. 
 
 
   
5. I agree for the interview to be audio recorded with a digital device.  
Any recordings will be held confidentially and will be stored on secure 
servers at UCL. 
 
 
   
6. I understand that data collected during the study may be looked at by 
individuals from UCL for audit purposes, from regulatory authorities 
or from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my 
data. 
 
 
 
 
   
Please 
initial 
boxes 
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7. I agree to be contacted by the study lead if necessary. 
 
 
 
Name of Patient Signature of Patient Date 
 
 
  
Name person taking consent Signature of person taking consent Date 
 
 
  
Role of person taking consent  
 
 
 
When completed: 1 copy for patient; 1 copy for researcher 
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Topic Guide for In-Depth Interviews 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Aim: To introduce the research and reassure of confidentiality 
 Introduce self, including role at UCL 
 Explain the aims of the research 
 The length of interview 
 Voluntary nature of participation and right to withdraw at any time 
 Introduce audio recorder 
 Stress confidentiality 
 Any questions 
 
1. Background 
Aim: To introduce the respondent and any background information that might be of 
relevance to the study 
 Age 
 Ethnicity 
 Religion 
 Household composition 
 Main daytime activity – whether working or not or occupation of partner 
Aims and objectives 
The overall aim of this study is to explore the pre-pregnancy knowledge, 
attitudes and health behaviour of women from ethnic communities with a 
previous neural tube defect (NTD) affected pregnancy.  
Key objectives to explore: 
 Definition of pre-pregnancy care 
 Knowledge of pre-pregnancy health advice, such as the benefits of 
taking folic acid for NTD prevention. 
 Pre-pregnancy health behaviours 
 Pre-pregnancy views and attitudes 
 Suggestions to improve both knowledge of pre-pregnancy interventions, 
such as taking folic acid, and women acting on this advice. 
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 Any chronic illnesses such as diabetes or epilepsy 
 
 
2. Definition of pre-pregnancy care 
Aim: To start with a broader question and explore what pre-pregnancy care means 
for them 
 What does the term “pre-pregnancy care” mean to them 
o What does pre-pregnancy care include i.e. 
 Folic acid for NTD prevention 
 Avoidance of alcohol, smoking 
 Healthy eating 
 Screening for infectious diseases 
 Immunizations 
 Genetic screening 
 
3. Health advice before pregnancy 
Aim: To establish what pre-pregnancy information was received, specifically the 
benefits of taking folic acid, and by who 
 Any advice given before pregnancy 
o Who gave this advice 
 Were they told about folic acid and what were they told about it i.e.: 
o Its’ role in NTD prevention 
o When it should be taken 
o Dose 
 Any advice given when they became pregnant and when was this advice 
given 
o Who was this advice given by 
 
4. Health behaviours before and during early pregnancy 
Aim: To establish any health behaviours/practices adopted in preparation for or 
during early pregnancy 
 Any particular health behaviour/ practices adopted before getting pregnant 
e.g.: 
o Visiting GP 
o Types of food consumed i.e. vegetarian or not 
o Folic acid use -  when started and for how long 
o Other vitamin use such as B12 
o Ceasing caffeine consumption 
o Ceasing smoking 
o Screening for infectious diseases 
o Immunizations 
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o Genetic screening 
 
 Any particular health behaviour/ practices adopted during pregnancy (see 
list above) 
o At what time point in pregnancy 
 
 Reasons for health behaviours being adopted 
 
 Were particular health behaviours stopped at any point before/during early 
pregnancy and for what reason i.e. 
o Religious reasons 
 
 Febrile illness during early pregnancy 
o Antibiotic and antipyretic use for this 
 
5. Pre-pregnancy views and attitudes 
Aim: To explore barriers and enablers to women accessing and acting on pre-
pregnancy information 
 Importance of pre-pregnancy period 
o Is pre-pregnancy care something that should be invested in 
o Views on pre-pregnancy health interventions 
 Who they most trust to give pre-pregnancy advice 
 Barriers vs. Enablers to women getting pre-pregnancy health advice 
o Unplanned vs. planned pregnancy 
o Information sources 
o Money 
 
6. Suggestions 
Aim: To explore suggestions of how dissemination and uptake of pre-pregnancy 
health advice can be improved 
 What should be done to improve the dissemination of pre-pregnancy health 
messages, such as folic acid use, and women following this advice.  
 
 
Close 
 Thank participant and ask whether they have any further questions 
 Reassure participant again about confidentiality 
 Reimburse travel expenses 
 Ask if they would like to be informed of the study outcomes (and take 
email address if this is how they would like to be informed) 
 
